cimetidine has been researched along with Recrudescence in 426 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Healing with bFGF (and cimetidine) was associated with reduced NSAID induced ulcer relapse in this model of gastric ulceration." | 9.08 | Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration. ( Brough, JL; Filipowicz, B; Hawkey, CJ; Hull, MA; Knifton, A; Vautier, G, 1997) |
| "The use of omeprazole is more effective than cimetidine in increasing intragastric pH and reducing rebleeding episodes in patients with bleeding peptic ulcers after successful endoscopic therapy." | 9.08 | A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. ( Lee, FY; Lin, HJ; Lo, WC; Perng, CL; Tseng, GY, 1998) |
| "We investigated the relationship between histological maturity of healed duodenal ulcer and ulcer recurrence after treatment with omeprazole or cimetidine for 4 weeks." | 9.07 | Histological maturity of healed duodenal ulcer and ulcer recurrence after treatment with omeprazole or cimetidine. ( Chen, SH; Liao, CH; Lien, GS; Pan, S, 1994) |
| "To assess the effect of the H2-antagonist cimetidine in the treatment of patients with interstitial cystitis (IC) refractory to other conservative therapies." | 9.07 | Cimetidine in the treatment of interstitial cystitis. ( Emerson, L; Morales, A; Seshadri, P, 1994) |
| "One hundred and twenty-two patients with confirmed duodenal ulcer were treated with cimetidine during 6 or 12 weeks." | 9.07 | [Effectiveness of maintenance treatment with cimetidine in duodenal ulcer. Variations depending on the risk group]. ( Arín, A; Burusco, MJ; Fortún, MT; Oreja, M; Uribarrena, R; Varela, JI, 1991) |
| "The relationship between histological maturity of healed duodenal ulcers and ulcer recurrence after 6 weeks of treatment with colloidal bismuth subcitrate or cimetidine was investigated." | 9.07 | Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine. ( Chen, SH; Liao, CH; Lien, GS; Pan, SA, 1991) |
| "5 mg twice daily), amantadine (100 mg nocte), or with the H2 blockers cimetidine (800 mg nocte), and famotidine (40 mg nocte) in 124 patients with endoscopically proven duodenal ulcer (DU)." | 9.07 | Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine. ( Duvnjak, M; Jagic, V; Mise, S; Petek, M; Rotkvic, I; Rucman, R; Seiwerth, S; Sikiric, P; Suchanek, E; Zjacic-Rotkvic, V, 1991) |
| "The effect on the recurrence of gastric ulcers after suppression of Helicobacter pylori by combined treatment with cimetidine and the antimicrobial drug cefixime was investigated." | 9.06 | Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime. ( Iishi, H; Ishikawa, H; Okuda, S; Tatsuta, M; Yokota, Y, 1990) |
| "A multicentre maintenance trial was conducted in 63 peptic ulcer patients to investigate the efficacy and safety of continuous cimetidine maintenance therapy for up to 5 years." | 9.06 | Five-year cimetidine maintenance trial for peptic ulcer disease. A clinical and endocrinologic approach. ( Dees, J; Hameeteman, W; Mulder, CJ; Tytgat, GN; van de Boomgaard, DM; Wiersinga, W, 1990) |
| "The effect of cimetidine and pirenzepine on the maintenance of healing in duodenal ulceration has been compared in a multi-centre, controlled study." | 9.06 | Comparison of cimetidine and pirenzepine in the healing and maintenance of remission in duodenal ulcer. ( Gent, AE; Hellier, MD, 1990) |
| "In a double-blind, prospective, randomized trial, the healing effect of somatostatin was compared with that of cimetidine in 67 patients with endoscopically confirmed duodenal ulcer with active bleeding (33 patients were treated with somatostatin, 34 with cimetidine)." | 9.06 | Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: a prospective, randomized, controlled trial. ( Bodnár, A; Gupta, R; Papp, J; Tulassay, Z, 1989) |
| "Sixty patients with chronic gastric ulcer (UGC) received randomly cimetidine (CMT) or ranitidine (RNT) for 2 years, at a dose of 400 mg/night CMT or 150 mg/night RNT, in a prospective, controlled, simple blind clinical trial of these medications and endoscopy findings." | 9.06 | [Ranitidine and cimetidine in long-term (2 years) maintenance therapy of chronic gastric ulcer]. ( Varas, MJ, 1989) |
| "The course of gastritis and Campylobacter pylori was studied in a single-blind randomized trial comparing cimetidine 200 mg three times a day and 400 mg at night and sucralfate 1 g four times a day orally for four weeks in 140 patients with proved duodenal ulcer." | 9.06 | Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori. ( Branicki, FJ; Fok, J; Ho, J; Hui, WM; Lai, CL; Lam, SK; Lau, WY; Lok, AS; Ng, I; Ng, MM, 1989) |
| "Two hundred and seventeen gastric ulcer patients whose ulcers had healed during omeprazole (30 mg) or cimetidine (1 g) treatment entered a follow-up study for 6 months." | 9.06 | Relapse of gastric ulcers after healing with omeprazole and cimetidine. A double-blind follow-up study. Danish Omeprazole Study Group. ( , 1989) |
| "Forty six patients with endoscopically diagnosed duodenal ulceration were randomly allocated to treatment with either sucralfate 1 g qds (n = 24) or cimetidine 200 mg tds and 400 mg nocte (n = 22)." | 9.06 | Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: a light and electron microscopy study. ( Baker, L; Clark, CG; Husband, EM; Jayaraj, AP; Lewin, MR; McPhail, G; Tovey, FI; Yiu, YC, 1989) |
| "A total of 46 patients with duodenal ulcer were randomly assigned, without the knowledge of the investigators, to treatment with cimetidine 200 mg three times daily and 400 mg at night or sucralfate 1 g four times daily followed by one year of maintenance treatment with cimetidine 400 mg at night or sucralfate 1 g twice daily, respectively, in those patients with healed ulcers." | 9.06 | Differences in mucosal appearances and in relapse rates in duodenal ulceration treated with sucralfate or cimetidine. ( Baker, L; Clark, CG; Husband, EM; Jayaraj, AP; Lewin, MR; McPhail, G; Tovey, FI; Yiu, YC, 1989) |
| "The efficacy of pirenzepin--of anticholinergic effect--and the H2-receptor blocking cimetidine has been studied in duodenal ulcer with random, double blind fashion." | 9.06 | [Pirenzepine and cimetidine in the treatment of duodenal ulcer]. ( Papp, J; Schandl, L; Szathmári, M; Tulassay, Z, 1988) |
| "We studied the effect of cimetidine maintenance therapy on the socioeconomic life of patients with gastric ulcers in the year after healing and the extent to which treatment was cost-effective." | 9.06 | The effect of maintenance cimetidine therapy on the medical, social and economic aspects of patients with chronic gastric ulcers. A placebo-controlled prospective study. ( Byth, K; Gellatly, R; Piper, DW; Pym, BM; Seville, P; Toy, S, 1986) |
| "Two hundred and sixty seven patients with duodenal ulceration were entered into a five year study of two strategies of treatment with cimetidine." | 9.06 | Long term management of duodenal ulcer in general practice: how best to use cimetidine? ( Rowley-Jones, D; Wade, AG, 1988) |
| "We compared ranitidine and cimetidine in maintenance therapy to prevent duodenal ulcer recurrence over a period of 24 months." | 9.06 | Prevention of duodenal ulcer occurrence. Double-blind comparison of ranitidine and cimetidine. ( Billington, B; Bolin, TD; Davis, AE, 1987) |
| "We randomly assigned 159 patients with non-ulcer dyspepsia, defined as chronic or recurrent epigastric pain without concomitant symptoms of the irritable bowel syndrome and with no evidence of organic disease, to treatment for three weeks with an antacid suspension one and three hours after meals, 400 mg of cimetidine twice a day, or placebo, according to a double-blind, double-dummy model." | 9.06 | Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. ( Adami, HO; Bates, S; Bergström, R; Gustavsson, S; Lööf, L; Nyberg, A; Nyrén, O, 1986) |
| "Eighty patients with duodenal ulcer were randomly allocated to treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine." | 9.06 | Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. ( Axon, AT; Bradbury, I; Hamilton, I; O'Connor, HJ; Wood, NC, 1986) |
| "The effect of cimetidine (400 mg at night) and of low-dose antacid (400 mg of aluminum hydroxide plus 400 mg of magnesium hydroxide four times a day) given alone or in combination was assessed in a double-blind double-dummy endoscopic trial on prevention of duodenal ulcer (DU)." | 9.06 | Long-term low-dose antacid versus cimetidine therapy in the treatment of duodenal ulcer recurrence. ( Bianchi Porro, G; Lazzaroni, M; Pace, F; Petrillo, M, 1986) |
| "The effects of cimetidine on the healing and recurrence of duodenal ulcers and gastric ulcers were compared." | 9.06 | Effects of cimetidine on the healing and recurrence of duodenal ulcers and gastric ulcers. ( Iishi, H; Okuda, S; Tatsuta, M, 1986) |
| "The effect of combined treatment with sulpiride plus cimetidine was compared against that of cimetidine alone on the healing of duodenal ulcer and on the subsequent relapse rate." | 9.06 | Deduction of duodenal ulcer recurrence by healing with cimetidine plus sulpiride. ( Iishi, H; Okuda, S; Tatsuta, M, 1986) |
| "Fifty-eight patients with endoscopically confirmed benign gastric ulceration were randomly allocated to treatment with 150 mg ranitidine twice daily, placebo matching ranitidine twice daily, or 200 mg cimetidine three times daily and 400 mg at night." | 9.05 | Effect of ranitidine and cimetidine on gastric ulcer healing and recurrence. ( Cockel, R; Dawson, J; Jain, S, 1984) |
| "Sixty-one patients with healed duodenal ulcer were studied during a 12-month maintenance trial with either 150 mg ranitidine at night or 400 mg cimetidine at night." | 9.05 | Comparison of ranitidine and cimetidine maintenance treatment of duodenal ulcer. ( Colin-Jones, DG; Colley, S; Dewar, EP; Frost, RA; Golding, PL; Hunt, RH; Misiewicz, JJ; Shepherd, TH; Trotman, I; Walt, RP, 1984) |
| "In a double-blind randomised trial in 75 patients with duodenal ulceration diagnosed endoscopically, 38 patients were given tripotassium dicitrato bismuthate and 37 cimetidine." | 9.05 | Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. ( Hollanders, D; Martin, DF; May, SJ; Miller, JP; Ravenscroft, MM; Tweedle, DE, 1981) |
| "In a comparative trial of preventive medication for duodenal ulceration with 51 participating centres, 484 patients were recruited for a year's maintenance treatment with the recommended bedtime dose of ranitidine (150 mg; n = 243) or cimetidine (400 mg; n = 241)." | 9.05 | Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial. ( Bardhan, KD; Crowe, JP; Gough, KR; Korman, MG; Lee, FI; Reed, PI; Smith, RN, 1984) |
| "A total of 110 subjects with duodenal ulcer healed with cimetidine (C) (50 patients), ranitidine (R) (40 patients) or pirenzepine (20 patients) was randomly divided in 3 groups." | 9.05 | Ranitidine, cimetidine and antacids in the prevention of recurrence after healed duodenal ulcer: one-year experience. ( Bresci, G; Capria, A; Corsini, G; Federici, G; Geloni, M; Rindi, G, 1983) |
| "The aim of the study was to determine the effectiveness of cimetidine in a dose of 400 mg twice daily in the prevention of gastric ulcer recurrence over a 2-yr period." | 9.05 | A two-year prospective controlled study of maintenance cimetidine and gastric ulcer. ( Barr, GD; Canalese, J; Kang, JY; Piper, DW, 1983) |
| "One hundred and forty six gastric ulcer patients were given open treatment using 1 g cimetidine daily to heal their ulcers." | 9.05 | Effect of cimetidine treatment in the prevention of gastric ulcer relapse: a one year double blind multicentre study. ( Hentschel, E; Horton, J; Judmair, G; Kerstan, E; Reichel, W; Rüdiger, E; Schütze, K; Weiss, W, 1983) |
| "A comparison between cimetidine and tripotassium dicitrato bismuthate liquid (TDB) in the treatment of endoscopically diagnosed duodenal ulcer by single-blind randomized trial in 48 patients has shown 18 (75%) out of 24 patients receiving TDB and 13 (54%) out of 24 patients receiving cimetidine healed after 4 weeks' therapy." | 9.05 | Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers. ( Jones, PE; Klass, HJ; Shreeve, DR, 1983) |
| "In a double-blind study 83 patients with duodenal ulcers, initially healed after treatment with either 1 g cimetidine daily or 50 mg trimipramine daily, were allocated by randomization to maintenance treatment with either 400 mg cimetidine daily, 25 mg trimipramine daily, or placebo for 6 months." | 9.05 | Relapse prevention of duodenal ulcers with trimipramine, cimetidine, or placebo. A double-blind comparison. ( Becker, U; Faurschou, P; Jensen, J; Lindorff, K; Pedersen, PB; Ranløv, PJ, 1984) |
| "Three hundred seventy patients with recently healed duodenal ulcer entered into a one-year, double-blind, randomized multicenter trial comparing placebo with three different dose schedules of cimetidine (200 mg twice a day, 300 mg twice a day, and 400 mg at bedtime) for the prevention of recurrent duodenal ulcer." | 9.05 | Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. ( Archambault, A; Belsito, A; Cohen, N; Davis, W; Farley, A; Graham, DY; Grunt, R; Kinnear, D; Sontag, S; Weiss, J, 1984) |
| "The rate of endoscopically confirmed gastric ulcer relapse was compared in two groups of patients with newly healed benign gastric ulcers, receiving either cimetidine 400 mg nocte or matching placebo, over a period of 1 year." | 9.05 | The effect of cimetidine on the maintenance of healing of gastric ulceration. ( Kinloch, JD; Pearson, AJ; Woolf, IL; Young, PH, 1984) |
| " Fifty-five patients with acute bleeding from chronic duodenal ulcers with SRH completed a randomized double-blind trial to assess the effect of administration of cimetidine (800 mg daily intravenously for 2 days, then 1000 mg daily orally for 10 days in divided doses) versus placebo on rebleeding and need for emergency surgery." | 9.05 | Cimetidine reduces the risk of rebleeding from duodenal ulcers displaying signs of recent haemorrhage. ( Barnes, PR; Byth, K; Heap, TR; Ruppin, DC; Stiel, D, 1984) |
| "Forty-four patients with chronic duodenal ulceration were allocated randomly to either long-term maintenance treatment with cimetidine or proximal gastric vagotomy." | 9.05 | Proximal gastric vagotomy versus long-term maintenance treatment with cimetidine for chronic duodenal ulcer: a prospective randomised trial. ( Gear, MW, 1983) |
| "Relapse rates of duodenal ulcer after treatment with sucralfate or cimetidine were investigated in a one-year follow-up study." | 9.05 | [Recurrence of duodenal ulcer after therapy with Sucralfat or cimetidine]. ( Dufek, W; Hentschel, E; Schütze, K, 1984) |
| "The effect of pirenzepine and cimetidine on healing, symptoms and relapse rate of duodenal ulcer was studied in a placebo-controlled double-blind trial." | 9.05 | Treatment and relapse prophylaxis of duodenal ulcer with pirenzepine and cimetidine. ( Birchler, R; Blum, AL; Eichenberger, PM; Giger, M; Gonvers, JJ; Mattle, W; Müller-Lissner, SA; Pelloni, S, 1982) |
| "In a randomised open study of 28 outpatients with endoscopically proven duodenal ulcers, 14 patients were treated with colloidal bismuth subcitrate (CBS) and 14 patients with cimetidine tablets." | 9.05 | A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer. ( Janssens, J; Rutgeerts, P; Schuurmans, P; Vantrappen, G, 1982) |
| "Colloidal bismuth subcitrate (CBS, DE-NOL) and cimetidine have been compared in a double-blind randomized trial in the management of 75 patients with duodenal ulcer." | 9.05 | Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate. ( Hollanders, D; Martin, DF; Miller, JP; Ravenscroft, MM; Tweedle, DE, 1982) |
| "Forty-Five consecutive patients with chronic peptic ulcer disease completed a double-blind controlled trial in which they were given cimetidine 0." | 9.05 | Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence. ( Danielsson, A; Ek, B; Steen, L, 1981) |
| "Cimetidine 1 g daily is often continued for a fixed period beyond the time of healing of duodenal ulcer on the assumption that it might reduce the subsequent relapse rate." | 9.05 | Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate? ( Bardhan, KD; Cole, DS; Franks, CR; Hawkins, BW, 1982) |
| "The long term effect of 400 mg cimetidine ingested at various times on ulcer recurrence and drug compliance was investigated in 66 patients with severe course of duodenal ulcer, now healed." | 9.05 | [Long-term prevention of duodenal ulcer with cimetidine. Effect of the rhythm of ingestion and drug compliance on the incidence of recurrence]. ( Hausmann, L; Heuser, E; Massarrat, S; Schubotz, R, 1982) |
| "Patients with a healed duodenal ulcer and who were symptom-free following 12 months of maintenance treatment with cimetidine 400 mg twice daily were randomized double-blind to a further 6 months therapy with either cimetidine 400 mg twice daily or placebo 2 tablets twice daily." | 9.05 | Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study. ( Don, G; Hansky, J; Hetzel, DJ; Korman, MG; Shearman, DJ, 1980) |
| "This double-blind controlled trial compares the relapse rate in 19 duodenal ulcer patients who received cimetidine for eight weeks with that in 19 patients who received cimetidine for four weeks and inactive tablets for four weeks." | 9.05 | Recurrence of duodenal ulcer pain after treatment with cimetidine for four and eight weeks. ( Greibe, J; Madsen, JR; Møllman, KM; Rahbek, I; Rune, SJ; Willumsen, L; Wulff, HR, 1980) |
| "Comparison of cimetidine and placebo in the prevention of recurrence of ulceration was carried out in the study of 696 patients with recently healed duodenal ulcers." | 9.05 | Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study. ( Beresford, J; Burland, WL; Hawkins, BW, 1980) |
| "The healing-rate of duodenal ulcer after short-term treatment with carbenoxolone was not significantly different from that after treatment with cimetidine." | 9.05 | Controlled trial of carbenoxolone sodium vs. cimetidine in duodenal ulcer. ( Domschke, W; Rösch, W; Schenk, J; Schmack, B, 1980) |
| "Twenty patients with gastric ulcer received treatment with cimetidine." | 9.05 | Long-term treatment of gastric ulcer with cimetidine. ( Da Silva, EP; Zaterka, S, 1981) |
| "The effect of pirenzepine and cimetidine on healing, symptoms, and relapse rate of duodenal ulcer was studied in a placebo controlled double blind trial." | 9.05 | [Treatment and prevention of recurrence of duodenal ulcer with pirenzepin and cimetidine]. ( Birchler, R; Blum, AL; Eichenberger, PM; Giger, M; Gonvers, JJ; Mattle, W; Müller-Lissner, SA; Pelloni, S, 1982) |
| "Sixty patients, whose duodenal ulcers had healed endoscopically after six weeks of treatment with cimetidine 1 g/day in divided doses, were treated with maintenance cimetidine 800 mg at bedtime for six months." | 9.05 | Bedtime cimetidine maintenance treatment: optimum dose and effect on subsequent natural history of duodenal ulcer. ( Blackwood, WS; Fitzpatrick, WJ; Northfield, TC, 1982) |
| "One hundred patients with benign gastric ulceration were treated in a single-blind, endoscopically controlled trial to assess the relative efficacy of cimetidine (1 g daily) and Caved-S (six tablets daily)." | 9.05 | Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. ( Darnborough, A; McAdam, WA; Morgan, AG; Pacsoo, C, 1982) |
| "The aim of the study was to compare the use of cimetidine and colloidal bismuth in the initial healing of chronic duodenal ulcer and to note the recurrence rate over 1 year after healing induced by both forms of treatment." | 9.05 | Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing. ( Kang, JY; Piper, DW, 1982) |
| "The effectiveness of cimetidine or antacid in healing recurrent jejunal peptic ulcers after Billroth II gastric resection without vagotomy was tested in a randomized study of 18 in-patients." | 9.05 | [Treatment of jejunal peptic ulcer with cimetidine or an antacid? Results of a long-term study]. ( Grönniger, J; Herzog, P; Holtermüller, KH; Rothmund, M; Weis, H, 1982) |
| "We conducted a double-blind randomized study of 132 patients to determine whether the new, investigational proton-pump inhibitor, omeprazole (30 mg per day), would accelerate healing and pain relief, as compared with cimetidine (1 g per day), in patients with duodenal ulcer." | 9.05 | Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. ( Andersen, HH; Bendtsen, F; Bytzer, P; Højlund, M; Jensen, KG; Kelbaek, H; Lauritsen, K; Linde, J; Rask-Madsen, J; Rune, SJ, 1985) |
| "Recurrence rates of chronic duodenal ulcer after initial therapy with pirenzepine or cimetidine were investigated in a prospective, randomized trial with a total of 80 patients." | 9.05 | [Recurrence of chronic duodenal ulcer following initial therapy with pirenzepine or cimetidine]. ( Dufek, W; Hentschel, E; Schütze, K, 1985) |
| "Patients with recently healed duodenal ulcers were enrolled at 14 participating centers in a 12-month study comparing the effectiveness of ranitidine and cimetidine, two H2-receptor blockers, for maintenance therapy." | 9.05 | Final report on the United States Multicenter Trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer. ( Silvis, SE, 1985) |
| "The effects of two dosage levels of a synthetic prostaglandin E1 analogue, misoprostol, and cimetidine on short-term duodenal ulcer healing were compared in a double-blind, endoscopically controlled 4-week study." | 9.05 | Misoprostol, a synthetic prostaglandin E1 analogue, in the treatment of duodenal ulcers. A double-blind, cimetidine-controlled trial. ( Mannion, G; Naiker, N; O'Keefe, SJ; Spitaels, JM, 1985) |
| "The aim of this study was to gain experience regarding the efficacy and safety of cimetidine 400 mg nightly for the long-term maintenance treatment of peptic ulcers three years." | 9.05 | Long term cimetidine therapy for the prevention of recurring peptic ulcer: a multicenter study. ( Rohner, HG, 1985) |
| "68 patients with chronic peptic ulcer took part in a double-blind trial in which 32 received the histamine H2-receptor antagonist cimetidine, (400 mg twice daily) and 36 received a placebo, for a year." | 9.04 | Maintenance treatment of recurrent peptic ulcer by cimetidine. ( Bodemar, G; Walan, A, 1978) |
| "In an open trial, 96 patients with endoscopically proven peptic ulcers were randomly allocated to treatment with cimetidine (1 g/day) for periods of 3, 6, 9, or 12 months." | 9.04 | Very long-term treatment of peptic ulcer with cimetidine. ( Cargill, JM; Peden, N; Saunders, JH; Wormsley, KG, 1978) |
| "The published world literature on the efficacy of cimetidine, a histamine H2-receptor antagonist, in the treatment of duodenal ulcer is reviewed." | 9.04 | Cimetidine in the treatment of duodenal ulcer: review and commentary. ( Winship, DH, 1978) |
| "Fifty-seven symptom-free patients with duodenal ulcer entered a double-blind trial to assess the prophylactic effect of cimetidine." | 9.04 | Prophylactic effect of cimetidine in duodenal ulcer disease. ( Gudmand-Høyer, E; Jensen, KB; Krag, E; Rahbek, I; Rask-Madsen, J; Rune, SJ; Wulff, HR, 1978) |
| "Sixty patients with endoscopically confirmed gastric ulceration took part in a single-blind trial of cimetidine 1 g daily compared with conventional treatment--namely, carbenoxolone in patients aged under 60 and Caved-(S) in those over 60." | 9.04 | Cimetidine: an advance in gastric ulcer treatment? ( McAdam, WA; Morgan, AG; Pacsoo, C; Simmons, AV; Walker, BE, 1978) |
| "Patients suffering from chronic duodenal ulceration were allocated at random to treatment with either cimetidine (400 mg twice daily) or matching placebo for six months." | 9.04 | Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. ( Bardhan, KD; Duthie, HL; Edwards, JL; Fussey, IV; Haggie, SJ; Saul, DM; Smith, PM; Wyllie, JH, 1979) |
| "Nineteen patients entered a double-blind randomized trial of the prophylactic effect of cimetidine in gastric ulcer disease." | 9.04 | Prophylactic effect of cimetidine in gastric ulcer patients. ( Jensen, KB; Madsen, JR; Møllmann, KM; Rahbek, I; Rune, SJ; Wulff, HR, 1979) |
| "Forty patients with chronic duodenal ulcer who had healed endoscopically with a 6-week course of cimetidine were randomized double blind to 1 year of either placebo or cimetidine tablets 400 mg bid (20 patients in each group)." | 9.04 | Long-term cimetidine in duodenal ulcer disease. ( Hansky, J; Korman, MG, 1979) |
| "Forty-two patients with endoscopically diagnosed duodenal ulcer were studied in a double-blind trial after their ulcers had been healed with cimetidine." | 9.04 | Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects. ( Batchelor, AJ; Dronfield, MW; Langman, MJ; Larkworthy, W, 1979) |
| "Fifty-one patients with duodenal ulcer which was healed by a six-week course of cimetidine completed a one-year double-blind study to compare the effects of cimetidine and placebo on the prevention of ulcer relapse." | 9.04 | Prevention of duodenal ulcer relapse by cimetidine: a one-year double-blind trial. ( Hecker, R; Hetzel, DJ; Shearman, DJ; Sheers, R, 1979) |
| "Fifty-eight patients with endoscopically verified duodenal ulcers were treated with cimetidine, 1 g/day, for 6--10 weeks." | 9.04 | Maintenance treatment of duodenal ulcer patients with a single bedtime dose of cimetidine. ( Aadland, E; Berstad, A; Carlsen, E; Kruse-Jensen, A; Myren, J; Semb, LS, 1979) |
| "The effect of long-term prophylaxis of duodenal ulceration with cimetidine was tested in a double blind trial." | 9.04 | [Prevention of duodenal ulcer recurrence with cimetidine (author's transl)]. ( Blum, AL; Kiene, K; Pelloni, S; Peter, P; Sonnenberg, A; Strohmeyer, G; Weber, KB; Wienbeck, M, 1979) |
| "Twenty-five patients with healed gastric ulcers completed an 11-month double-blind controlled trial comparing cimetidine 1 g daily with placebo in the prevention of ulcer relapse." | 9.04 | Cimetidine in the prevention of gastric ulcer relapse. ( Ciclitira, PJ; Dick, AP; Farthing, MJ; Hunter, JO; Machell, RJ, 1979) |
| "Cimetidine therapy in gastric ulcer disease has been evaluated in four complete and one incomplete controlled, double blind trials." | 9.04 | Cimetidine in the treatment of gastric ulcer: review and commentary. ( Freston, JW, 1978) |
| "In a double-blind trial of patients with duodenal ulcer at three centres the healing rate after a four-week course of treatment (1 g cimetidine daily) was 79% (30 out of 38 patients), compared with 58% (23 out of 40 patients) on placebos." | 9.04 | [Cimetidine in the treatment of duodenal ulcer (author's transl)]. ( Blum, AL; Gonvers, JJ; Hofstetter, JR; Kiene, K; Pelloni, S; Peter, P; Richter, O; Schmitz, H; Sonnenberg, A; Strohmeyer, G; Weber, K, 1978) |
| "Effect of lafutidine ((+/-)-2-(furfurylsulfinyl)-N-[4-[4-(piperidinomethyl)-2-pyr idyl] oxy-(Z)-2-butenyl] acetamide, FRG-8813), a novel antiulcer agent, on the healing and relapse in acetic acid-induced gastric ulcer in rats was investigated." | 7.70 | [Effect of lafutidine, a novel antiulcer agent, on healing and relapse of acetic acid-induced gastric ulcer in rats]. ( Aoyama, M; Arai, Y; Ohnishi, H; Onodera, S; Shibata, M; Tanaka, M; Yamaura, T, 1998) |
| "This study was done to elucidate whether rebamipide during the initial period of acetic acid-induced gastric ulcer affected healing and future ulcer relapse." | 7.69 | Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. ( Arakawa, T; Fukuda, T; Kobayashi, K; Watanabe, T; Yamasaki, K, 1995) |
| "We found indomethacin aggravates healed gastric ulcers (ulcer relapse) in rats." | 7.69 | Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor. ( Asano, S; Inada, I; Maeda, R; Murakami, I; Sato, F; Satoh, H; Shino, A, 1997) |
| "The aim of this study is to propose a regimen of omeprazole 20 mg twice weekly for the prevention of duodenal ulcer (DU) relapse." | 7.68 | [Study on omeprazole 20 mg twice weekly in prevention of duodenal ulcer relapse]. ( Bei, L; Chen, SP; Wen, SH, 1993) |
| "45 patients with uncomplicated duodenal ulcer who did not respond to cimetidine underwent elective proximal gastric vagotomy (PGV)." | 7.67 | Failure of proximal gastric vagotomy for duodenal ulcer resistant to cimetidine. ( Hansen, JH; Knigge, U, 1984) |
| "The incidence of duodenal ulcer relapse after initial therapy with concentrated aluminium-magnesium hydroxide (Maalox 70) or cimetidine (Tagamet) was investigated in a one-year follow-up study." | 7.67 | Relapse rates of duodenal ulcer healed with concentrated antacid or cimetidine. ( Dufek, W; Hentschel, E; Schuetze, K, 1984) |
| "Healing rates were examined retrospectively in 124 outpatients with peptic ulcer who had received cimetidine for at least four weeks." | 7.67 | Unsuccessful cimetidine treatment of peptic ulcer: analysis of the factors involved. ( Angelini, GP; Celli, L; Granelli, P, 1984) |
| "Fifty five patients with severe longstanding dyspepsia originally selected as candidates for elective duodenal ulcer surgery were instead entered into a maintenance cimetidine study." | 7.67 | Maintenance cimetidine instead of surgery for duodenal ulcer: the first decade. ( Gillespie, G; Gray, GR; Hansell, DT; McGushin, M; Meddings, RN; Smith, IS, 1989) |
| "253 patients were treated for 3 years with 400 mg cimetidine at night to prevent relapses of recently healed duodenal ulcers." | 7.67 | [3-year long-term therapy of recurrent duodenal ulcer with 400 mg cimetidine nocte]. ( Brandstätter, G; Hentschel, E; Judmaier, G; Kerstan, E; Kratochvil, P; Reichel, W; Rüdiger, E; Schütze, K; Weiss, W, 1987) |
| "Chronic gastric ulcers were produced by injection of 20% acetic acid (0." | 7.67 | Effects of trimoprostil on healing and recurrence of acetic acid-induced gastric ulcer in rats. ( Nakamura, K; Umeda, Y, 1986) |
| "In this retrospective study, a cohort of gastric ulcer patients treated with antacids was compared with a well-matched group of patients treated with a combination of antacids and cimetidine." | 7.67 | Effect of cimetidine on healing and surgical treatment of gastric ulcers. ( Haddad, W; Kestenbaum, DJ; Wang, HS, 1985) |
| "Eighty two patients with an endoscopically healed gastric ulcer, were treated for two years with either Caved-S tablets, two twice daily or cimetidine 400 mg at night." | 7.67 | Maintenance therapy: a two year comparison between Caved-S and cimetidine treatment in the prevention of symptomatic gastric ulcer recurrence. ( McAdam, WA; Morgan, AG; Pacsoo, C, 1985) |
| "The authors here present a work dealing pith two groups of subjects, both groups having the diagnose of bleeding duodenal ulcer; one group using therapy antacid alone, the other using cimetidine and antacid." | 7.66 | [Short-term effects of cimetidine in patients with bleeding duodenal ulcer. Presentation of cases]. ( Monti, G; Rumi, A; Testone, G; Uggeri, G, 1983) |
| "A total of 60 patients with endoscopically diagnosed duodenal ulcer were treated with pirenzepine or cimetidine for 8-10 weeks until endoscopic healing of the ulcer." | 7.66 | Pirenzepine in long-term therapy for duodenal ulcer. ( Bresci, G; Capria, A; Del Tacca, M; Geloni, M; Polloni, A; Rindi, G, 1983) |
| "Twenty-one patients with duodenal ulcer were treated with cimetidine." | 7.66 | The value of the new interpretation of the insulin test in predicting duodenal ulcer relapse after treatment with cimetidine. ( Carr-Locke, DL; Maybury, NK, 1980) |
| "Twenty-two duodenal and 16 gastric ulcer patients were treated with 400 mg cimetidine twice daily for one year after their ulcers had healed." | 7.66 | Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers. ( Festen, HP; Lamers, CB; Tangerman, A; van Tongeren, JH, 1980) |
| "Patients with symptomatic duodenal ulcer can be effectively treated with antacids or cimetidine." | 7.66 | Treating duodenal ulcer: antacids or cimetidine? ( Feinberg, LE, 1980) |
| "Intermittent treatment with short courses of cimetidine given only when symptoms recurred was assessed in patients with duodenal ulcer as an alternative to maintenance treatment." | 7.66 | Intermittent treatment of duodenal ulcer with cimetidine. ( Bardhan, KD, 1980) |
| " The misoprostol healing rates obtained in duodenal ulcer and gastric ulcer therapy at 200 micrograms qid are not significantly different from those seen in the same studies with cimetidine at a dose of 300 mg qid." | 6.15 | Overview of misoprostol clinical experience. ( Herting, RL; Nissen, CH, 1986) |
| " Duodenal ulcer relapse following healing and withdrawal of active therapy has been studied in 18 prospectively randomised comparative studies involving cimetidine and alternative healing agents." | 6.15 | The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome. ( Byrne, AJ; Dudley, FJ; Harrison, PM; Ioannides-Demos, L; McCarthy, P; McLean, AJ, 1985) |
| "Recent controlled clinical trials have shown that acute episodes of duodenal ulcer can be treated successfully with either anti-secretory (cimetidine), mucosa-protective (carbenoxolone, organic bismuth preparation) or antacid drugs." | 6.14 | Medical treatment of duodenal ulcer. ( Misiewicz, JJ, 1979) |
| "The influence of KU-1257 on the recurrence and relapse of acetic acid ulcers in rats was investigated grossly and histologically in comparison with that of cimetidine." | 5.29 | [Influence of KU-1257 on the recurrence and relapse of acetic acid-induced chronic gastric ulcers in rats]. ( Kobayashi, F; Ohkubo, H; Ohsawa, A; Sekiguchi, H; Taga, F, 1996) |
| "Operative management also reduces recurrence rates, which, however, are commoner in patients coming to surgery nowadays." | 5.28 | High doses of ranitidine in maintenance therapy of duodenal ulcer patients. ( Lee, FI, 1990) |
| "Relapse was defined as the recurrence of an ulcer crater or erosions or both." | 5.27 | Low dose maintenance treatment with cimetidine in duodenal ulcer: intermediate-term results. ( Bardhan, KD; Bose, K; Hinchliffe, RF, 1986) |
| "The problem of recurrence is addressed." | 5.26 | Peptic ulcer: antacids or cimetidine? ( McCarthy, DM, 1979) |
| " Eighty-five patients with benign gastric ulcer were divided into four groups: treated with antacids (I), cimetidine (II), ranitidine (III), and colloidal bismuth subcitrate (De-Nol) (IV)." | 5.08 | Healing of gastric body ulcer with gastroprotective versus antisecretory treatment. ( Jablonská, M, 1995) |
| "There is little information on the natural history of refractory gastric ulcer, defined as non-healing on cimetidine > or = 1 g daily given for at least 3 months." | 5.08 | The management of refractory gastric ulcer using H2-receptor antagonists. ( Bardhan, KD; Beresford, J; Raju, GS; Royston, C, 1996) |
| "Healing with bFGF (and cimetidine) was associated with reduced NSAID induced ulcer relapse in this model of gastric ulceration." | 5.08 | Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration. ( Brough, JL; Filipowicz, B; Hawkey, CJ; Hull, MA; Knifton, A; Vautier, G, 1997) |
| "The use of omeprazole is more effective than cimetidine in increasing intragastric pH and reducing rebleeding episodes in patients with bleeding peptic ulcers after successful endoscopic therapy." | 5.08 | A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. ( Lee, FY; Lin, HJ; Lo, WC; Perng, CL; Tseng, GY, 1998) |
| "We investigated the relationship between histological maturity of healed duodenal ulcer and ulcer recurrence after treatment with omeprazole or cimetidine for 4 weeks." | 5.07 | Histological maturity of healed duodenal ulcer and ulcer recurrence after treatment with omeprazole or cimetidine. ( Chen, SH; Liao, CH; Lien, GS; Pan, S, 1994) |
| "To assess the effect of the H2-antagonist cimetidine in the treatment of patients with interstitial cystitis (IC) refractory to other conservative therapies." | 5.07 | Cimetidine in the treatment of interstitial cystitis. ( Emerson, L; Morales, A; Seshadri, P, 1994) |
| "Four hundred and two patients with peptic ulcer were selected for acute therapy with either pirenzepine (100 mg/day) or cimetidine (800 mg/day) using the envelope method." | 5.07 | Predictors of relapse in peptic ulcer. ( Asaki, S; Inoue, S; Ishimori, A; Kano, A; Kawakami, K; Kawamura, T; Koizumi, F; Takahashi, T, 1992) |
| "We randomized 785 patients with healed duodenal ulcer to receive: (1) no treatment; (2) mealtime antacids with an acid-neutralizing capacity of 80 mmol/day; (3) an antidepressant, trimipramine 25 mg; (4) an anticholinergic, pirenzepine 50 mg; (5) cimetidine 200 mg; (6) cimetidine 400 mg; (7) ranitidine 150 mg; or (8) sucralfate 1 g twice a day." | 5.07 | Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment. ( Hui, WM; Lai, CL; Lam, SK; Lok, AS; Ng, MM, 1992) |
| "As part of an open clinical trial, 18 out of 23 (78%) patients were treated with bismuth subnitrate (3 x 700 mg/d) and 15 out of 25 (60%) patients were treated with cimetidine (1 x 800 mg/d) to cure peptic ulcers linked with H." | 5.07 | Ulcer relapse rates following initial treatment with bismuth subnitrate as compared with cimetidine respectively. ( Eberhardt, R; Kuhn, D; Mateblowski, M; Topfmeier, P, 1991) |
| "One hundred and twenty-two patients with confirmed duodenal ulcer were treated with cimetidine during 6 or 12 weeks." | 5.07 | [Effectiveness of maintenance treatment with cimetidine in duodenal ulcer. Variations depending on the risk group]. ( Arín, A; Burusco, MJ; Fortún, MT; Oreja, M; Uribarrena, R; Varela, JI, 1991) |
| "The relationship between histological maturity of healed duodenal ulcers and ulcer recurrence after 6 weeks of treatment with colloidal bismuth subcitrate or cimetidine was investigated." | 5.07 | Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine. ( Chen, SH; Liao, CH; Lien, GS; Pan, SA, 1991) |
| "5 mg twice daily), amantadine (100 mg nocte), or with the H2 blockers cimetidine (800 mg nocte), and famotidine (40 mg nocte) in 124 patients with endoscopically proven duodenal ulcer (DU)." | 5.07 | Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine. ( Duvnjak, M; Jagic, V; Mise, S; Petek, M; Rotkvic, I; Rucman, R; Seiwerth, S; Sikiric, P; Suchanek, E; Zjacic-Rotkvic, V, 1991) |
| "The effect on the recurrence of gastric ulcers after suppression of Helicobacter pylori by combined treatment with cimetidine and the antimicrobial drug cefixime was investigated." | 5.06 | Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime. ( Iishi, H; Ishikawa, H; Okuda, S; Tatsuta, M; Yokota, Y, 1990) |
| "Twenty three children with coexistent duodenal ulcer and Helicobacter pylori infection were treated with either two weeks of amoxycillin (25 mg/kg/day) in addition to six weeks of cimetidine, or cimetidine alone." | 5.06 | Helicobacter pylori and associated duodenal ulcer. ( Branicki, FJ; Fu, KH; Ng, WF; Saing, H; Tsang, TM; Yeung, CK; Yuen, KY, 1990) |
| "A multicentre maintenance trial was conducted in 63 peptic ulcer patients to investigate the efficacy and safety of continuous cimetidine maintenance therapy for up to 5 years." | 5.06 | Five-year cimetidine maintenance trial for peptic ulcer disease. A clinical and endocrinologic approach. ( Dees, J; Hameeteman, W; Mulder, CJ; Tytgat, GN; van de Boomgaard, DM; Wiersinga, W, 1990) |
| "The effect of cimetidine and pirenzepine on the maintenance of healing in duodenal ulceration has been compared in a multi-centre, controlled study." | 5.06 | Comparison of cimetidine and pirenzepine in the healing and maintenance of remission in duodenal ulcer. ( Gent, AE; Hellier, MD, 1990) |
| "In a double-blind, prospective, randomized trial, the healing effect of somatostatin was compared with that of cimetidine in 67 patients with endoscopically confirmed duodenal ulcer with active bleeding (33 patients were treated with somatostatin, 34 with cimetidine)." | 5.06 | Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: a prospective, randomized, controlled trial. ( Bodnár, A; Gupta, R; Papp, J; Tulassay, Z, 1989) |
| "Following a multicenter, double-blind trial comparing cimetidine, antacid, and placebo for the treatment of gastric ulcer, patients whose ulcers had healed were followed prospectively to assess the frequency of ulcer relapse." | 5.06 | Gastric ulcer recurrence: follow-up of a double-blind, placebo-controlled trial. ( Gertler, SL; Isenberg, JI; Peterson, WL; Sandersfeld, MA; Wolosin, JD, 1989) |
| "Sixty patients with chronic gastric ulcer (UGC) received randomly cimetidine (CMT) or ranitidine (RNT) for 2 years, at a dose of 400 mg/night CMT or 150 mg/night RNT, in a prospective, controlled, simple blind clinical trial of these medications and endoscopy findings." | 5.06 | [Ranitidine and cimetidine in long-term (2 years) maintenance therapy of chronic gastric ulcer]. ( Varas, MJ, 1989) |
| "The course of gastritis and Campylobacter pylori was studied in a single-blind randomized trial comparing cimetidine 200 mg three times a day and 400 mg at night and sucralfate 1 g four times a day orally for four weeks in 140 patients with proved duodenal ulcer." | 5.06 | Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori. ( Branicki, FJ; Fok, J; Ho, J; Hui, WM; Lai, CL; Lam, SK; Lau, WY; Lok, AS; Ng, I; Ng, MM, 1989) |
| "Two hundred and seventeen gastric ulcer patients whose ulcers had healed during omeprazole (30 mg) or cimetidine (1 g) treatment entered a follow-up study for 6 months." | 5.06 | Relapse of gastric ulcers after healing with omeprazole and cimetidine. A double-blind follow-up study. Danish Omeprazole Study Group. ( , 1989) |
| "Forty six patients with endoscopically diagnosed duodenal ulceration were randomly allocated to treatment with either sucralfate 1 g qds (n = 24) or cimetidine 200 mg tds and 400 mg nocte (n = 22)." | 5.06 | Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: a light and electron microscopy study. ( Baker, L; Clark, CG; Husband, EM; Jayaraj, AP; Lewin, MR; McPhail, G; Tovey, FI; Yiu, YC, 1989) |
| "A total of 46 patients with duodenal ulcer were randomly assigned, without the knowledge of the investigators, to treatment with cimetidine 200 mg three times daily and 400 mg at night or sucralfate 1 g four times daily followed by one year of maintenance treatment with cimetidine 400 mg at night or sucralfate 1 g twice daily, respectively, in those patients with healed ulcers." | 5.06 | Differences in mucosal appearances and in relapse rates in duodenal ulceration treated with sucralfate or cimetidine. ( Baker, L; Clark, CG; Husband, EM; Jayaraj, AP; Lewin, MR; McPhail, G; Tovey, FI; Yiu, YC, 1989) |
| "Of 113 patients in whom endoscopy revealed a bleeding gastric or duodenal ulcer 55 were randomly allocated to receive endoscopic sclerosis (ES) (injections of adrenaline/polidocanol) plus cimetidine while 58 received cimetidine alone as controls." | 5.06 | Controlled trial of endoscopic sclerosis in bleeding peptic ulcers. ( Forné, M; Garau, J; Garcia-Olivares, E; Marco, C; Panés, J; Viver, J, 1987) |
| "The efficacy of pirenzepin--of anticholinergic effect--and the H2-receptor blocking cimetidine has been studied in duodenal ulcer with random, double blind fashion." | 5.06 | [Pirenzepine and cimetidine in the treatment of duodenal ulcer]. ( Papp, J; Schandl, L; Szathmári, M; Tulassay, Z, 1988) |
| "We studied the effect of cimetidine maintenance therapy on the socioeconomic life of patients with gastric ulcers in the year after healing and the extent to which treatment was cost-effective." | 5.06 | The effect of maintenance cimetidine therapy on the medical, social and economic aspects of patients with chronic gastric ulcers. A placebo-controlled prospective study. ( Byth, K; Gellatly, R; Piper, DW; Pym, BM; Seville, P; Toy, S, 1986) |
| "Two hundred and sixty seven patients with duodenal ulceration were entered into a five year study of two strategies of treatment with cimetidine." | 5.06 | Long term management of duodenal ulcer in general practice: how best to use cimetidine? ( Rowley-Jones, D; Wade, AG, 1988) |
| "We compared ranitidine and cimetidine in maintenance therapy to prevent duodenal ulcer recurrence over a period of 24 months." | 5.06 | Prevention of duodenal ulcer occurrence. Double-blind comparison of ranitidine and cimetidine. ( Billington, B; Bolin, TD; Davis, AE, 1987) |
| "In a Swedish multicenter double blind trial cimetidine was compared to sucralfate in the treatment of peptic ulcer." | 5.06 | Treatment of peptic ulcers--acid reduction or cytoprotection? ( Carling, L; Glise, H; Hallerbäck, B; Kagevi, I; Solhaug, JH; Svedberg, LE; Wahlby, L, 1987) |
| "We randomly assigned 159 patients with non-ulcer dyspepsia, defined as chronic or recurrent epigastric pain without concomitant symptoms of the irritable bowel syndrome and with no evidence of organic disease, to treatment for three weeks with an antacid suspension one and three hours after meals, 400 mg of cimetidine twice a day, or placebo, according to a double-blind, double-dummy model." | 5.06 | Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. ( Adami, HO; Bates, S; Bergström, R; Gustavsson, S; Lööf, L; Nyberg, A; Nyrén, O, 1986) |
| "Eighty patients with duodenal ulcer were randomly allocated to treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine." | 5.06 | Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. ( Axon, AT; Bradbury, I; Hamilton, I; O'Connor, HJ; Wood, NC, 1986) |
| "Forty-two patients, 35 with duodenal ulcer, 6 with prepyloric ulcer, and 1 with gastric ulcer, were, in accordance with their own choice, allocated to either maintenance therapy with cimetidine or intermittent therapy in connection with symptoms and endoscopically proven relapse." | 5.06 | Results of long-term treatment with cimetidine. ( Worning, H, 1986) |
| "The aim of the present investigation was to compare the efficacy of a low-dose antacid (Maalox 70, 280 mmol/day) with that of the H2-receptor antagonist cimetidine (Tagamet, 200 mg three times daily and 400 mg/day) after 14 and 28 days in the treatment of duodenal ulcer." | 5.06 | Treatment of duodenal ulcer with low-dose antacids. ( Brunner, H; Hentschel, H; Lederer, PC; Lux, G; Rohner, HG; Rösch, W; Schütze, K, 1986) |
| "The effect of cimetidine (400 mg at night) and of low-dose antacid (400 mg of aluminum hydroxide plus 400 mg of magnesium hydroxide four times a day) given alone or in combination was assessed in a double-blind double-dummy endoscopic trial on prevention of duodenal ulcer (DU)." | 5.06 | Long-term low-dose antacid versus cimetidine therapy in the treatment of duodenal ulcer recurrence. ( Bianchi Porro, G; Lazzaroni, M; Pace, F; Petrillo, M, 1986) |
| "A unicenter, single-blind, randomized study was conducted on 283 patients with active duodenal ulcer to compare possible factors that may affect healing and relapse in patients treated with a potent antisecretory agent, cimetidine, or a site-protective and cytoprotective agent, sucralfate." | 5.06 | Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. ( Branicki, FJ; Choi, TK; Fok, PJ; Hui, WM; Lai, CL; Lam, SK; Lau, WY; Lok, AS; Ng, MM; Poon, GP, 1987) |
| "The effects of cimetidine on the healing and recurrence of duodenal ulcers and gastric ulcers were compared." | 5.06 | Effects of cimetidine on the healing and recurrence of duodenal ulcers and gastric ulcers. ( Iishi, H; Okuda, S; Tatsuta, M, 1986) |
| "The effect of combined treatment with sulpiride plus cimetidine was compared against that of cimetidine alone on the healing of duodenal ulcer and on the subsequent relapse rate." | 5.06 | Deduction of duodenal ulcer recurrence by healing with cimetidine plus sulpiride. ( Iishi, H; Okuda, S; Tatsuta, M, 1986) |
| "Fifty-eight patients with endoscopically confirmed benign gastric ulceration were randomly allocated to treatment with 150 mg ranitidine twice daily, placebo matching ranitidine twice daily, or 200 mg cimetidine three times daily and 400 mg at night." | 5.05 | Effect of ranitidine and cimetidine on gastric ulcer healing and recurrence. ( Cockel, R; Dawson, J; Jain, S, 1984) |
| "The long-term efficacy and safety of ranitidine for the prevention of duodenal ulcer recurrence were studied in two sets of double-blind, randomized, multicenter clinical trials." | 5.05 | Protocol design for recent duodenal ulcer maintenance trials. ( Eshelman, FN; Holland, CE, 1984) |
| "Sixty-one patients with healed duodenal ulcer were studied during a 12-month maintenance trial with either 150 mg ranitidine at night or 400 mg cimetidine at night." | 5.05 | Comparison of ranitidine and cimetidine maintenance treatment of duodenal ulcer. ( Colin-Jones, DG; Colley, S; Dewar, EP; Frost, RA; Golding, PL; Hunt, RH; Misiewicz, JJ; Shepherd, TH; Trotman, I; Walt, RP, 1984) |
| "The duodenal ulcer healing and relapse rates reported in studies of short-term and long-term treatment with cimetidine or placebo have been used to predict the results of three treatment strategies." | 5.05 | Model of medical treatment for duodenal ulcer. ( Pounder, RE, 1981) |
| "In a double-blind randomised trial in 75 patients with duodenal ulceration diagnosed endoscopically, 38 patients were given tripotassium dicitrato bismuthate and 37 cimetidine." | 5.05 | Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. ( Hollanders, D; Martin, DF; May, SJ; Miller, JP; Ravenscroft, MM; Tweedle, DE, 1981) |
| "Ranitidine has been shown to heal the majority of duodenal ulcers during treatment with 300 or 320 mg daily for 4 to 8 weeks." | 5.05 | Clinical and endocrine aspects of treatment with ranitidine. ( Boyd, EJ; Browning, MC; Peden, NR; Saunders, JH; Wormsley, KG, 1981) |
| "In a comparative trial of preventive medication for duodenal ulceration with 51 participating centres, 484 patients were recruited for a year's maintenance treatment with the recommended bedtime dose of ranitidine (150 mg; n = 243) or cimetidine (400 mg; n = 241)." | 5.05 | Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial. ( Bardhan, KD; Crowe, JP; Gough, KR; Korman, MG; Lee, FI; Reed, PI; Smith, RN, 1984) |
| "A total of 110 subjects with duodenal ulcer healed with cimetidine (C) (50 patients), ranitidine (R) (40 patients) or pirenzepine (20 patients) was randomly divided in 3 groups." | 5.05 | Ranitidine, cimetidine and antacids in the prevention of recurrence after healed duodenal ulcer: one-year experience. ( Bresci, G; Capria, A; Corsini, G; Federici, G; Geloni, M; Rindi, G, 1983) |
| "The aim of the study was to determine the effectiveness of cimetidine in a dose of 400 mg twice daily in the prevention of gastric ulcer recurrence over a 2-yr period." | 5.05 | A two-year prospective controlled study of maintenance cimetidine and gastric ulcer. ( Barr, GD; Canalese, J; Kang, JY; Piper, DW, 1983) |
| "This study was designed to compare the rates of duodenal ulcer healing and recurrence after treatment with cimetidine or antacid." | 5.05 | Recurrent ulcer after successful treatment with cimetidine or antacid. ( Cano, R; Elashoff, J; Frankl, H; Ippoliti, A; Koretz, R; Samloff, M; Valenzuela, J, 1983) |
| "One hundred and forty six gastric ulcer patients were given open treatment using 1 g cimetidine daily to heal their ulcers." | 5.05 | Effect of cimetidine treatment in the prevention of gastric ulcer relapse: a one year double blind multicentre study. ( Hentschel, E; Horton, J; Judmair, G; Kerstan, E; Reichel, W; Rüdiger, E; Schütze, K; Weiss, W, 1983) |
| "A comparison between cimetidine and tripotassium dicitrato bismuthate liquid (TDB) in the treatment of endoscopically diagnosed duodenal ulcer by single-blind randomized trial in 48 patients has shown 18 (75%) out of 24 patients receiving TDB and 13 (54%) out of 24 patients receiving cimetidine healed after 4 weeks' therapy." | 5.05 | Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers. ( Jones, PE; Klass, HJ; Shreeve, DR, 1983) |
| "In a double-blind study 83 patients with duodenal ulcers, initially healed after treatment with either 1 g cimetidine daily or 50 mg trimipramine daily, were allocated by randomization to maintenance treatment with either 400 mg cimetidine daily, 25 mg trimipramine daily, or placebo for 6 months." | 5.05 | Relapse prevention of duodenal ulcers with trimipramine, cimetidine, or placebo. A double-blind comparison. ( Becker, U; Faurschou, P; Jensen, J; Lindorff, K; Pedersen, PB; Ranløv, PJ, 1984) |
| "Three hundred seventy patients with recently healed duodenal ulcer entered into a one-year, double-blind, randomized multicenter trial comparing placebo with three different dose schedules of cimetidine (200 mg twice a day, 300 mg twice a day, and 400 mg at bedtime) for the prevention of recurrent duodenal ulcer." | 5.05 | Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. ( Archambault, A; Belsito, A; Cohen, N; Davis, W; Farley, A; Graham, DY; Grunt, R; Kinnear, D; Sontag, S; Weiss, J, 1984) |
| "The rate of endoscopically confirmed gastric ulcer relapse was compared in two groups of patients with newly healed benign gastric ulcers, receiving either cimetidine 400 mg nocte or matching placebo, over a period of 1 year." | 5.05 | The effect of cimetidine on the maintenance of healing of gastric ulceration. ( Kinloch, JD; Pearson, AJ; Woolf, IL; Young, PH, 1984) |
| " Fifty-five patients with acute bleeding from chronic duodenal ulcers with SRH completed a randomized double-blind trial to assess the effect of administration of cimetidine (800 mg daily intravenously for 2 days, then 1000 mg daily orally for 10 days in divided doses) versus placebo on rebleeding and need for emergency surgery." | 5.05 | Cimetidine reduces the risk of rebleeding from duodenal ulcers displaying signs of recent haemorrhage. ( Barnes, PR; Byth, K; Heap, TR; Ruppin, DC; Stiel, D, 1984) |
| "Forty-four patients with chronic duodenal ulceration were allocated randomly to either long-term maintenance treatment with cimetidine or proximal gastric vagotomy." | 5.05 | Proximal gastric vagotomy versus long-term maintenance treatment with cimetidine for chronic duodenal ulcer: a prospective randomised trial. ( Gear, MW, 1983) |
| "Relapse rates of duodenal ulcer after treatment with sucralfate or cimetidine were investigated in a one-year follow-up study." | 5.05 | [Recurrence of duodenal ulcer after therapy with Sucralfat or cimetidine]. ( Dufek, W; Hentschel, E; Schütze, K, 1984) |
| "The effect of pirenzepine and cimetidine on healing, symptoms and relapse rate of duodenal ulcer was studied in a placebo-controlled double-blind trial." | 5.05 | Treatment and relapse prophylaxis of duodenal ulcer with pirenzepine and cimetidine. ( Birchler, R; Blum, AL; Eichenberger, PM; Giger, M; Gonvers, JJ; Mattle, W; Müller-Lissner, SA; Pelloni, S, 1982) |
| "An intensive antacid regimen, 15 to 30 ml 1 and 3 hours after each meal and at bedtime, has a significant effect on duodenal ulcer healing as compared to placebo and is as effective as cimetidine in endoscopically assessed trials." | 5.05 | Antacid therapy for duodenal and gastric ulcer: the experience in the United States. ( Ippoliti, AF, 1982) |
| "In a randomised open study of 28 outpatients with endoscopically proven duodenal ulcers, 14 patients were treated with colloidal bismuth subcitrate (CBS) and 14 patients with cimetidine tablets." | 5.05 | A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer. ( Janssens, J; Rutgeerts, P; Schuurmans, P; Vantrappen, G, 1982) |
| "Colloidal bismuth subcitrate (CBS, DE-NOL) and cimetidine have been compared in a double-blind randomized trial in the management of 75 patients with duodenal ulcer." | 5.05 | Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate. ( Hollanders, D; Martin, DF; Miller, JP; Ravenscroft, MM; Tweedle, DE, 1982) |
| "Forty-Five consecutive patients with chronic peptic ulcer disease completed a double-blind controlled trial in which they were given cimetidine 0." | 5.05 | Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence. ( Danielsson, A; Ek, B; Steen, L, 1981) |
| "Cimetidine 1 g daily is often continued for a fixed period beyond the time of healing of duodenal ulcer on the assumption that it might reduce the subsequent relapse rate." | 5.05 | Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate? ( Bardhan, KD; Cole, DS; Franks, CR; Hawkins, BW, 1982) |
| "The long term effect of 400 mg cimetidine ingested at various times on ulcer recurrence and drug compliance was investigated in 66 patients with severe course of duodenal ulcer, now healed." | 5.05 | [Long-term prevention of duodenal ulcer with cimetidine. Effect of the rhythm of ingestion and drug compliance on the incidence of recurrence]. ( Hausmann, L; Heuser, E; Massarrat, S; Schubotz, R, 1982) |
| "Patients with a healed duodenal ulcer and who were symptom-free following 12 months of maintenance treatment with cimetidine 400 mg twice daily were randomized double-blind to a further 6 months therapy with either cimetidine 400 mg twice daily or placebo 2 tablets twice daily." | 5.05 | Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study. ( Don, G; Hansky, J; Hetzel, DJ; Korman, MG; Shearman, DJ, 1980) |
| "This double-blind controlled trial compares the relapse rate in 19 duodenal ulcer patients who received cimetidine for eight weeks with that in 19 patients who received cimetidine for four weeks and inactive tablets for four weeks." | 5.05 | Recurrence of duodenal ulcer pain after treatment with cimetidine for four and eight weeks. ( Greibe, J; Madsen, JR; Møllman, KM; Rahbek, I; Rune, SJ; Willumsen, L; Wulff, HR, 1980) |
| "Comparison of cimetidine and placebo in the prevention of recurrence of ulceration was carried out in the study of 696 patients with recently healed duodenal ulcers." | 5.05 | Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study. ( Beresford, J; Burland, WL; Hawkins, BW, 1980) |
| "The healing-rate of duodenal ulcer after short-term treatment with carbenoxolone was not significantly different from that after treatment with cimetidine." | 5.05 | Controlled trial of carbenoxolone sodium vs. cimetidine in duodenal ulcer. ( Domschke, W; Rösch, W; Schenk, J; Schmack, B, 1980) |
| "Twenty patients with gastric ulcer received treatment with cimetidine." | 5.05 | Long-term treatment of gastric ulcer with cimetidine. ( Da Silva, EP; Zaterka, S, 1981) |
| "Ulcer healing and relapse rates after treatment with cimetidine and sucralfate in 112 subjects with endoscopically proven gastric and duodenal ulcers were compared in a randomized trial." | 5.05 | Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate. ( Girdwood, AH; Lucke, W; Marks, IN; Wright, JP, 1981) |
| "The effect of pirenzepine and cimetidine on healing, symptoms, and relapse rate of duodenal ulcer was studied in a placebo controlled double blind trial." | 5.05 | [Treatment and prevention of recurrence of duodenal ulcer with pirenzepin and cimetidine]. ( Birchler, R; Blum, AL; Eichenberger, PM; Giger, M; Gonvers, JJ; Mattle, W; Müller-Lissner, SA; Pelloni, S, 1982) |
| "Sixty patients, whose duodenal ulcers had healed endoscopically after six weeks of treatment with cimetidine 1 g/day in divided doses, were treated with maintenance cimetidine 800 mg at bedtime for six months." | 5.05 | Bedtime cimetidine maintenance treatment: optimum dose and effect on subsequent natural history of duodenal ulcer. ( Blackwood, WS; Fitzpatrick, WJ; Northfield, TC, 1982) |
| "One hundred patients with benign gastric ulceration were treated in a single-blind, endoscopically controlled trial to assess the relative efficacy of cimetidine (1 g daily) and Caved-S (six tablets daily)." | 5.05 | Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. ( Darnborough, A; McAdam, WA; Morgan, AG; Pacsoo, C, 1982) |
| "The aim of the study was to compare the use of cimetidine and colloidal bismuth in the initial healing of chronic duodenal ulcer and to note the recurrence rate over 1 year after healing induced by both forms of treatment." | 5.05 | Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing. ( Kang, JY; Piper, DW, 1982) |
| "The effectiveness of cimetidine or antacid in healing recurrent jejunal peptic ulcers after Billroth II gastric resection without vagotomy was tested in a randomized study of 18 in-patients." | 5.05 | [Treatment of jejunal peptic ulcer with cimetidine or an antacid? Results of a long-term study]. ( Grönniger, J; Herzog, P; Holtermüller, KH; Rothmund, M; Weis, H, 1982) |
| "The effects of 3 months' maintenance treatments with cimetidine, 400 mg at bedtime, or with carbenoxolone, 150 mg/daily, in patients whose duodenal ulcers healed after an initial course with cimetidine were compared." | 5.05 | Carbenoxolone maintenance in cimetidine-healed patients. ( Cambielli, M; Guslandi, M; Tittobello, A, 1980) |
| " At our department, the pharmacological part of the treatment of the first episode of an active duodenal ulcer as well as the first recurrences will usually consist of cimetidine 800 mg as a single nocturnal dose or in divided doses, for 4-6 weeks." | 5.05 | Prevention of ulcer recurrence--medical vs surgical treatment. The physician's view. ( Ström, M; Walan, A, 1985) |
| "To assess the efficacy of cimetidine versus sucralfate in terminating or preventing further bleeding of peptic ulcers, patients presenting with bleeding from duodenal or gastric ulcers were openly randomized to receive cimetidine 1800 mg/day or sucralfate 8 g/day for a 1-wk period." | 5.05 | A comparison of cimetidine and sucralfate in the treatment of bleeding peptic ulcers. ( Czaja, MJ; Goldfarb, JP, 1985) |
| "We conducted a double-blind randomized study of 132 patients to determine whether the new, investigational proton-pump inhibitor, omeprazole (30 mg per day), would accelerate healing and pain relief, as compared with cimetidine (1 g per day), in patients with duodenal ulcer." | 5.05 | Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. ( Andersen, HH; Bendtsen, F; Bytzer, P; Højlund, M; Jensen, KG; Kelbaek, H; Lauritsen, K; Linde, J; Rask-Madsen, J; Rune, SJ, 1985) |
| "A six month, double blind, controlled study was performed in 107 asymptomatic duodenal ulcer patients who, after short term cimetidine treatment, showed complete or incomplete endoscopic healing." | 5.05 | Incompletely and completely healed duodenal ulcers' outcome in maintenance treatment: a double blind controlled study. ( Carratù, R; Paoluzi, P; Proietti, F; Ricotta, G; Ripoli, F; Torsoli, A; Zaccardelli, E, 1985) |
| "Recurrence rates of chronic duodenal ulcer after initial therapy with pirenzepine or cimetidine were investigated in a prospective, randomized trial with a total of 80 patients." | 5.05 | [Recurrence of chronic duodenal ulcer following initial therapy with pirenzepine or cimetidine]. ( Dufek, W; Hentschel, E; Schütze, K, 1985) |
| "Patients with recently healed duodenal ulcers were enrolled at 14 participating centers in a 12-month study comparing the effectiveness of ranitidine and cimetidine, two H2-receptor blockers, for maintenance therapy." | 5.05 | Final report on the United States Multicenter Trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer. ( Silvis, SE, 1985) |
| "The effects of two dosage levels of a synthetic prostaglandin E1 analogue, misoprostol, and cimetidine on short-term duodenal ulcer healing were compared in a double-blind, endoscopically controlled 4-week study." | 5.05 | Misoprostol, a synthetic prostaglandin E1 analogue, in the treatment of duodenal ulcers. A double-blind, cimetidine-controlled trial. ( Mannion, G; Naiker, N; O'Keefe, SJ; Spitaels, JM, 1985) |
| "The aim of this study was to gain experience regarding the efficacy and safety of cimetidine 400 mg nightly for the long-term maintenance treatment of peptic ulcers three years." | 5.05 | Long term cimetidine therapy for the prevention of recurring peptic ulcer: a multicenter study. ( Rohner, HG, 1985) |
| "68 patients with chronic peptic ulcer took part in a double-blind trial in which 32 received the histamine H2-receptor antagonist cimetidine, (400 mg twice daily) and 36 received a placebo, for a year." | 5.04 | Maintenance treatment of recurrent peptic ulcer by cimetidine. ( Bodemar, G; Walan, A, 1978) |
| "45 patients with healed duodenal ulcers completed a six-month double-blind trial to compare the effects of cimetidine and placebo on the prevention of duodenal-ulcer relapse." | 5.04 | Prevention by bedtime cimetidine of duodenal-ulcer relapse. ( Blackwood, WS; Maudgal, DP; Northfield, TC, 1978) |
| "In an open trial, 96 patients with endoscopically proven peptic ulcers were randomly allocated to treatment with cimetidine (1 g/day) for periods of 3, 6, 9, or 12 months." | 5.04 | Very long-term treatment of peptic ulcer with cimetidine. ( Cargill, JM; Peden, N; Saunders, JH; Wormsley, KG, 1978) |
| "The published world literature on the efficacy of cimetidine, a histamine H2-receptor antagonist, in the treatment of duodenal ulcer is reviewed." | 5.04 | Cimetidine in the treatment of duodenal ulcer: review and commentary. ( Winship, DH, 1978) |
| "Fifty-seven symptom-free patients with duodenal ulcer entered a double-blind trial to assess the prophylactic effect of cimetidine." | 5.04 | Prophylactic effect of cimetidine in duodenal ulcer disease. ( Gudmand-Høyer, E; Jensen, KB; Krag, E; Rahbek, I; Rask-Madsen, J; Rune, SJ; Wulff, HR, 1978) |
| "In a randomised controlled trial cimetidine 1 g daily for six weeks was compared with placebo in the treatment of recurrent ulcers after gastrectomy or vagotomy for duodenal ulcer." | 5.04 | Cimetidine for recurrent ulcer after vagotomy or gastrectomy: a randomised controlled trial. ( Kennedy, T; Spencer, A, 1978) |
| "Sixty patients with endoscopically confirmed gastric ulceration took part in a single-blind trial of cimetidine 1 g daily compared with conventional treatment--namely, carbenoxolone in patients aged under 60 and Caved-(S) in those over 60." | 5.04 | Cimetidine: an advance in gastric ulcer treatment? ( McAdam, WA; Morgan, AG; Pacsoo, C; Simmons, AV; Walker, BE, 1978) |
| "Forty-seven patients were treated in a double-blind trial to evaluate the efficacy of 400 mg cimetidine, an H2- receptor antagonist (Tagamet; SKF), twice a day in the prevention of recurrent duodenal ulcers." | 5.04 | Long-term treatment with cimetidine. ( Mekel, RC, 1978) |
| "Patients suffering from chronic duodenal ulceration were allocated at random to treatment with either cimetidine (400 mg twice daily) or matching placebo for six months." | 5.04 | Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. ( Bardhan, KD; Duthie, HL; Edwards, JL; Fussey, IV; Haggie, SJ; Saul, DM; Smith, PM; Wyllie, JH, 1979) |
| "Nineteen patients entered a double-blind randomized trial of the prophylactic effect of cimetidine in gastric ulcer disease." | 5.04 | Prophylactic effect of cimetidine in gastric ulcer patients. ( Jensen, KB; Madsen, JR; Møllmann, KM; Rahbek, I; Rune, SJ; Wulff, HR, 1979) |
| "Forty patients with chronic duodenal ulcer who had healed endoscopically with a 6-week course of cimetidine were randomized double blind to 1 year of either placebo or cimetidine tablets 400 mg bid (20 patients in each group)." | 5.04 | Long-term cimetidine in duodenal ulcer disease. ( Hansky, J; Korman, MG, 1979) |
| "Forty-two patients with endoscopically diagnosed duodenal ulcer were studied in a double-blind trial after their ulcers had been healed with cimetidine." | 5.04 | Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects. ( Batchelor, AJ; Dronfield, MW; Langman, MJ; Larkworthy, W, 1979) |
| "Fifty-one patients with duodenal ulcer which was healed by a six-week course of cimetidine completed a one-year double-blind study to compare the effects of cimetidine and placebo on the prevention of ulcer relapse." | 5.04 | Prevention of duodenal ulcer relapse by cimetidine: a one-year double-blind trial. ( Hecker, R; Hetzel, DJ; Shearman, DJ; Sheers, R, 1979) |
| "Fifty-eight patients with endoscopically verified duodenal ulcers were treated with cimetidine, 1 g/day, for 6--10 weeks." | 5.04 | Maintenance treatment of duodenal ulcer patients with a single bedtime dose of cimetidine. ( Aadland, E; Berstad, A; Carlsen, E; Kruse-Jensen, A; Myren, J; Semb, LS, 1979) |
| "The effect of long-term prophylaxis of duodenal ulceration with cimetidine was tested in a double blind trial." | 5.04 | [Prevention of duodenal ulcer recurrence with cimetidine (author's transl)]. ( Blum, AL; Kiene, K; Pelloni, S; Peter, P; Sonnenberg, A; Strohmeyer, G; Weber, KB; Wienbeck, M, 1979) |
| "Twenty-five patients with healed gastric ulcers completed an 11-month double-blind controlled trial comparing cimetidine 1 g daily with placebo in the prevention of ulcer relapse." | 5.04 | Cimetidine in the prevention of gastric ulcer relapse. ( Ciclitira, PJ; Dick, AP; Farthing, MJ; Hunter, JO; Machell, RJ, 1979) |
| "Cimetidine therapy in gastric ulcer disease has been evaluated in four complete and one incomplete controlled, double blind trials." | 5.04 | Cimetidine in the treatment of gastric ulcer: review and commentary. ( Freston, JW, 1978) |
| "In a double-blind trial of patients with duodenal ulcer at three centres the healing rate after a four-week course of treatment (1 g cimetidine daily) was 79% (30 out of 38 patients), compared with 58% (23 out of 40 patients) on placebos." | 5.04 | [Cimetidine in the treatment of duodenal ulcer (author's transl)]. ( Blum, AL; Gonvers, JJ; Hofstetter, JR; Kiene, K; Pelloni, S; Peter, P; Richter, O; Schmitz, H; Sonnenberg, A; Strohmeyer, G; Weber, K, 1978) |
| "We used published results from clinical trials to evaluate the efficacy of ranitidine and cimetidine as maintenance therapy following healing of acute duodenal ulcers." | 4.77 | Comparison of ranitidine and cimetidine ulcer maintenance therapy. ( Koch, GG; Kurata, JH; Nogawa, AN, 1987) |
| "Cimetidine is a specific competitive histamine H2-receptor antagonist which effectively inhibits gastric acid secretion and is advocated for the treatment of chronic peptic ulceration, haemorrhage from erosive gastritis, and the control of gastric hypersecretion and peptic ulceration in the Zollinger-Ellison syndrome." | 4.75 | Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| "The first accepted form of treatment for gastric ulceration was carbenoxolone sodium and though a high incidence of side effects were reported with its use, it enabled treatment on an outpatient basis." | 3.75 | Medical management of gastric ulcer. ( LaBrooy, SJ, 1983) |
| "Effect of lafutidine ((+/-)-2-(furfurylsulfinyl)-N-[4-[4-(piperidinomethyl)-2-pyr idyl] oxy-(Z)-2-butenyl] acetamide, FRG-8813), a novel antiulcer agent, on the healing and relapse in acetic acid-induced gastric ulcer in rats was investigated." | 3.70 | [Effect of lafutidine, a novel antiulcer agent, on healing and relapse of acetic acid-induced gastric ulcer in rats]. ( Aoyama, M; Arai, Y; Ohnishi, H; Onodera, S; Shibata, M; Tanaka, M; Yamaura, T, 1998) |
| "This study was done to elucidate whether rebamipide during the initial period of acetic acid-induced gastric ulcer affected healing and future ulcer relapse." | 3.69 | Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. ( Arakawa, T; Fukuda, T; Kobayashi, K; Watanabe, T; Yamasaki, K, 1995) |
| "The clinical efficacy of twice-daily cimetidine (20 mg/kg/day) was retrospectively studied in 19 children with gastric ulcer (GU) and 23 with duodenal ulcer (DU) in the active stage." | 3.69 | Efficacy of twice-daily cimetidine in pediatric peptic ulcer. ( Kato, S; Nakagawa, H; Ohtake, M; Ozawa, A; Shibuya, H, 1994) |
| "We found indomethacin aggravates healed gastric ulcers (ulcer relapse) in rats." | 3.69 | Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor. ( Asano, S; Inada, I; Maeda, R; Murakami, I; Sato, F; Satoh, H; Shino, A, 1997) |
| "The aim of this study is to propose a regimen of omeprazole 20 mg twice weekly for the prevention of duodenal ulcer (DU) relapse." | 3.68 | [Study on omeprazole 20 mg twice weekly in prevention of duodenal ulcer relapse]. ( Bei, L; Chen, SP; Wen, SH, 1993) |
| "Maintenance therapy with either ranitidine or cimetidine has been administered for up to 5 years to several hundred patients suffering from duodenal or gastric ulcer disease." | 3.68 | Maintenance therapy of duodenal and gastric ulcer with H2-receptor antagonists. ( Boyd, EJ; Penston, JG; Wormsley, KG, 1990) |
| "Long-term drug therapy of peptic ulcers may be practiced using cimetidine, ranitidine, sucralfate or possibly pirenzepine, but H2-blockers are considered to be the best treatment." | 3.67 | [Long term management of peptic ulcer. Indications and side effects of drug therapy compared with surgical procedure]. ( Rösch, W, 1984) |
| "45 patients with uncomplicated duodenal ulcer who did not respond to cimetidine underwent elective proximal gastric vagotomy (PGV)." | 3.67 | Failure of proximal gastric vagotomy for duodenal ulcer resistant to cimetidine. ( Hansen, JH; Knigge, U, 1984) |
| "The incidence of duodenal ulcer relapse after initial therapy with concentrated aluminium-magnesium hydroxide (Maalox 70) or cimetidine (Tagamet) was investigated in a one-year follow-up study." | 3.67 | Relapse rates of duodenal ulcer healed with concentrated antacid or cimetidine. ( Dufek, W; Hentschel, E; Schuetze, K, 1984) |
| "Healing rates were examined retrospectively in 124 outpatients with peptic ulcer who had received cimetidine for at least four weeks." | 3.67 | Unsuccessful cimetidine treatment of peptic ulcer: analysis of the factors involved. ( Angelini, GP; Celli, L; Granelli, P, 1984) |
| "Fifty five patients with severe longstanding dyspepsia originally selected as candidates for elective duodenal ulcer surgery were instead entered into a maintenance cimetidine study." | 3.67 | Maintenance cimetidine instead of surgery for duodenal ulcer: the first decade. ( Gillespie, G; Gray, GR; Hansell, DT; McGushin, M; Meddings, RN; Smith, IS, 1989) |
| "253 patients were treated for 3 years with 400 mg cimetidine at night to prevent relapses of recently healed duodenal ulcers." | 3.67 | [3-year long-term therapy of recurrent duodenal ulcer with 400 mg cimetidine nocte]. ( Brandstätter, G; Hentschel, E; Judmaier, G; Kerstan, E; Kratochvil, P; Reichel, W; Rüdiger, E; Schütze, K; Weiss, W, 1987) |
| "Ulcer relapses after short-term treatment of duodenal, prepyloric and gastric ulcers with Cimetidine 400 mg b." | 3.67 | Ulcer recurrences following initial ulcer healing with sucralfate or cimetidine. ( Carling, L; Glise, H; Hallerbäck, B; Hallgren, T; Kagevi, I; Solhaug, JH; Svedberg, LE; Wählby, L, 1987) |
| "Chronic gastric ulcers were produced by injection of 20% acetic acid (0." | 3.67 | Effects of trimoprostil on healing and recurrence of acetic acid-induced gastric ulcer in rats. ( Nakamura, K; Umeda, Y, 1986) |
| "Fifty-seven patients, with chronic duodenal ulceration resistant to cimetidine therapy, underwent proximal gastric vagotomy during the period August 1979 to May 1984." | 3.67 | Proximal gastric vagotomy in patients resistant to cimetidine. ( Temple, JG; Weaver, RM, 1985) |
| "In this retrospective study, a cohort of gastric ulcer patients treated with antacids was compared with a well-matched group of patients treated with a combination of antacids and cimetidine." | 3.67 | Effect of cimetidine on healing and surgical treatment of gastric ulcers. ( Haddad, W; Kestenbaum, DJ; Wang, HS, 1985) |
| "Eighty two patients with an endoscopically healed gastric ulcer, were treated for two years with either Caved-S tablets, two twice daily or cimetidine 400 mg at night." | 3.67 | Maintenance therapy: a two year comparison between Caved-S and cimetidine treatment in the prevention of symptomatic gastric ulcer recurrence. ( McAdam, WA; Morgan, AG; Pacsoo, C, 1985) |
| "Review of a 5 year clinical experience with the histamine H2-receptor antagonists metiamide, cimetidine, and ranitidine in 20 patients with Zollinger-Ellison syndrome disclosed a treatment failure rate of 50 percent." | 3.66 | Failure of histamine H2-receptor antagonist therapy in Zollinger-Ellison syndrome. ( Ippoliti, AF; Passaro, E; Stabile, BE; Walsh, JH, 1983) |
| "The relapse rate following successful short-term therapy with sucralfate or cimetidine was studied in a group of 86 patients with recently healed duodenal or gastric ulcer." | 3.66 | Relapse rates following initial ulcer healing with sucralfate and cimetidine. ( Girdwood, AH; Lucke, W; Marks, IN; Wright, JP, 1983) |
| "The authors here present a work dealing pith two groups of subjects, both groups having the diagnose of bleeding duodenal ulcer; one group using therapy antacid alone, the other using cimetidine and antacid." | 3.66 | [Short-term effects of cimetidine in patients with bleeding duodenal ulcer. Presentation of cases]. ( Monti, G; Rumi, A; Testone, G; Uggeri, G, 1983) |
| "A total of 60 patients with endoscopically diagnosed duodenal ulcer were treated with pirenzepine or cimetidine for 8-10 weeks until endoscopic healing of the ulcer." | 3.66 | Pirenzepine in long-term therapy for duodenal ulcer. ( Bresci, G; Capria, A; Del Tacca, M; Geloni, M; Polloni, A; Rindi, G, 1983) |
| "The relapse rate after successful short-term therapy with sucralfate (Sc) or cimetidine (Cm) was studied in a group of 86 patients with recently healed duodenal or gastric ulcers." | 3.66 | Relapse rates after initial ulcer healing with sucralfate and cimetidine. ( Girdwood, AH; Lucke, W; Marks, IN; Wright, JP, 1982) |
| "Twenty-one patients with duodenal ulcer were treated with cimetidine." | 3.66 | The value of the new interpretation of the insulin test in predicting duodenal ulcer relapse after treatment with cimetidine. ( Carr-Locke, DL; Maybury, NK, 1980) |
| "Twenty-two duodenal and 16 gastric ulcer patients were treated with 400 mg cimetidine twice daily for one year after their ulcers had healed." | 3.66 | Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers. ( Festen, HP; Lamers, CB; Tangerman, A; van Tongeren, JH, 1980) |
| " The use of cimetidine or frequent administration of a potent liquid antacid ensures initial healing of duodenal ulcers in 75% to 90% of patients." | 3.66 | An aggressive approach to the medical management of peptic ulcer disease. ( Achkar, E; Fleshler, B, 1981) |
| "Patients with symptomatic duodenal ulcer can be effectively treated with antacids or cimetidine." | 3.66 | Treating duodenal ulcer: antacids or cimetidine? ( Feinberg, LE, 1980) |
| "Intermittent treatment with short courses of cimetidine given only when symptoms recurred was assessed in patients with duodenal ulcer as an alternative to maintenance treatment." | 3.66 | Intermittent treatment of duodenal ulcer with cimetidine. ( Bardhan, KD, 1980) |
| "pylori eradication rate and ulcer recurrence rate were compared." | 2.69 | Assessment of decisions in the treatment of Helicobacter pylori-related duodenal ulcer: a cost-effectiveness study. ( Chen, J; Chen, SY; Wang, JY; Zhang, SS; Zhang, XD, 1999) |
| "Ulcer recurrence and H." | 2.68 | Effects of Helicobacter pylori infection on healing and recurrence of gastric ulcers. ( Iishi, H; Tatsuta, M; Yokota, Y, 1995) |
| "There were no recurrences in surgically treated patients at an average of 3." | 2.68 | Pyloric channel ulcers: management and three-year follow-up. ( Goh, P; Low, C; Ngoi, SS; Tekant, Y, 1995) |
| "But the difference of recurrence rate (19." | 2.68 | [Clinical and experimental studies of yuyang powder in treatment of peptic ulcer]. ( Wan, QX; Wang, D; Wang, Y, 1996) |
| "Relapses were re-treated with omeprazole 40 mg; upon rehealing, patients were put on maintenance omeprazole 20 mg daily for up to 4." | 2.68 | Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment. ( Bardhan, KD; Bishop, A; Brooks, A; Cherian, P; D'Silva, J; Gillon, KR; Jones, RB; Manek, S; Morris, P; Parkin, S; Patterson, J; Polak, J; Thompson, M; Vaishnavi, A, 1997) |
| "Cimetidine was significantly effective in preventing the relapse (p < 0." | 2.67 | The relationship between Helicobacter pylori and oxygen-derived free radicals in the mechanism of duodenal ulceration. ( Salim, AS, 1993) |
| "Cimetidine was significantly effective in preventing ulcer relapse (p < 0." | 2.67 | Sulphydryl-containing agents and the prevention of duodenal ulcer relapse. ( Salim, AS, 1993) |
| "Cimetidine was significantly effective (p less than 0." | 2.67 | Oxygen-derived free radicals and the prevention of duodenal ulcer relapse: a new approach. ( Salim, AS, 1990) |
| "H2-blockers reduce the annual recurrence from nearly 70% to about 25%." | 2.66 | H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection. ( Freston, JW, 1987) |
| " As a result of these studies we recommend a cimetidine maintenance dosage of 400 mg twice a day for all patients whose ulcers are slow to heal on 1 g cimetidine a day and in patients with prepyloric ulcer disease regardless of rate of healing." | 2.66 | Results of short- and long-term cimetidine treatment in patients with juxtapyloric ulcers, with special reference to gastric acid and pepsin secretion. ( Berstad, A; Bodemar, G; Ström, M; Walan, A, 1986) |
| "The effect of cimetidine on ulcer recurrence, however, was confined to smokers; relapse risk among nonsmokers did not differ significantly between the treatment groups." | 2.66 | Psychological group counseling for the prevention of ulcer relapses. A controlled randomized trial in duodenal and prepyloric ulcer disease. ( Adami, HO; Bates, S; Brodin, U; Fagerström, KO; Gustavsson, S; Lööf, L; Nyberg, A; Nyrén, O, 1987) |
| "The median time to recurrence in the cimetidine-treated group was 17 weeks among smokers, compared to 43 weeks among non-smokers (p less than 0." | 2.66 | Recurrent ulcer after treatment with cimetidine or sucralfate. ( Carling, L; Glise, H; Hallerbäck, B; Hallgren, T; Kagevi, I; Solhaug, JH; Svedberg, LE; Wählby, L, 1987) |
| " The more convenient dosage schedule of ranitidine may be important for patient compliance with initial therapy of peptic ulcer disease, and the greater duration of ranitidine antisecretory effects may enhance effectiveness of long-term maintenance therapy by providing more complete inhibition of nocturnal acid secretion." | 2.65 | Review of peptic ulcer maintenance trials. ( Robinson, M, 1984) |
| "Ulcer recurrence rates were in 19, 24, and 35 percent for the ranitidine-treated patients and 44, 54, and 60 percent for patients taking placebo at four, eight, and 12 months, respectively (p less than 0." | 2.65 | Results of the United States ranitidine maintenance trials. ( Silvis, SE, 1984) |
| "Postoperative complications, ulcer recurrence rates, the overall clinical results (Visick classification), and blood test results were similar in the two groups." | 2.65 | Prospective, randomized trial of selective proximal vagotomy with ulcer excision and partial gastrectomy with gastroduodenostomy in the treatment of corporeal gastric ulcer. ( Emås, S; Hammarberg, C, 1983) |
| " While very safe, clinicians need to know correct dosing guidelines, drug interactions, and side effect profiles." | 2.38 | The clinical use of histamine-2 receptor antagonists. ( Michocki, RJ; Richardson, JP, 1992) |
| "A theoretical basis for similar recurrence rates among H2-receptor antagonists exists based on recent concepts of ulcer recurrence, ulcer healing and suppression of nocturnal gastric acidity." | 2.38 | Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis. ( Frank, WO; Karlstadt, R; Palmer, RH, 1990) |
| "Therapeutic measures for acute pancreatitis depend on the severity of the disease and its complications." | 2.37 | Acute and chronic pancreatitis. An update on management. ( Lankisch, PG, 1984) |
| "In patients without maintenance treatment, relapse was markedly higher (50/78 group I, 529/742 group II), but group II still bled significantly less (20% group I vs." | 1.30 | The outcome of bleeding duodenal ulcer in the era of H2 receptor antagonist therapy. ( Bardhan, KD; Nayyar, AK; Royston, C, 1998) |
| "Giant gastric ulcer is uncommon." | 1.30 | Giant gastric ulcer: its natural history and outcome in the H2RA era. ( Bardhan, KD; Beresford, J; Raju, GS; Royston, C, 1999) |
| "The estimated cumulative recurrence rate after 2, 5, and 8 years was 10%, 19% and 33%, respectively." | 1.29 | Late outcome of bleeding gastric ulcer. Five to eight years' follow-up. ( Fischer, L; Rørbaek-Madsen, M; Thomsen, H; Wara, P, 1994) |
| "Between 1965 and 1990 200 patients were treated for peptic esophageal stricture by surgery or bougienage with antisecretory medication." | 1.29 | Peptic esophageal stricture: is surgery still necessary? ( Bischof, G; Feil, W; Riegler, M; Schiessel, R; Wenzl, E, 1996) |
| "The influence of KU-1257 on the recurrence and relapse of acetic acid ulcers in rats was investigated grossly and histologically in comparison with that of cimetidine." | 1.29 | [Influence of KU-1257 on the recurrence and relapse of acetic acid-induced chronic gastric ulcers in rats]. ( Kobayashi, F; Ohkubo, H; Ohsawa, A; Sekiguchi, H; Taga, F, 1996) |
| "A technique was designed for the treatment of duodenal ulcer patients by electromagnetic radiation of the millimeter range (ERMR); 30 patients were treated by this method, while 50 patients received traditional therapy; other patients were treated by lasers, cithemidin." | 1.28 | [The local treatment of patients with a duodenal ulcer with millimeter-range electromagnetic radiation]. ( Netiazhenko, VZ; Zlyĭ, MV; Zlyĭ, VV, 1992) |
| "None of these 15 patients had a recurrence 3 months later." | 1.28 | The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist. ( Liao, CH; Pan, S, 1990) |
| "Five of 99 cases of gastric cancer were exposed to cimetidine at least two years before diagnosis, whereas nine of 365 controls (selected from among users of the Group Health Cooperative pharmacy, matched on age, sex, and first year of pharmacy use) were similarly exposed." | 1.28 | Cimetidine use and gastric cancer. ( Feld, AD; Jick, H; Jick, SS; Schumacher, MC, 1990) |
| "Operative management also reduces recurrence rates, which, however, are commoner in patients coming to surgery nowadays." | 1.28 | High doses of ranitidine in maintenance therapy of duodenal ulcer patients. ( Lee, FI, 1990) |
| "Chronic duodenal ulcer is diagnosed more frequently in children since recent advances in panendoscopy techniques." | 1.28 | Chronic duodenal ulcer in children: clinical observation and response to treatment. ( Chang, MH; Chiang, BL; Hsu, JY; Lin, MI; Wang, CY; Wang, TH, 1989) |
| "Duodenal ulcer was found to relapse more frequently in patients with total serum pepsinogen more than 109 micrograms tyr X ml-1 X 24 h-1 and in patients with maximal acid output more than 60 mmol/h (Logrank test; both p less than 0." | 1.27 | Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers. ( Battaglia, G; Burlina, A; Di Mario, F; Farini, R; Naccarato, R; Piccoli, A; Plebani, M; Vianello, F, 1984) |
| "The use of recurrence in the model makes the results of earlier CBA's based on the healing of a single episode, open to question." | 1.27 | Cost-benefit analysis of medicinal treatment for gastric ulcers. Long-term model including healing and recurrence. ( Fujino, S; Suzuki, Y; Tanaka, T, 1985) |
| "In this group there was not a single anaphylactic reaction." | 1.27 | Repeat chemonucleolysis. ( Sutton, JC, 1986) |
| "As in the treatment of peptic ulcer disease prostaglandin-analogues are only effective in preventing NOSAC-induced peptic lesions when given in antisecretory doses." | 1.27 | [Therapy and prevention of peptic lesions by prostaglandins]. ( Dammann, HG; Müller, P; Simon, B, 1987) |
| "Pain was predominant in the hip area, disappeared within a few days after withdrawal and recurred three weeks after resuming therapy." | 1.27 | Recurrent myalgias associated with cimetidine. ( Cabanne, JF; Dubot, P; Labeeuw, M, 1986) |
| "Relapse was defined as the recurrence of an ulcer crater or erosions or both." | 1.27 | Low dose maintenance treatment with cimetidine in duodenal ulcer: intermediate-term results. ( Bardhan, KD; Bose, K; Hinchliffe, RF, 1986) |
| "A symptomatic recurrence was controlled with the addition of propantheline." | 1.26 | The effect of cimetidine and propantheline on the symptoms of a patient with systemic mastocytosis. ( Achord, JL; Langford, H, 1980) |
| "The hypotension was found to be refractory to intravenous fluids, dopamine, and antihistamines, but was immediately reversed by intravenous epinephrine." | 1.26 | Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks. ( Oates, JA; Roberts, LJ; Turk, JW, 1982) |
| "Cimetidine is a highly effective and safe drug which, compared with the other treatments currently available, can be considered as the best solution of this problem." | 1.26 | [Cimetidine: solution to a problem?]. ( Cambielli, M, 1981) |
| "The ulcer recurrence, respectively persistance rate was high." | 1.26 | Cimetidine treatment of recurrent ulcer after vagotomy. ( Jensen, HE; Kjaergaard, J; Thomsen, F, 1980) |
| "The results of surgical treatment of gastric ulcer are satisfactory." | 1.26 | [Surgical treatment of ulcers]. ( Aeberhard, P, 1980) |
| "The problem of recurrence is addressed." | 1.26 | Peptic ulcer: antacids or cimetidine? ( McCarthy, DM, 1979) |
| " According to American studies, antacid therapy in the above-mentioned dosage may achieve a similar healing rate in duodenal ulcer patients in acute attack." | 1.26 | [Cimetidine versus antacids]. ( Halter, F, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 346 (81.22) | 18.7374 |
| 1990's | 73 (17.14) | 18.2507 |
| 2000's | 5 (1.17) | 29.6817 |
| 2010's | 2 (0.47) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, KM | 1 |
| Gunaga, S | 1 |
| Wu, DY | 1 |
| Guo, M | 1 |
| Gao, YS | 1 |
| Kang, YH | 1 |
| Guo, JC | 1 |
| Jiang, XL | 1 |
| Chen, F | 1 |
| Liu, T | 1 |
| Li, M | 1 |
| Hedden, AZ | 1 |
| Bardhan, KD | 16 |
| Nayyar, AK | 2 |
| Royston, C | 4 |
| Lin, HJ | 2 |
| Lo, WC | 2 |
| Cheng, YC | 1 |
| Perng, CL | 2 |
| Pinto, A | 1 |
| Lindemeyer, RG | 1 |
| Sollecito, TP | 1 |
| Lankisch, PG | 1 |
| Rösch, W | 3 |
| Dawson, J | 1 |
| Jain, S | 1 |
| Cockel, R | 1 |
| Klinger, J | 1 |
| Maggiolo, P | 1 |
| Goić, A | 1 |
| Schubert, TT | 1 |
| Misiewicz, JJ | 7 |
| Battaglia, G | 4 |
| Farini, R | 2 |
| Di Mario, F | 4 |
| Piccoli, A | 3 |
| Plebani, M | 2 |
| Vianello, F | 3 |
| Burlina, A | 1 |
| Naccarato, R | 3 |
| Robinson, M | 1 |
| Eshelman, FN | 1 |
| Holland, CE | 1 |
| Silvis, SE | 2 |
| Gough, KR | 4 |
| Koch, GG | 3 |
| McCanless, I | 1 |
| Ward, JF | 1 |
| Boyd, EJ | 4 |
| Wilson, JA | 2 |
| Wormsley, KG | 9 |
| Walt, RP | 2 |
| Hunt, RH | 1 |
| Trotman, I | 1 |
| Colley, S | 1 |
| Dewar, EP | 1 |
| Frost, RA | 1 |
| Shepherd, TH | 1 |
| Golding, PL | 1 |
| Colin-Jones, DG | 1 |
| Martin, D | 1 |
| Miller, JP | 5 |
| Marks, IN | 5 |
| Clémençon, GH | 1 |
| Pounder, RE | 2 |
| Martin, DF | 2 |
| Hollanders, D | 2 |
| May, SJ | 1 |
| Ravenscroft, MM | 2 |
| Tweedle, DE | 2 |
| Peden, NR | 1 |
| Browning, MC | 1 |
| Saunders, JH | 2 |
| Gray, GR | 3 |
| McWhinnie, D | 1 |
| Smith, IS | 5 |
| Gillespie, G | 4 |
| Domschke, S | 1 |
| Domschke, W | 2 |
| Stabile, BE | 1 |
| Ippoliti, AF | 2 |
| Walsh, JH | 1 |
| Passaro, E | 1 |
| Senfft, U | 1 |
| Hentschel, E | 8 |
| Korman, MG | 7 |
| Hansky, J | 3 |
| Eaves, ER | 1 |
| Schmidt, GT | 1 |
| Londong, W | 1 |
| Peppercorn, MA | 1 |
| Hansen, JH | 1 |
| Knigge, U | 1 |
| LaBrooy, SJ | 1 |
| Kelly, KA | 1 |
| Malagelada, JR | 2 |
| Hoffman, J | 1 |
| Jensen, HE | 2 |
| Lee, FI | 4 |
| Crowe, JP | 3 |
| Reed, PI | 3 |
| Smith, RN | 3 |
| Bianchi Porro, G | 4 |
| Lazzaroni, M | 2 |
| Petrillo, M | 3 |
| De Nicola, C | 1 |
| Ström, M | 4 |
| Bodemar, G | 5 |
| Lindhagen, J | 1 |
| Sjödahl, R | 1 |
| Walan, A | 8 |
| Legendre, C | 1 |
| Canaud, B | 1 |
| Beraud, JJ | 1 |
| Brunin, JL | 1 |
| Balmes, JL | 1 |
| Mirouze, J | 1 |
| Piper, DW | 6 |
| Bresci, G | 3 |
| Capria, A | 3 |
| Rindi, G | 3 |
| Geloni, M | 3 |
| Federici, G | 2 |
| Corsini, G | 2 |
| Darle, N | 1 |
| Almskog, B | 1 |
| Bergegårdh, S | 1 |
| Falk, A | 1 |
| Faxén, A | 1 |
| Ivarsson, LE | 1 |
| Jivegård, L | 1 |
| Karlström, L | 1 |
| Barr, GD | 1 |
| Kang, JY | 3 |
| Canalese, J | 1 |
| Ippoliti, A | 2 |
| Elashoff, J | 1 |
| Valenzuela, J | 1 |
| Cano, R | 1 |
| Frankl, H | 1 |
| Samloff, M | 1 |
| Koretz, R | 1 |
| Schütze, K | 5 |
| Weiss, W | 2 |
| Rüdiger, E | 2 |
| Judmair, G | 1 |
| Reichel, W | 2 |
| Kerstan, E | 2 |
| Horton, J | 1 |
| Libeskind, M | 2 |
| Emås, S | 1 |
| Hammarberg, C | 1 |
| Shreeve, DR | 1 |
| Klass, HJ | 1 |
| Jones, PE | 1 |
| Zuckerman, G | 2 |
| Welch, R | 1 |
| Douglas, A | 1 |
| Troxell, R | 1 |
| Cohen, S | 1 |
| Lorber, S | 1 |
| Melnyk, C | 1 |
| Bliss, C | 1 |
| Christiansen, P | 1 |
| Kern, F | 1 |
| Becker, U | 1 |
| Faurschou, P | 1 |
| Jensen, J | 1 |
| Lindorff, K | 1 |
| Pedersen, PB | 1 |
| Ranløv, PJ | 1 |
| Carr-Locke, DL | 2 |
| Taverner, D | 1 |
| Wicks, AC | 1 |
| Sontag, S | 2 |
| Graham, DY | 2 |
| Belsito, A | 1 |
| Weiss, J | 1 |
| Farley, A | 1 |
| Grunt, R | 1 |
| Cohen, N | 1 |
| Kinnear, D | 1 |
| Davis, W | 1 |
| Archambault, A | 1 |
| Kinloch, JD | 1 |
| Pearson, AJ | 1 |
| Woolf, IL | 1 |
| Young, PH | 1 |
| Cherniavskiĭ, AA | 2 |
| Zubeev, PS | 2 |
| Stiel, D | 1 |
| Barnes, PR | 1 |
| Ruppin, DC | 1 |
| Byth, K | 2 |
| Heap, TR | 1 |
| Gear, MW | 1 |
| Shushan, E | 1 |
| Novis, B | 1 |
| Pomeranz, I | 1 |
| Broor, SL | 1 |
| Shrestha, GP | 1 |
| Mukewar, SV | 1 |
| Augustine, P | 1 |
| Mehta, SK | 1 |
| Sharma, BK | 1 |
| Dew, MJ | 1 |
| Harries, AD | 1 |
| Hughes, P | 1 |
| Keeling, S | 1 |
| Fenton-May, V | 1 |
| Rhodes, J | 1 |
| Cuilleret, J | 1 |
| Espalieu, P | 1 |
| Balique, JG | 1 |
| Mosimann, F | 1 |
| Sorgi, M | 1 |
| Donovan, IA | 1 |
| Alexander-Williams, J | 2 |
| Sircus, W | 2 |
| Ananthakrishnan, N | 1 |
| Wakefield, D | 1 |
| Van Deventer, GM | 1 |
| Schuetze, K | 1 |
| Dufek, W | 3 |
| Wright, JP | 3 |
| Lucke, W | 3 |
| Girdwood, AH | 3 |
| Grigor'ev, PIa | 2 |
| Khar'kovskiĭ, NN | 1 |
| El'tsova, GB | 1 |
| Prianishnikova, AS | 1 |
| Iakovenko, EP | 1 |
| Kratzsch, KH | 1 |
| Stibenz, J | 1 |
| Kubisch, H | 1 |
| Detterbeck, F | 1 |
| Langenbach, R | 1 |
| Smith, J | 1 |
| Roxe, DM | 1 |
| Uggeri, G | 1 |
| Monti, G | 1 |
| Rumi, A | 1 |
| Testone, G | 1 |
| Polloni, A | 1 |
| Del Tacca, M | 1 |
| Saito, T | 1 |
| Granelli, P | 1 |
| Angelini, GP | 1 |
| Celli, L | 1 |
| Sherlock, DJ | 1 |
| Holl-Allen, RT | 1 |
| Gugler, R | 1 |
| Rohner, HG | 3 |
| Eichenberger, PM | 2 |
| Giger, M | 2 |
| Mattle, W | 2 |
| Pelloni, S | 4 |
| Müller-Lissner, SA | 3 |
| Gonvers, JJ | 4 |
| Birchler, R | 2 |
| Blum, AL | 5 |
| Vantrappen, G | 1 |
| Schuurmans, P | 1 |
| Rutgeerts, P | 1 |
| Janssens, J | 1 |
| Tytgat, GN | 3 |
| van Bentem, N | 1 |
| van Olffen, G | 1 |
| Dekker, W | 1 |
| Rutgeerts, L | 1 |
| de Boer, J | 1 |
| Achord, JL | 1 |
| Langford, H | 1 |
| Danielsson, A | 1 |
| Ek, B | 1 |
| Steen, L | 1 |
| Cole, DS | 1 |
| Hawkins, BW | 2 |
| Franks, CR | 1 |
| Massarrat, S | 1 |
| Heuser, E | 1 |
| Hausmann, L | 1 |
| Schubotz, R | 1 |
| Poleski, MH | 1 |
| Amdrup, E | 3 |
| Thomson, AB | 2 |
| Brust, R | 1 |
| Dwyer, JM | 1 |
| Wensel, R | 1 |
| Sherbaniuk, R | 1 |
| Walker, K | 1 |
| Corman, J | 1 |
| Smeesters, C | 1 |
| Beaudoin, M | 1 |
| Cartier, R | 1 |
| Hurtubise, M | 1 |
| Gélinas, C | 1 |
| Baillargeon, J | 1 |
| Emond, M | 1 |
| Caussignac, Y | 1 |
| Andersen, D | 2 |
| Sørensen, FH | 2 |
| Jensen, KB | 4 |
| Chojnacki, J | 2 |
| Tkaczewski, W | 2 |
| Klupińska, G | 2 |
| Grzegorczyk, K | 2 |
| Michowicz, A | 1 |
| Berndt, H | 1 |
| Otto, R | 1 |
| Rune, SJ | 5 |
| Møllman, KM | 2 |
| Rahbek, I | 4 |
| Berg, P | 1 |
| Bär, U | 1 |
| Hausamen, TU | 1 |
| Lingenberg, G | 1 |
| Pfleiderer, T | 1 |
| Raedsch, R | 1 |
| Saeger, HD | 1 |
| Sailer, S | 1 |
| Schwigon, CD | 1 |
| Seidel, G | 1 |
| Stiehl, A | 1 |
| Hetzel, DJ | 4 |
| Shearman, DJ | 4 |
| Don, G | 1 |
| Bader, AP | 1 |
| Morin, T | 2 |
| Druguet, M | 1 |
| Lambert, R | 2 |
| Dupuy, P | 1 |
| Bétourné, C | 1 |
| Greibe, J | 1 |
| Madsen, JR | 2 |
| Willumsen, L | 1 |
| Wulff, HR | 4 |
| Maybury, NK | 1 |
| Burland, WL | 2 |
| Beresford, J | 4 |
| Grossman, MI | 1 |
| Soulé, JC | 2 |
| Delchier, JC | 2 |
| Bader, JP | 3 |
| Snodgrass, PJ | 1 |
| Marini, U | 1 |
| Spotti, D | 1 |
| Visconti, G | 1 |
| Geniram, A | 1 |
| Schenk, J | 1 |
| Schmack, B | 1 |
| Greaney, MG | 1 |
| Irvin, TT | 1 |
| Da Silva, EP | 1 |
| Zaterka, S | 2 |
| Sonnenberg, A | 3 |
| Vogel, E | 1 |
| Schmid, P | 1 |
| Peter, P | 3 |
| Strohmeyer, G | 3 |
| Gotthard, R | 1 |
| Fitzpatrick, WJ | 1 |
| Blackwood, WS | 3 |
| Northfield, TC | 3 |
| Morgan, AG | 3 |
| McAdam, WA | 3 |
| Pacsoo, C | 3 |
| Darnborough, A | 1 |
| Rothmund, M | 2 |
| Wagner, PK | 1 |
| Koo, J | 1 |
| Lam, SK | 7 |
| Ong, GB | 1 |
| Thompson, JC | 1 |
| da Silva, JJ | 1 |
| Bettarello, A | 1 |
| Roberts, LJ | 1 |
| Turk, JW | 1 |
| Oates, JA | 1 |
| Fritsch, WP | 1 |
| Holtermüller, KH | 1 |
| Grönniger, J | 1 |
| Herzog, P | 1 |
| Weis, H | 1 |
| Danø, P | 1 |
| Düsel, W | 1 |
| Lehmann, L | 1 |
| Rietbrock, I | 1 |
| Seez, P | 1 |
| Galeone, M | 1 |
| Moise, G | 1 |
| Casula, PL | 1 |
| Bignamini, AA | 1 |
| Festen, HP | 2 |
| Lamers, CB | 2 |
| Tangerman, A | 1 |
| van Tongeren, JH | 2 |
| Hake, DH | 1 |
| Fleshler, B | 1 |
| Achkar, E | 2 |
| Cambielli, M | 3 |
| Shemesh, E | 1 |
| Skapa, E | 1 |
| Schneubaum, S | 1 |
| Batt, L | 1 |
| Shanahan, F | 1 |
| Crowe, J | 1 |
| Ugarte, G | 1 |
| Kennedy, T | 2 |
| Green, WE | 1 |
| Isenberg, JI | 2 |
| Thomsen, F | 1 |
| Kjaergaard, J | 1 |
| Feinberg, LE | 1 |
| Knudson, KB | 1 |
| Dyck, WP | 1 |
| Aeberhard, P | 1 |
| Guslandi, M | 2 |
| Tittobello, A | 2 |
| Girodet, J | 1 |
| Toutounji, M | 1 |
| Rougier, P | 1 |
| Mignon, M | 1 |
| Bonfils, S | 1 |
| Speranza, V | 1 |
| Basso, N | 1 |
| Lezoche, E | 1 |
| Materia, A | 1 |
| Bagarani, M | 1 |
| Paduos, A | 1 |
| Hecker, R | 3 |
| Jablonská, M | 1 |
| Arakawa, T | 1 |
| Watanabe, T | 1 |
| Fukuda, T | 1 |
| Yamasaki, K | 1 |
| Kobayashi, K | 2 |
| Horie, Y | 1 |
| Norimoto, M | 1 |
| Tajima, F | 1 |
| Sasaki, H | 1 |
| Nanba, E | 1 |
| Kawasaki, H | 1 |
| Boonyapisit, S | 1 |
| Manatsathit, S | 1 |
| Kachintorn, U | 1 |
| Tanwandee, T | 1 |
| Sattawatthamrong, Y | 1 |
| Chinapak, O | 1 |
| Rørbaek-Madsen, M | 1 |
| Fischer, L | 1 |
| Thomsen, H | 1 |
| Wara, P | 1 |
| Tatsuta, M | 4 |
| Iishi, H | 4 |
| Yokota, Y | 2 |
| Riedl, CR | 1 |
| Zinnbauer, B | 1 |
| Pan, S | 2 |
| Liao, CH | 3 |
| Lien, GS | 2 |
| Chen, SH | 2 |
| Tekant, Y | 1 |
| Goh, P | 1 |
| Low, C | 1 |
| Ngoi, SS | 1 |
| Katschinski, B | 1 |
| Logan, R | 1 |
| Davies, J | 1 |
| Faulkner, G | 1 |
| Pearson, J | 1 |
| Langman, M | 1 |
| Ota, S | 1 |
| Terano, A | 1 |
| Ishimori, A | 4 |
| Neeman, A | 1 |
| Kadish, U | 1 |
| Seshadri, P | 1 |
| Emerson, L | 1 |
| Morales, A | 1 |
| Kreĭmer, LI | 1 |
| Krivosheev, AB | 1 |
| Khvan, LA | 1 |
| Chia, JK | 1 |
| Kim, DO | 1 |
| Lebow, RC | 1 |
| Kato, S | 1 |
| Ozawa, A | 1 |
| Shibuya, H | 1 |
| Ohtake, M | 1 |
| Nakagawa, H | 1 |
| Ohtsuka, A | 1 |
| Koyama, S | 1 |
| Horie, T | 1 |
| Dubracić, D | 1 |
| Pulanić, R | 1 |
| Katicić, M | 1 |
| Car, D | 1 |
| Georgijević, A | 1 |
| Cvitanović, B | 1 |
| Chen, SP | 1 |
| Bei, L | 1 |
| Wen, SH | 1 |
| Salim, AS | 6 |
| Sarris, AH | 1 |
| Younes, A | 1 |
| McLaughlin, P | 1 |
| Moore, D | 1 |
| Hagemeister, F | 1 |
| Swan, F | 1 |
| Rodriguez, MA | 1 |
| Romaguera, J | 1 |
| North, L | 1 |
| Mansfield, P | 1 |
| Callendar, D | 1 |
| Mesina, O | 1 |
| Cabanillas, F | 1 |
| Shirotani, T | 1 |
| Okada, M | 1 |
| Murayama, H | 1 |
| Maeda, K | 1 |
| Seo, M | 1 |
| Okabe, N | 1 |
| Nakahara, T | 1 |
| Oh, K | 1 |
| Nakayama, Y | 1 |
| Hoshiko, K | 1 |
| Oda, K | 1 |
| Okumura, M | 1 |
| Bischof, G | 1 |
| Feil, W | 1 |
| Riegler, M | 1 |
| Wenzl, E | 1 |
| Schiessel, R | 1 |
| Sekiguchi, H | 1 |
| Ohsawa, A | 1 |
| Kobayashi, F | 1 |
| Ohkubo, H | 1 |
| Taga, F | 1 |
| Ruszniewski, P | 1 |
| Wan, QX | 1 |
| Wang, Y | 1 |
| Wang, D | 1 |
| Raju, GS | 2 |
| Hull, MA | 1 |
| Knifton, A | 1 |
| Filipowicz, B | 1 |
| Brough, JL | 1 |
| Vautier, G | 1 |
| Hawkey, CJ | 1 |
| Satoh, H | 1 |
| Asano, S | 1 |
| Maeda, R | 1 |
| Murakami, I | 1 |
| Inada, I | 1 |
| Sato, F | 1 |
| Shino, A | 1 |
| Lee, FY | 1 |
| Tseng, GY | 1 |
| Cherian, P | 1 |
| Jones, RB | 1 |
| Vaishnavi, A | 1 |
| Manek, S | 1 |
| Bishop, A | 1 |
| Polak, J | 1 |
| Brooks, A | 1 |
| Morris, P | 1 |
| Thompson, M | 1 |
| D'Silva, J | 1 |
| Parkin, S | 1 |
| Patterson, J | 1 |
| Gillon, KR | 1 |
| Onodera, S | 1 |
| Tanaka, M | 1 |
| Aoyama, M | 1 |
| Arai, Y | 1 |
| Shibata, M | 1 |
| Yamaura, T | 1 |
| Ohnishi, H | 1 |
| Zuccaro, G | 1 |
| Della Bella, S | 2 |
| Polizzi, B | 1 |
| Vanoli, M | 2 |
| Scorza, R | 2 |
| Fujino, S | 1 |
| Suzuki, Y | 2 |
| Tanaka, T | 2 |
| Chen, SY | 1 |
| Wang, JY | 1 |
| Chen, J | 1 |
| Zhang, XD | 1 |
| Zhang, SS | 1 |
| Allen, AL | 1 |
| Siegfried, EC | 1 |
| Maudgal, DP | 1 |
| Machell, RJ | 2 |
| Ciclitira, PJ | 2 |
| Farthing, MJ | 2 |
| Dick, AP | 2 |
| Hunter, JO | 3 |
| Taylor, RH | 1 |
| Menzies-Gow, N | 1 |
| Lovell, D | 1 |
| La Brooy, SJ | 2 |
| Langman, MJ | 2 |
| Cargill, JM | 1 |
| Peden, N | 1 |
| Hoare, AM | 2 |
| Bradby, GV | 1 |
| Hawkins, CF | 2 |
| Dykes, PW | 1 |
| McCarthy, DM | 1 |
| Harting, JW | 1 |
| De Cock, W | 1 |
| De Cree, J | 1 |
| Verhaegen, H | 1 |
| Molinari, F | 1 |
| Turello, V | 1 |
| Giacosa, A | 1 |
| Ciancamerla, G | 1 |
| Cheli, R | 1 |
| Hansky, PJ | 1 |
| Taggart, GJ | 1 |
| Jackson, R | 1 |
| Gabb, BW | 1 |
| Mackenzie, I | 2 |
| Winship, DH | 1 |
| Brogden, RN | 1 |
| Heel, RC | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Gudmand-Høyer, E | 1 |
| Krag, E | 1 |
| Rask-Madsen, J | 2 |
| Spencer, A | 1 |
| Jones, EL | 1 |
| Stillman, AE | 1 |
| Walker, BE | 1 |
| Simmons, AV | 1 |
| Peterson, W | 1 |
| Mekel, RC | 1 |
| Saul, DM | 1 |
| Edwards, JL | 1 |
| Smith, PM | 2 |
| Haggie, SJ | 3 |
| Wyllie, JH | 3 |
| Duthie, HL | 1 |
| Fussey, IV | 1 |
| Møllmann, KM | 1 |
| Driessen, WM | 1 |
| Dronfield, MW | 1 |
| Batchelor, AJ | 1 |
| Larkworthy, W | 1 |
| Sheers, R | 1 |
| Edwards, J | 1 |
| Libman, L | 1 |
| Sarner, M | 1 |
| Croker, J | 1 |
| Cotton, P | 1 |
| Berstad, A | 3 |
| Carlsen, E | 2 |
| Semb, LS | 2 |
| Kruse Jensen, A | 1 |
| Myren, J | 2 |
| Aadland, E | 2 |
| Clark, CG | 6 |
| Boulos, PB | 2 |
| Kruse-Jensen, A | 1 |
| Norlander, B | 1 |
| Larsson, R | 1 |
| Baron, JH | 1 |
| Bennett, JR | 1 |
| Halter, F | 1 |
| Petite, JP | 2 |
| Bloch, F | 1 |
| Kiene, K | 2 |
| Weber, KB | 1 |
| Wienbeck, M | 1 |
| McDonald, AM | 1 |
| Publig, W | 1 |
| Wyndham, N | 1 |
| Reichmann, J | 1 |
| Gyr, K | 1 |
| Stage, JG | 1 |
| Henriksen, FW | 1 |
| Kehlet, H | 1 |
| Scott-Findlay, J | 1 |
| Freston, JW | 2 |
| Bierti, L | 1 |
| Fordtran, JS | 1 |
| Weber, K | 1 |
| Schmitz, H | 1 |
| Richter, O | 1 |
| Hofstetter, JR | 1 |
| Sharpe, PC | 1 |
| Wastell, C | 1 |
| Hawkins, B | 1 |
| Horton, RJ | 1 |
| Gray, G | 1 |
| Kawamura, T | 3 |
| Koizumi, F | 3 |
| Kawakami, K | 1 |
| Inoue, S | 1 |
| Kano, A | 1 |
| Takahashi, T | 1 |
| Asaki, S | 1 |
| Zlyĭ, MV | 1 |
| Netiazhenko, VZ | 1 |
| Zlyĭ, VV | 1 |
| Hui, WM | 5 |
| Lok, AS | 4 |
| Ng, MM | 4 |
| Lai, CL | 4 |
| Jensen, SL | 1 |
| Funch Jensen, P | 1 |
| Michocki, RJ | 1 |
| Richardson, JP | 1 |
| Fukutomi, H | 1 |
| Nakahara, A | 1 |
| Iwasaki, A | 1 |
| Matsuo, Y | 1 |
| Isakov, VA | 1 |
| Topfmeier, P | 1 |
| Eberhardt, R | 2 |
| Mateblowski, M | 1 |
| Kuhn, D | 1 |
| Radelli, L | 1 |
| Molteni, M | 1 |
| Galimberti, D | 1 |
| Mascagni, B | 1 |
| Coppola, C | 1 |
| Uribarrena, R | 1 |
| Arín, A | 1 |
| Varela, JI | 1 |
| Oreja, M | 1 |
| Burusco, MJ | 1 |
| Fortún, MT | 1 |
| Lind, CD | 1 |
| Blaser, MJ | 1 |
| Pan, SA | 1 |
| Primrose, JN | 2 |
| Naik, KS | 1 |
| Blackett, RL | 1 |
| King, RF | 1 |
| Holmfield, JH | 1 |
| Lagopolous, M | 1 |
| Johnston, D | 2 |
| Palmer, RH | 1 |
| Frank, WO | 1 |
| Karlstadt, R | 1 |
| Sikiric, P | 1 |
| Rotkvic, I | 1 |
| Mise, S | 1 |
| Petek, M | 1 |
| Rucman, R | 1 |
| Seiwerth, S | 1 |
| Zjacic-Rotkvic, V | 1 |
| Duvnjak, M | 1 |
| Jagic, V | 1 |
| Suchanek, E | 1 |
| Schumacher, MC | 1 |
| Jick, SS | 1 |
| Jick, H | 1 |
| Feld, AD | 1 |
| Wozel, G | 1 |
| Sahre, EM | 1 |
| Barth, J | 1 |
| Maxton, DG | 1 |
| Heald, J | 1 |
| Whorwell, PJ | 1 |
| Haboubi, NY | 1 |
| Ishikawa, H | 1 |
| Okuda, S | 3 |
| Yeung, CK | 1 |
| Fu, KH | 1 |
| Yuen, KY | 1 |
| Ng, WF | 1 |
| Tsang, TM | 1 |
| Branicki, FJ | 4 |
| Saing, H | 1 |
| Hameeteman, W | 1 |
| Mulder, CJ | 1 |
| Wiersinga, W | 1 |
| van de Boomgaard, DM | 1 |
| Dees, J | 1 |
| Penston, JG | 1 |
| Gent, AE | 1 |
| Hellier, MD | 1 |
| Ito, M | 1 |
| Tulassay, Z | 2 |
| Gupta, R | 1 |
| Papp, J | 2 |
| Bodnár, A | 1 |
| Marshall, BJ | 2 |
| Warren, JR | 1 |
| Goodwin, CS | 2 |
| Ho, J | 2 |
| Ng, I | 2 |
| Wichan, P | 1 |
| Zabielski, G | 1 |
| Schirmer, BD | 1 |
| Wolosin, JD | 1 |
| Gertler, SL | 1 |
| Peterson, WL | 1 |
| Sandersfeld, MA | 1 |
| Varas, MJ | 1 |
| Lau, WY | 3 |
| Fok, J | 1 |
| Bayerdörffer, E | 1 |
| Mannes, GA | 1 |
| Pfaller, P | 1 |
| Sauerbruch, T | 1 |
| Chiang, BL | 1 |
| Chang, MH | 1 |
| Lin, MI | 1 |
| Hsu, JY | 1 |
| Wang, CY | 1 |
| Wang, TH | 1 |
| Tovey, FI | 2 |
| Husband, EM | 2 |
| Yiu, YC | 2 |
| Baker, L | 2 |
| McPhail, G | 2 |
| Lewin, MR | 2 |
| Jayaraj, AP | 2 |
| Hansell, DT | 1 |
| McGushin, M | 1 |
| Meddings, RN | 1 |
| Flind, AC | 1 |
| Greenberger, PA | 1 |
| Patterson, R | 1 |
| Tapio, CM | 1 |
| Kueh, YK | 1 |
| LaBrooy, S | 1 |
| Sutton, JC | 1 |
| Panés, J | 1 |
| Viver, J | 1 |
| Forné, M | 1 |
| Garcia-Olivares, E | 1 |
| Marco, C | 1 |
| Garau, J | 1 |
| Pinto, E | 1 |
| Verre, L | 1 |
| De Stefano, A | 1 |
| Trombì, G | 1 |
| Dobrilla, G | 1 |
| Vallaperta, P | 1 |
| Amplatz, S | 1 |
| Lane, MR | 1 |
| Lee, SP | 2 |
| Sakai, H | 1 |
| Oka, H | 1 |
| Sakaguchi, M | 1 |
| Tani, N | 1 |
| Miwa, T | 1 |
| Ishikawa, M | 1 |
| Saito, H | 1 |
| Sato, J | 1 |
| Tomasko, MA | 1 |
| Luskin, AT | 1 |
| Luttwak, EM | 1 |
| Saltz, NJ | 1 |
| Kurata, JH | 2 |
| Nogawa, AN | 2 |
| Daneshmend, TK | 1 |
| Sander-Jensen, K | 1 |
| Thomsen, K | 1 |
| Lee, CH | 1 |
| P'eng, FK | 1 |
| Lui, WY | 1 |
| Kasper, G | 1 |
| Dettmer, A | 1 |
| Höchter, W | 1 |
| Hagena, D | 1 |
| Rokkas, T | 1 |
| Sladen, GE | 1 |
| Szathmári, M | 1 |
| Schandl, L | 1 |
| Capezzuto, E | 1 |
| De Santis, G | 1 |
| Russell, RI | 1 |
| Hines, C | 1 |
| Martin, T | 1 |
| Gaussen, L | 1 |
| Herting, RL | 2 |
| Nissen, CH | 1 |
| Pym, BM | 1 |
| Toy, S | 1 |
| Gellatly, R | 1 |
| Seville, P | 1 |
| Brandstätter, G | 1 |
| Judmaier, G | 1 |
| Kratochvil, P | 1 |
| Müller, P | 1 |
| Dammann, HG | 1 |
| Simon, B | 1 |
| Lieberman, DA | 1 |
| Wade, AG | 1 |
| Rowley-Jones, D | 1 |
| Axon, AT | 2 |
| Maggiolo, F | 1 |
| Ohnmeiss, H | 1 |
| Vickhoff, T | 1 |
| Blincow, ED | 1 |
| Wilson, DH | 1 |
| Blackbourn, S | 1 |
| Phillips, M | 1 |
| Bertschinger, P | 1 |
| Lacher, G | 1 |
| Aenishänslin, W | 1 |
| Baerlocher, C | 1 |
| Bernoulli, R | 1 |
| Egger, G | 1 |
| Eisner, M | 1 |
| Fasel, F | 1 |
| Fehr, HR | 1 |
| Fumagalli, I | 1 |
| Bianchi-Porro, G | 1 |
| Delattre, M | 1 |
| Bolin, TD | 1 |
| Davis, AE | 1 |
| Billington, B | 1 |
| Aärimaa, M | 1 |
| Lööf, L | 2 |
| Adami, HO | 2 |
| Bates, S | 2 |
| Fagerström, KO | 1 |
| Gustavsson, S | 2 |
| Nyberg, A | 2 |
| Nyrén, O | 2 |
| Brodin, U | 1 |
| Hallerbäck, B | 3 |
| Solhaug, JH | 3 |
| Carling, L | 3 |
| Glise, H | 3 |
| Hallgren, T | 2 |
| Kagevi, I | 3 |
| Svedberg, LE | 3 |
| Wählby, L | 3 |
| Busman, DC | 1 |
| Brombacher, PJ | 1 |
| Munting, JD | 1 |
| Fok, PJ | 2 |
| Poon, GP | 2 |
| Kinney, E | 1 |
| Goderwis, D | 1 |
| Mullins, RJ | 1 |
| Larson, GM | 1 |
| List, AF | 1 |
| Beaird, DH | 1 |
| Kummet, T | 1 |
| Sakai, M | 1 |
| Magni, G | 1 |
| Borgherini, G | 1 |
| Donzella, G | 1 |
| Pellegrini, C | 1 |
| Bergström, R | 1 |
| Hamilton, I | 1 |
| O'Connor, HJ | 1 |
| Wood, NC | 1 |
| Bradbury, I | 1 |
| Worning, H | 1 |
| Smagin, VG | 1 |
| Titov, MI | 1 |
| Bulgakov, SA | 1 |
| Propisnova, EP | 1 |
| Lux, G | 1 |
| Hentschel, H | 1 |
| Brunner, H | 1 |
| Lederer, PC | 1 |
| Pace, F | 1 |
| Simpson, CJ | 1 |
| Lamont, G | 1 |
| Macdonald, I | 1 |
| Choi, TK | 1 |
| Farinati, F | 1 |
| Carmichael, JM | 1 |
| Zell, SC | 1 |
| Nio, CY | 1 |
| García-Barón Portolés, A | 1 |
| Romero, E | 1 |
| Tsimmerman, IaS | 1 |
| Syman, LN | 1 |
| Golovanova, ES | 1 |
| Labeeuw, M | 1 |
| Cabanne, JF | 1 |
| Dubot, P | 1 |
| Hinchliffe, RF | 1 |
| Bose, K | 1 |
| Umeda, Y | 1 |
| Nakamura, K | 1 |
| Wang, JF | 1 |
| Lu, GY | 1 |
| Zhan, WH | 1 |
| McLean, AJ | 3 |
| McCarthy, P | 3 |
| Dudley, FJ | 3 |
| Boyd, E | 1 |
| Yeomans, ND | 1 |
| Goldfarb, JP | 1 |
| Czaja, MJ | 1 |
| Lauritsen, K | 1 |
| Bytzer, P | 1 |
| Kelbaek, H | 1 |
| Jensen, KG | 1 |
| Bendtsen, F | 1 |
| Linde, J | 1 |
| Højlund, M | 1 |
| Andersen, HH | 1 |
| Deveney, CW | 1 |
| Deveney, KE | 1 |
| Jean, F | 1 |
| Bonnefond, A | 1 |
| Gislon, J | 1 |
| Kloeti, G | 1 |
| Rautureau, J | 1 |
| Roberti, A | 1 |
| Zeitoun, P | 1 |
| Paoluzi, P | 1 |
| Ricotta, G | 1 |
| Ripoli, F | 1 |
| Proietti, F | 1 |
| Zaccardelli, E | 1 |
| Carratù, R | 1 |
| Torsoli, A | 1 |
| Harrison, PM | 1 |
| Ioannides-Demos, L | 1 |
| Byrne, AJ | 1 |
| Pavlotzky, M | 1 |
| Eshchar, J | 1 |
| O'Keefe, SJ | 1 |
| Spitaels, JM | 1 |
| Mannion, G | 1 |
| Naiker, N | 1 |
| Spiro, HM | 1 |
| Clay, GA | 1 |
| Nowak, W | 1 |
| Klare, M | 1 |
| Weaver, RM | 1 |
| Temple, JG | 1 |
| Tsega, E | 1 |
| Abebe, M | 1 |
| Haddad, W | 1 |
| Kestenbaum, DJ | 1 |
| Wang, HS | 1 |
| Truhan, AP | 1 |
| Raab, B | 1 |
| Huber, O | 1 |
| Houriet, M | 1 |
| Kobel, T | 1 |
| Rohner, A | 1 |
| Beger, HG | 1 |
| Roscher, R | 1 |
| Lorenz, W | 1 |
| Thon, K | 1 |
| Ohmann, C | 1 |
| Röher, HD | 1 |
| Hull, DH | 1 |
| Beale, PJ | 1 |
| de Miguel Gómez, J | 1 |
| Gómez Cortijo, T | 1 |
| de Miguel del Campo, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of High Dose Infusion and Low Dose Bolus Intravenous Omeprazole for Treatment of Bleeding Ulcer With Adherent Clot[NCT02536989] | Phase 4 | 40 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
| Personalized Treatment for Refractory H Pylori Infection[NCT02547025] | 126 participants (Actual) | Interventional | 2012-08-01 | Completed | |||
| Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss: a Pilot Randomized Controlled Trial[NCT02141555] | Phase 2/Phase 3 | 4 participants (Actual) | Interventional | 2014-08-31 | Completed | ||
| Immune Modulation by Misoprostol[NCT02259309] | Early Phase 1 | 15 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Assessment of medication side effects including: nausea, vomiting, headache, fever (over 100.4 F), dizziness, diarrhea, bad taste, dry mouth Did you experience any of these side effects? If so, how long did they last?~Patients asked on a scale of 0 to 3, where:~Side Effect scale:~0 = never~1= less than one day 2 = 1 to 2 days 3 = more than 2 days" (NCT02141555)
Timeframe: one week
| Intervention | Participants (Count of Participants) |
|---|---|
| Vaginal Misoprostol | 0 |
| Buccal Misoprostol | 0 |
"Written surveys patients will fill out at follow up visit assessing patient's satisfaction with the procedure.~How satisfied were you with your procedure?~The satisfaction scale used was:~1 =Very Satisfied, comfortable, likely to recommend 3= Neutral 5= Very unsatisfied/uncomfortable, unlike to recommend" (NCT02141555)
Timeframe: one week
| Intervention | Participants (Count of Participants) |
|---|---|
| Vaginal Misoprostol | 2 |
| Buccal Misoprostol | 2 |
Number of participants with complete abortion without surgical intervention defined as no evidence of a gestational sac on transvaginal ultrasound at the follow up visit. (NCT02141555)
Timeframe: one week
| Intervention | Participants (Count of Participants) |
|---|---|
| Vaginal Misoprostol | 1 |
| Buccal Misoprostol | 2 |
The percentage of women who are offered enrollment and accept. (NCT02141555)
Timeframe: One year
| Intervention | Participants (Count of Participants) |
|---|---|
| Vaginal Misoprostol | 2 |
| Buccal Misoprostol | 2 |
40 reviews available for cimetidine and Recrudescence
| Article | Year |
|---|---|
The PFAPA syndrome in oral medicine: differential diagnosis and treatment.
Topics: Analgesics; Anti-Inflammatory Agents; Child; Child, Preschool; Cimetidine; Diagnosis, Differential; | 2006 |
Acute and chronic pancreatitis. An update on management.
Topics: Acute Disease; Animals; Aprotinin; Chronic Disease; Cimetidine; Dogs; Enzyme Inhibitors; Enzyme Ther | 1984 |
Update in treatment of peptic ulcer disease.
Topics: Adult; Aged; Alcohol Drinking; Aluminum; Antacids; Anti-Ulcer Agents; Aspirin; Bismuth; Cimetidine; | 1984 |
Medical management of peptic ulcer.
Topics: Aluminum; Antacids; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Humans; Omep | 1984 |
Current therapy in peptic ulcer.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Drug Therapy, Combination; Histamine H2 Antagonists; H | 1980 |
[Conservative therapy of peptic ulcer].
Topics: Antacids; Benzodiazepinones; Carbenoxolone; Cimetidine; Gastric Acid; Gastroscopy; Histamine H2 Anta | 1980 |
[Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Topics: Binding, Competitive; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Fur | 1983 |
Drug therapy of peptic ulcer disease.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Bismuth; Carbenoxolone; Cimetidine; Gastric Mucosa; Histamine | 1983 |
Medical management of gastric ulcer.
Topics: Aged; Animals; Antacids; Carbenoxolone; Cimetidine; Clinical Trials as Topic; Dogs; Double-Blind Met | 1983 |
Medical and surgical treatment of chronic gastric ulcer.
Topics: Antacids; Chronic Disease; Cimetidine; Gastrectomy; Histamine H2 Antagonists; Humans; Peptic Ulcer; | 1984 |
Drugs for the prevention of peptic ulcer recurrence.
Topics: Aluminum; Anti-Ulcer Agents; Benzodiazepinones; Cimetidine; Humans; Parasympatholytics; Peptic Ulcer | 1983 |
Long-term treatment of duodenal ulcer.
Topics: Cimetidine; Costs and Cost Analysis; Duodenal Ulcer; Humans; Postoperative Complications; Ranitidine | 1984 |
[Ulcer recurrence after selective proximal vagotomy (review of the literature)].
Topics: Cimetidine; Duodenal Ulcer; Humans; Prognosis; Recurrence; Reoperation; Stomach Ulcer; Vagotomy; Vag | 1984 |
Medical versus surgical therapy for duodenal ulcer: making the right choices.
Topics: Antacids; Cimetidine; Cost-Benefit Analysis; Duodenal Ulcer; Humans; Parasympatholytics; Postoperati | 1980 |
[Maintenance cimetidine treatment in duodenal ulcer disease. First part: Effect on gastric physiology and clinical efficacy (author's transl)].
Topics: Animals; Cimetidine; Duodenal Ulcer; Guanidines; Humans; Rats; Recurrence; Stomach | 1980 |
Role of protective drugs in the prevention of ulcer relapse.
Topics: Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Humans; Peptic Ulcer; Recurrence; Sucralfate | 1994 |
[Therapeutic management of duodenal ulcer except in emergency cases: antisecretory treatment].
Topics: Anti-Ulcer Agents; Cimetidine; Cost-Benefit Analysis; Duodenal Ulcer; Humans; Ranitidine; Recurrence | 1996 |
What's new in human papillomavirus infection.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Child; Cidofovir; Cimetidine; Cyto | 2000 |
Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.
Topics: Acute Disease; Animals; Cimetidine; Duodenal Ulcer; Gastric Juice; Gastrins; Gastrointestinal Hemorr | 1978 |
Peptic ulceration and its correlation with symptoms.
Topics: Carbenoxolone; Chronic Disease; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Duodenum; Endo | 1978 |
Modern medical therapy of uncomplicated duodenal ulcer.
Topics: Antacids; Cimetidine; Duodenal Ulcer; Humans; Parasympatholytics; Recurrence | 1978 |
The pharmacology of peptic ulcer disease.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Carbenoxolone; Cimetidine; Clinical Trials as Topic; Costs and | 1979 |
Medical treatment of duodenal ulcer.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Citrates; Clinical Trials as Topic; Dose-Response Rela | 1979 |
Role of sucralfate in peptic disease.
Topics: Cimetidine; Dyspepsia; Esophagitis, Peptic; Gastritis; Humans; Peptic Ulcer; Ranitidine; Recurrence; | 1992 |
The clinical use of histamine-2 receptor antagonists.
Topics: Cimetidine; Drug Evaluation; Famotidine; Gastroesophageal Reflux; Humans; Nizatidine; Peptic Ulcer; | 1992 |
[Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
Topics: Cimetidine; Drug Therapy, Combination; Histamine H2 Antagonists; Humans; Peptic Ulcer; Ranitidine; R | 1991 |
Helicobacter pylori and duodenal ulceration.
Topics: Cimetidine; Duodenal Ulcer; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Human | 1991 |
Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis.
Topics: Cimetidine; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Meta-Analysis as Topic; Placebos; Rani | 1990 |
Current status of proximal gastric vagotomy.
Topics: Cimetidine; Combined Modality Therapy; Duodenal Ulcer; Emergencies; Gastric Acid; Humans; Peptic Ulc | 1989 |
Duodenal ulcer. Who should have long-term maintenance therapy?
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male | 1987 |
Influence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials.
Topics: Anti-Ulcer Agents; Cimetidine; Histamine H2 Antagonists; Humans; Peptic Ulcer; Ranitidine; Recurrenc | 1988 |
Bismuth: effects on gastritis and peptic ulcer.
Topics: Cimetidine; Duodenal Ulcer; Dyspepsia; Gastritis; Humans; Organometallic Compounds; Peptic Ulcer; Re | 1988 |
Overview of misoprostol clinical experience.
Topics: Alprostadil; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Diarrhea; Duodenal Ulcer; Fema | 1986 |
[Treatment of recurrent ulcers after vagotomy].
Topics: Cimetidine; Gastrectomy; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Po | 1987 |
Medical and surgical prophylaxis for duodenal ulcer, the role of sucralfate.
Topics: Cimetidine; Duodenal Ulcer; Humans; Recurrence; Sucralfate | 1987 |
Highly selective vagotomy and serum gastrin levels.
Topics: Adult; Chronic Disease; Cimetidine; Duodenal Ulcer; Evaluation Studies as Topic; Female; Follow-Up S | 1987 |
Comparison of ranitidine and cimetidine ulcer maintenance therapy.
Topics: Cimetidine; Duodenal Ulcer; Humans; Ranitidine; Recurrence | 1987 |
Medical treatment of peptic ulcers.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Cimetidine; Humans; Omeprazole; Para | 1985 |
The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome.
Topics: Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Prospective Studies | 1985 |
[Recent state of therapy of peptic disease].
Topics: Antacids; Anti-Ulcer Agents; Cimetidine; Gastric Acid; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage | 1985 |
195 trials available for cimetidine and Recrudescence
| Article | Year |
|---|---|
Clinical effects of psychological intervention and drug therapy against peptic ulcer.
Topics: Adult; Anti-Ulcer Agents; Anxiety; China; Cimetidine; Cognitive Behavioral Therapy; Combined Modalit | 2012 |
Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
Topics: Adult; Aged; Anti-Ulcer Agents; Blood Transfusion; Cimetidine; Drug Administration Schedule; Electro | 2006 |
Effect of ranitidine and cimetidine on gastric ulcer healing and recurrence.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; | 1984 |
[Ranitidine, cimetidine and placebo in the short and longer term treatment of duodenal ulcer].
Topics: Adolescent; Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Duoden | 1984 |
Review of peptic ulcer maintenance trials.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Peptic Ulcer; Placebos; Ranitidine; Re | 1984 |
Protocol design for recent duodenal ulcer maintenance trials.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Humans; Placebos; | 1984 |
Results of the United States ranitidine maintenance trials.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged | 1984 |
Interim analysis of a comparative trial of ranitidine and cimetidine in the prevention of duodenal ulcer.
Topics: Adult; Aged; Australia; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; D | 1984 |
Interpretation of statistical methodology associated with maintenance trials.
Topics: Actuarial Analysis; Analysis of Variance; Cimetidine; Clinical Trials as Topic; Follow-Up Studies; H | 1984 |
Comparison of ranitidine and cimetidine maintenance treatment of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; | 1984 |
Model of medical treatment for duodenal ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Duodenal Ul | 1981 |
Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.
Topics: Adolescent; Adult; Aged; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodena | 1981 |
Clinical and endocrine aspects of treatment with ranitidine.
Topics: Administration, Oral; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Fem | 1981 |
Five-year study of cimetidine or surgery for severe duodenal ulcer dyspepsia.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Dyspepsia; Female; Follow | 1982 |
[Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Topics: Binding, Competitive; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Fur | 1983 |
Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Metho | 1983 |
Medical management of gastric ulcer.
Topics: Aged; Animals; Antacids; Carbenoxolone; Cimetidine; Clinical Trials as Topic; Dogs; Double-Blind Met | 1983 |
Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Humans; Midd | 1984 |
Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine.
Topics: Adult; Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Meth | 1984 |
Cimetidine or parietal-cell vagotomy in patients with juxtapyloric ulcers.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Female; Gastric Acid; Humans; Male; Middle Aged; | 1984 |
Ranitidine, cimetidine and antacids in the prevention of recurrence after healed duodenal ulcer: one-year experience.
Topics: Antacids; Cimetidine; Duodenal Ulcer; Humans; Ranitidine; Recurrence | 1983 |
Treatment of acute massive gastroduodenal haemorrhage with cimetidine in elderly patients.
Topics: Acute Disease; Aged; Blood Transfusion; Cimetidine; Double-Blind Method; Female; Gastrointestinal He | 1984 |
A two-year prospective controlled study of maintenance cimetidine and gastric ulcer.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Guanidines; Humans; | 1983 |
Recurrent ulcer after successful treatment with cimetidine or antacid.
Topics: Aluminum Hydroxide; Antacids; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Combin | 1983 |
Effect of cimetidine treatment in the prevention of gastric ulcer relapse: a one year double blind multicentre study.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Guanidines; Humans; | 1983 |
Maintenance treatment of patients with healed peptic ulcer with sucralfate, placebo and cimetidine.
Topics: Aluminum; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Humans; Pept | 1983 |
Prospective, randomized trial of selective proximal vagotomy with ulcer excision and partial gastrectomy with gastroduodenostomy in the treatment of corporeal gastric ulcer.
Topics: Antacids; Cimetidine; Clinical Trials as Topic; Duodenum; Gastrectomy; Humans; Middle Aged; Prospect | 1983 |
Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers.
Topics: Adolescent; Adult; Age Factors; Aged; Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; | 1983 |
Controlled trial of medical therapy for active upper gastrointestinal bleeding and prevention of rebleeding.
Topics: Adult; Aged; Antacids; Cimetidine; Clinical Trials as Topic; Drug Therapy, Combination; Esophageal a | 1984 |
Relapse prevention of duodenal ulcers with trimipramine, cimetidine, or placebo. A double-blind comparison.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Dibenzazepines; Double-Blind Method; Duodenal Ulc | 1984 |
Cimetidine therapy does not prevent rebleeding from peptic ulceration.
Topics: Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Mal | 1984 |
Cimetidine, cigarette smoking, and recurrence of duodenal ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Mid | 1984 |
[A prospective, randomized, multicenter, double-blind clinical trial of "xi lei san" in the treatment of duodenal ulcer].
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulce | 1984 |
The effect of cimetidine on the maintenance of healing of gastric ulceration.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Gastroscopy; Humans; | 1984 |
Cimetidine reduces the risk of rebleeding from duodenal ulcers displaying signs of recent haemorrhage.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Mid | 1984 |
Proximal gastric vagotomy versus long-term maintenance treatment with cimetidine for chronic duodenal ulcer: a prospective randomised trial.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; | 1983 |
Duodenal ulcer: maintenance treatment with cimetidine.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Humans; Long-Term | 1983 |
Maintenance therapy for duodenal ulcer--a trial comparing cimetidine with a prostaglandin synthetase promoter.
Topics: Anti-Ulcer Agents; Benzenesulfonates; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duo | 1984 |
[Recurrence of duodenal ulcer after therapy with Sucralfat or cimetidine].
Topics: Aluminum; Cimetidine; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurren | 1984 |
Treatment and relapse prophylaxis of duodenal ulcer with pirenzepine and cimetidine.
Topics: Adult; Anti-Ulcer Agents; Benzodiazepinones; Cimetidine; Clinical Trials as Topic; Double-Blind Meth | 1982 |
Antacid therapy for duodenal and gastric ulcer: the experience in the United States.
Topics: Antacids; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Male; Recurrence; Stomach Ul | 1982 |
A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Endos | 1982 |
Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration.
Topics: Adult; Aged; Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blin | 1982 |
Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; | 1982 |
Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Gastric Acid; Guanid | 1981 |
Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate?
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guanidines | 1982 |
[Long-term prevention of duodenal ulcer with cimetidine. Effect of the rhythm of ingestion and drug compliance on the incidence of recurrence].
Topics: Adult; Aged; Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Female; Guanidines; Humans; L | 1982 |
[Comparative treatment of gastroduodenal haemorrhage with secretin and cimetidine].
Topics: Adult; Cimetidine; Female; Gastrointestinal Hemorrhage; Guanidines; Humans; Male; Mathematics; Pepti | 1982 |
Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; | 1980 |
[Prevention by cimetidine of duodenal ulcer relapses: a multicenter controlled trial (author's transl)].
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guanidines | 1980 |
Recurrence of duodenal ulcer pain after treatment with cimetidine for four and eight weeks.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guan | 1980 |
Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; | 1980 |
New medical and surgical treatments for peptic ulcer disease.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Prostaglandins, Synthetic; Recurrence; | 1980 |
Proven clinical uses of cimetidine.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Guanidines; Humans; Pepti | 1980 |
[Prevention of duodenal ulcer recurrences with a maintenance dosage of cimetidine].
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Guanidines; | 1980 |
Controlled trial of carbenoxolone sodium vs. cimetidine in duodenal ulcer.
Topics: Adolescent; Adult; Aged; Carbenoxolone; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female | 1980 |
Cimetidine for the treatment of symptomatic gastro-oesophageal reflux.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Gastroesophageal Reflux; Guanidin | 1981 |
Long-term treatment of gastric ulcer with cimetidine.
Topics: Adolescent; Adult; Antacids; Cimetidine; Clinical Trials as Topic; Female; Gastric Acid; Guanidines; | 1981 |
Predictors of duodenal ulcer healing and relapse.
Topics: Adult; Age Factors; Alcohol Drinking; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duo | 1981 |
Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
Topics: Aluminum; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Follow-Up Studies | 1981 |
Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers.
Topics: Aluminum Hydroxide; Antacids; Atropine; Cimetidine; Clinical Trials as Topic; Double-Blind Method; D | 1981 |
[Treatment and prevention of recurrence of duodenal ulcer with pirenzepin and cimetidine].
Topics: Adult; Aged; Benzodiazepinones; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Guanid | 1982 |
Bedtime cimetidine maintenance treatment: optimum dose and effect on subsequent natural history of duodenal ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ad | 1982 |
Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy.
Topics: Aged; Aluminum Hydroxide; Bismuth; Cimetidine; Clinical Trials as Topic; Drug Combinations; Female; | 1982 |
Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing.
Topics: Bismuth; Cimetidine; Clinical Trials as Topic; Colloids; Drug Therapy, Combination; Duodenal Ulcer; | 1982 |
[Effect of cimetidine and secretin on acute bleedings from gastroduodenal ulcers and erosions: a prospective study (author's transl)].
Topics: Cimetidine; Guanidines; Humans; Peptic Ulcer Hemorrhage; Prospective Studies; Recurrence; Secretin; | 1982 |
[Treatment of jejunal peptic ulcer with cimetidine or an antacid? Results of a long-term study].
Topics: Adult; Antacids; Cimetidine; Female; Gastrectomy; Gastrins; Guanidines; Humans; Jejunal Diseases; Ma | 1982 |
[Two-year study on incidence of ulcer recurrence following proglumide therapy. A comparative study].
Topics: Cimetidine; Duodenal Ulcer; Female; Follow-Up Studies; Glutamine; Humans; Male; Middle Aged; Proglum | 1981 |
Carbenoxolone maintenance in cimetidine-healed patients.
Topics: Adult; Carbenoxolone; Cimetidine; Duodenal Ulcer; Glycyrrhetinic Acid; Guanidines; Humans; Middle Ag | 1980 |
Healing of gastric body ulcer with gastroprotective versus antisecretory treatment.
Topics: Adult; Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Follow-Up Studies; Helicobacter Infections; | 1995 |
Effects of cigarette smoking on duodenal ulcer healing and relapse rate.
Topics: Adolescent; Adult; Aged; Bismuth; Cimetidine; Colloids; Duodenal Ulcer; Female; Humans; Male; Middle | 1994 |
Effects of Helicobacter pylori infection on healing and recurrence of gastric ulcers.
Topics: Adult; Cimetidine; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; | 1995 |
Histological maturity of healed duodenal ulcer and ulcer recurrence after treatment with omeprazole or cimetidine.
Topics: Adolescent; Adult; Aged; Cimetidine; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; | 1994 |
Pyloric channel ulcers: management and three-year follow-up.
Topics: Cimetidine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Peptic Ulcer; Pyloric Antrum; Rani | 1995 |
Prognostic factors in upper gastrointestinal bleeding.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cimetidine; Duodenal Ulcer; Female | 1994 |
Prevention of peptic ulcer relapse.
Topics: Cimetidine; Double-Blind Method; Humans; Life Tables; Peptic Ulcer; Pirenzepine; Proportional Hazard | 1994 |
Selection of patients for treatment of duodenal ulcer infected with Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Fe | 1994 |
Cimetidine in the treatment of interstitial cystitis.
Topics: Administration, Oral; Biopsy; Chronic Disease; Cimetidine; Cystitis; Female; Follow-Up Studies; Huma | 1994 |
Role of free radical scavengers in the management of refractory duodenal ulceration. A new approach.
Topics: Adult; Aged; Alcohol Drinking; Allopurinol; Cimetidine; Dimethyl Sulfoxide; Double-Blind Method; Dru | 1994 |
The relationship between Helicobacter pylori and oxygen-derived free radicals in the mechanism of duodenal ulceration.
Topics: Adult; Aged; Allopurinol; Cimetidine; Dimethyl Sulfoxide; Duodenal Ulcer; Female; Free Radical Scave | 1993 |
Sulphydryl-containing agents and the prevention of duodenal ulcer relapse.
Topics: Adolescent; Adult; Aged; Cimetidine; Cysteine; Double-Blind Method; Duodenal Ulcer; Female; Humans; | 1993 |
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cimetidine; Cross-Over Studies; Cyclosp | 1996 |
Effect of the eradication of Helicobacter pylori on duodenal ulcer healing and ulcer relapse: randomized controlled study in Japan.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cimetidine; Drug Administration Schedu | 1996 |
[Clinical and experimental studies of yuyang powder in treatment of peptic ulcer].
Topics: Adolescent; Adult; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Drugs, Chinese Herbal; Duodenal Ulc | 1996 |
The management of refractory gastric ulcer using H2-receptor antagonists.
Topics: Adult; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Female; Gastric Mucosa; Gastroscopy; Histamin | 1996 |
Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cimetidine; Cross-Over S | 1997 |
A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Blood Transfusion; Cimetidine; Female | 1998 |
Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Topics: Adult; Aged; Biopsy; Cimetidine; Drug Administration Schedule; Drug Resistance; Enzyme Inhibitors; E | 1997 |
Assessment of decisions in the treatment of Helicobacter pylori-related duodenal ulcer: a cost-effectiveness study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; China; Cimetidine; Cost-Be | 1999 |
Maintenance treatment of recurrent peptic ulcer by cimetidine.
Topics: Adult; Aged; Chronic Disease; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Fol | 1978 |
Prevention by bedtime cimetidine of duodenal-ulcer relapse.
Topics: Adult; Child; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Duodenal U | 1978 |
Very long-term treatment of peptic ulcer with cimetidine.
Topics: Cimetidine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule | 1978 |
Duodenal erosions during cimetidine therapy.
Topics: Cimetidine; Duodenal Ulcer; Esophagitis, Peptic; Guanidines; Humans; Recurrence; Syndrome | 1979 |
Cimetidine in bleeding peptic ulcer.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Follow-Up Studies; Guanid | 1979 |
[Endoscopic control of the course of duodenal ulcer after a 4-week treatment with cimetidine (proceedings)].
Topics: Cimetidine; Clinical Trials as Topic; Drug Evaluation; Duodenal Ulcer; Endoscopy; Guanidines; Humans | 1977 |
Cimetidine treatment of duodenal ulceration: short term clinical trial and maintenance study.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guanidines | 1978 |
Long term cimetidine in the management of severe duodenal ulcer dyspepsia.
Topics: Adult; Chronic Disease; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; D | 1978 |
Cimetidine in the treatment of duodenal ulcer: review and commentary.
Topics: Antacids; Cimetidine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Duodenal Ulcer; Gu | 1978 |
Prophylactic effect of cimetidine in duodenal ulcer disease.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guan | 1978 |
Cimetidine for recurrent ulcer after vagotomy or gastrectomy: a randomised controlled trial.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Gastrectomy; Guanidines; Humans; Recurrence; S | 1978 |
Cimetidine for ulcers recurring after gastric surgery.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Female; Guanidines; Humans; Male; Middle Aged; Pe | 1978 |
[Cimetidine, II. Therapeutic trials].
Topics: Cimetidine; Clinical Trials as Topic; Drug Evaluation; Duodenal Ulcer; Esophagitis, Peptic; Gastroin | 1978 |
Peptic ulceration and its correlation with symptoms.
Topics: Carbenoxolone; Chronic Disease; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Duodenum; Endo | 1978 |
Cimetidine: an advance in gastric ulcer treatment?
Topics: Adult; Aged; Carbenoxolone; Cimetidine; Clinical Trials as Topic; Female; Follow-Up Studies; Glycyrr | 1978 |
The pharmacology of peptic ulcer disease.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Carbenoxolone; Cimetidine; Clinical Trials as Topic; Costs and | 1979 |
Long-term treatment with cimetidine.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; | 1978 |
Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration.
Topics: Chronic Disease; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; | 1979 |
Prophylactic effect of cimetidine in gastric ulcer patients.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Gua | 1979 |
Medical treatment of duodenal ulcer.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Citrates; Clinical Trials as Topic; Dose-Response Rela | 1979 |
Cimetidine in anastomotic ulceration after partial gastrectomy.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Gastrectomy; Guanidines; | 1979 |
Long-term cimetidine in duodenal ulcer disease.
Topics: Alcohol Drinking; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Endosco | 1979 |
Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guanidines | 1979 |
Prevention of duodenal ulcer relapse by cimetidine: a one-year double-blind trial.
Topics: Adult; Antacids; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Endoscop | 1979 |
Controlled trial of cimetidine in upper gastrointestinal haemorrhage.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Gastrointestinal Hem | 1979 |
[Long-term treatment of recurrent duodenal ulcer with cimetidine. A controlled trial of the effects of 1 year's medication].
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Guanidines; Humans; Male; | 1979 |
Cimetidine and the gastric surgeon.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Guanidines; H | 1979 |
Maintenance treatment of duodenal ulcer patients with a single bedtime dose of cimetidine.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guan | 1979 |
Short- and long-term treatment with cimetidine in peptic ulcer disease and the pharmacokinetics of cimetidine.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Endoscopy; Female; Fiber Optic Tec | 1979 |
[Prevention of duodenal ulcer recurrence with cimetidine (author's transl)].
Topics: Adult; Aged; Cimetidine; Double-Blind Method; Duodenal Ulcer; Female; Guanidines; Humans; Male; Midd | 1979 |
Cimetidine in the prevention of gastric ulcer relapse.
Topics: Aged; Cimetidine; Double-Blind Method; Evaluation Studies as Topic; Guanidines; Humans; Middle Aged; | 1979 |
Cimetidine in the treatment of gastric ulcer: review and commentary.
Topics: Antacids; Cimetidine; Guanidines; Hospitalization; Humans; Pain; Recurrence; Stomach Ulcer | 1978 |
[Cimetidine in the treatment of duodenal ulcer (author's transl)].
Topics: Adult; Aged; Ambulatory Care; Cimetidine; Double-Blind Method; Duodenal Ulcer; Female; Guanidines; H | 1978 |
Effect of drug therapy on the relapse of peptic ulcers. 1st communication: the effect of acute therapy.
Topics: Cimetidine; Double-Blind Method; Humans; Peptic Ulcer; Pirenzepine; Recurrence; Stomach Ulcer | 1992 |
Effect of drug therapy on the relapse of peptic ulcers. 2nd communication: the effect of maintenance therapy.
Topics: Cimetidine; Double-Blind Method; Humans; Peptic Ulcer; Pirenzepine; Recurrence | 1992 |
Sulphydryl-containing agents stimulate the healing of duodenal ulceration in man.
Topics: Adolescent; Adult; Aged; Cimetidine; Cysteine; Double-Blind Method; Drug Therapy, Combination; Duode | 1992 |
Predictors of relapse in peptic ulcer.
Topics: Adult; Cimetidine; Double-Blind Method; Female; Humans; Male; Peptic Ulcer; Pirenzepine; Prognosis; | 1992 |
Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment.
Topics: Adult; Antacids; Cimetidine; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Hong Kong; Hospita | 1992 |
Allopurinol and dimethyl sulfoxide improve treatment outcomes in smokers with peptic ulcer disease.
Topics: Adult; Alcohol Drinking; Allopurinol; Cimetidine; Dimethyl Sulfoxide; Double-Blind Method; Duodenal | 1992 |
Ulcer relapse rates following initial treatment with bismuth subnitrate as compared with cimetidine respectively.
Topics: Adult; Aged; Antacids; Bismuth; Cimetidine; Endoscopy, Gastrointestinal; Female; Helicobacter pylori | 1991 |
[Effectiveness of maintenance treatment with cimetidine in duodenal ulcer. Variations depending on the risk group].
Topics: Adolescent; Adult; Aged; Cimetidine; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Middle | 1991 |
Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Female; H | 1991 |
Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine.
Topics: Adult; Aged; Amantadine; Bromocriptine; Cimetidine; Duodenal Ulcer; Famotidine; Female; Humans; Male | 1991 |
[Effectiveness of combination treatment with H1-(Tavegyl) and H2-antagonists (Altramet) in chronic/chronically-recurrent urticaria].
Topics: Adult; Chronic Disease; Cimetidine; Clemastine; Double-Blind Method; Female; Humans; Male; Middle Ag | 1990 |
Controlled trial of pyrogastrone and cimetidine in the treatment of reflux oesophagitis.
Topics: Alginates; Aluminum Hydroxide; Antacids; Bicarbonates; Carbenoxolone; Cimetidine; Drug Combinations; | 1990 |
Oxygen-derived free radicals and the prevention of duodenal ulcer relapse: a new approach.
Topics: Allopurinol; Cimetidine; Dimethyl Sulfoxide; Duodenal Ulcer; Female; Follow-Up Studies; Free Radical | 1990 |
Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime.
Topics: Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combination; Female; Helicobacter Infections; Helico | 1990 |
Helicobacter pylori and associated duodenal ulcer.
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Cimetidine; Drug Therapy, Combination; Duodenal Ul | 1990 |
Five-year cimetidine maintenance trial for peptic ulcer disease. A clinical and endocrinologic approach.
Topics: Adult; Aged; Chi-Square Distribution; Cimetidine; Endoscopy, Gastrointestinal; Hormones; Humans; Mid | 1990 |
Comparison of cimetidine and pirenzepine in the healing and maintenance of remission in duodenal ulcer.
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Pirenzepine; Recurrence; | 1990 |
Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: a prospective, randomized, controlled trial.
Topics: Aged; Cimetidine; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Peptic Ulcer Hemorrhage; Prospe | 1989 |
Gastric ulcer recurrence: follow-up of a double-blind, placebo-controlled trial.
Topics: Adult; Aged; Antacids; Cimetidine; Clinical Trials as Topic; Cohort Studies; Double-Blind Method; Fe | 1989 |
[Ranitidine and cimetidine in long-term (2 years) maintenance therapy of chronic gastric ulcer].
Topics: Adult; Aged; Chronic Disease; Cimetidine; Clinical Trials as Topic; Female; Gastroscopy; Humans; Mal | 1989 |
Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.
Topics: Adult; Campylobacter; Campylobacter Infections; Chronic Disease; Cimetidine; Clinical Trials as Topi | 1989 |
Relapse of gastric ulcers after healing with omeprazole and cimetidine. A double-blind follow-up study. Danish Omeprazole Study Group.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Follow-U | 1989 |
Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: a light and electron microscopy study.
Topics: Adolescent; Adult; Aged; Cimetidine; Duodenal Ulcer; Humans; Intestinal Mucosa; Microscopy, Electron | 1989 |
Differences in mucosal appearances and in relapse rates in duodenal ulceration treated with sucralfate or cimetidine.
Topics: Adolescent; Adult; Aged; Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Duodenum; Female; | 1989 |
Maintenance cimetidine for up to three years.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Humans; Peptic Ulcer; Recurrence; Time Fa | 1985 |
Prevention of ulcer recurrence--medical vs surgical treatment. The physician's view.
Topics: Cimetidine; Clinical Trials as Topic; Cost-Benefit Analysis; Duodenal Ulcer; Histamine H2 Antagonist | 1985 |
The natural history of peptic ulcer disease: the influence of H2-antagonist treatment.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Follow-Up Studies; Histamine H2 Antagonists; H | 1986 |
Duodenal ulcer. Who should have long-term maintenance therapy?
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male | 1987 |
Controlled trial of endoscopic sclerosis in bleeding peptic ulcers.
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Endoscopy; Epinephrine; Humans; M | 1987 |
H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
Topics: Cimetidine; Clinical Trials as Topic; Costs and Cost Analysis; Duodenal Ulcer; Famotidine; Histamine | 1987 |
Recurrence of duodenal ulcer after medical treatment.
Topics: Adult; Aged; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal | 1988 |
[Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
Topics: Adult; Aged; Bismuth; Campylobacter; Campylobacter Infections; Cimetidine; Clinical Trials as Topic; | 1988 |
[Pirenzepine and cimetidine in the treatment of duodenal ulcer].
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Gast | 1988 |
[Ranitidine, cimetidine and surgery in the treatment of duodenal ulcer. A short and long term comparative multicenter controlled study on 164 cases].
Topics: Adult; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Duodenum; Female; Follow-Up Studies; Ga | 1988 |
Antacid maintenance therapy in the prevention of duodenal ulcer relapse.
Topics: Adult; Aged; Aluminum; Aluminum Hydroxide; Antacids; Cimetidine; Clinical Trials as Topic; Double-Bl | 1988 |
Overview of misoprostol clinical experience.
Topics: Alprostadil; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Diarrhea; Duodenal Ulcer; Fema | 1986 |
Results of short- and long-term cimetidine treatment in patients with juxtapyloric ulcers, with special reference to gastric acid and pepsin secretion.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Gastric Acid; Humans; Pepsin A; Recurrence; St | 1986 |
The effect of maintenance cimetidine therapy on the medical, social and economic aspects of patients with chronic gastric ulcers. A placebo-controlled prospective study.
Topics: Adult; Aged; Chronic Disease; Cimetidine; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Bl | 1986 |
Medical therapy for chronic reflux esophagitis. Long-term follow-up.
Topics: Barrett Esophagus; Chronic Disease; Cimetidine; Clinical Trials as Topic; Drug Therapy, Combination; | 1987 |
Long term management of duodenal ulcer in general practice: how best to use cimetidine?
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Cimetidine; Drug Administration Schedule; Duodenal Ulce | 1988 |
Prostaglandins, smoking, and duodenal ulcer relapse.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Prostagland | 1988 |
Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
Topics: Anti-Ulcer Agents; Campylobacter; Campylobacter Infections; Cimetidine; Clinical Trials as Topic; Do | 1988 |
Presenting characteristics of patients with duodenal ulcer and outcome of medical treatment in controlled clinical trials using cimetidine and diethylamine persilate to treat ulcer attack and diethylamine persilate and placebo to prevent relapses.
Topics: Adult; Anti-Ulcer Agents; Benzenesulfonates; Cimetidine; Clinical Trials as Topic; Double-Blind Meth | 1987 |
Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Recu | 1987 |
Prevention of duodenal ulcer occurrence. Double-blind comparison of ranitidine and cimetidine.
Topics: Adult; Aged; Chronic Disease; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ul | 1987 |
Psychological group counseling for the prevention of ulcer relapses. A controlled randomized trial in duodenal and prepyloric ulcer disease.
Topics: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Counseling; Duodenal Ulcer; Female; H | 1987 |
Recurrent ulcer after treatment with cimetidine or sucralfate.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Follow-Up | 1987 |
Treatment of peptic ulcers--acid reduction or cytoprotection?
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Gastric Acid; H | 1987 |
Sucralfate versus cimetidine in duodenal ulcer--factors affecting healing and relapse.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Follow-Up Studies; Humans; Random Allocation; | 1987 |
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
Topics: Adolescent; Adult; Antacids; Chronic Disease; Cimetidine; Clinical Trials as Topic; Double-Blind Met | 1986 |
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Femal | 1986 |
Results of long-term treatment with cimetidine.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Middle Aged; Recurrence; Risk; Stomach | 1986 |
Prevention of relapse with various antiulcer drugs.
Topics: Adult; Antacids; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle | 1986 |
[Clinical approval of dalargin--a new agent for treating peptic ulcer].
Topics: Adolescent; Adult; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Enkephalin, Leucine; Enk | 1986 |
Treatment of duodenal ulcer with low-dose antacids.
Topics: Adolescent; Adult; Aged; Antacids; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Hum | 1986 |
Long-term low-dose antacid versus cimetidine therapy in the treatment of duodenal ulcer recurrence.
Topics: Antacids; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Duod | 1986 |
Effect of cimetidine on prognosis after simple closure of perforated duodenal ulcer.
Topics: Aged; Aged, 80 and over; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Middle Aged; | 1987 |
Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission.
Topics: Adult; Cimetidine; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Patient Compliance; Pros | 1987 |
Effects of cimetidine on the healing and recurrence of duodenal ulcers and gastric ulcers.
Topics: Cimetidine; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Recurrence; Stom | 1986 |
Deduction of duodenal ulcer recurrence by healing with cimetidine plus sulpiride.
Topics: Adult; Cimetidine; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Humans; Male; Mid | 1986 |
Is maximal acid output useful in identifying relapsing duodenal ulcer patients?
Topics: Adult; Aged; Benzodiazepinones; Cimetidine; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Acid; | 1985 |
A comparison of cimetidine and sucralfate in the treatment of bleeding peptic ulcers.
Topics: Aluminum; Blood Transfusion; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Peptic Ul | 1985 |
Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial.
Topics: Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Clinical Trials as Topic; Double-Blind M | 1985 |
Treatment of duodenal ulcers using pirenzepine and cimetidine: controlled trial.
Topics: Adult; Anti-Ulcer Agents; Benzodiazepinones; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; F | 1985 |
[Maintenance therapy of ulcer disease. Comparative multicenter study of sucralfate, cimetidine and a placebo].
Topics: Aluminum; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; M | 1985 |
Incompletely and completely healed duodenal ulcers' outcome in maintenance treatment: a double blind controlled study.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Endoscopy; Female; | 1985 |
[Recurrence of chronic duodenal ulcer following initial therapy with pirenzepine or cimetidine].
Topics: Adult; Aged; Benzodiazepinones; Chronic Disease; Cimetidine; Clinical Trials as Topic; Duodenal Ulce | 1985 |
The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome.
Topics: Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Prospective Studies | 1985 |
[Ranitidine and cimetidine in the prevention of recurrence of duodenal ulcer. A randomized, double-blind, multicenter comparative study].
Topics: Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Huma | 1985 |
Final report on the United States Multicenter Trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Follow-Up Studies | 1985 |
Misoprostol, a synthetic prostaglandin E1 analogue, in the treatment of duodenal ulcers. A double-blind, cimetidine-controlled trial.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Ma | 1985 |
Overview of clinical safety with misoprostol.
Topics: Alprostadil; Anti-Ulcer Agents; Biopsy; Cimetidine; Clinical Trials as Topic; Diarrhea; Double-Blind | 1985 |
Overview of clinical safety with misoprostol.
Topics: Alprostadil; Anti-Ulcer Agents; Biopsy; Cimetidine; Clinical Trials as Topic; Diarrhea; Double-Blind | 1985 |
Overview of clinical safety with misoprostol.
Topics: Alprostadil; Anti-Ulcer Agents; Biopsy; Cimetidine; Clinical Trials as Topic; Diarrhea; Double-Blind | 1985 |
Overview of clinical safety with misoprostol.
Topics: Alprostadil; Anti-Ulcer Agents; Biopsy; Cimetidine; Clinical Trials as Topic; Diarrhea; Double-Blind | 1985 |
Long term cimetidine therapy for the prevention of recurring peptic ulcer: a multicenter study.
Topics: Cimetidine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule | 1985 |
199 other studies available for cimetidine and Recrudescence
| Article | Year |
|---|---|
Cimetidine-induced lactic acidosis and acute pancreatitis.
Topics: Acidosis, Lactic; Acute Disease; Cimetidine; Diabetes Mellitus, Type 2; Drug Interactions; Female; G | 2010 |
Persistent molluscum contagiosum. Case study in a 6-year-old girl with asthma and eczema.
Topics: Asthma; Child; Cimetidine; Cryotherapy; Curettage; Diagnosis, Differential; Eczema; Female; Histamin | 2002 |
History in our lifetime: the changing nature of refractory duodenal ulcer in the era of histamine H2 receptor antagonists.
Topics: Adult; Cimetidine; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; D | 2003 |
[Long term management of peptic ulcer. Indications and side effects of drug therapy compared with surgical procedure].
Topics: Aluminum; Antacids; Cimetidine; Humans; Peptic Ulcer; Ranitidine; Recurrence; Sucralfate; Vagotomy | 1984 |
Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers.
Topics: Adolescent; Adult; Alcohol Drinking; Anti-Ulcer Agents; Benzodiazepinones; Blood Group Antigens; Cim | 1984 |
The fate of asymptomatic recurrences of duodenal ulcer.
Topics: Cimetidine; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prog | 1984 |
Cimetidine and course of peptic ulcer disease.
Topics: Cimetidine; Guanidines; Humans; Peptic Ulcer; Recurrence | 1980 |
[Modified H2 receptor blockers in ulcus therapy].
Topics: Cimetidine; Furans; Histamine H2 Antagonists; Humans; Peptic Ulcer; Ranitidine; Recurrence; Time Fac | 1982 |
Failure of histamine H2-receptor antagonist therapy in Zollinger-Ellison syndrome.
Topics: Adult; Aged; Cimetidine; Female; Furans; Gastric Acidity Determination; Histamine H2 Antagonists; Hu | 1983 |
[A new H2-receptor antagonist in the treatment of gastrointestinal diseases].
Topics: Anti-Ulcer Agents; Chemical Phenomena; Chemistry; Cimetidine; Duodenal Ulcer; Furans; Gastroesophage | 1982 |
[Drug therapy and prevention of acute upper gastrointestinal hemorrhage].
Topics: Acute Disease; Anti-Ulcer Agents; Cimetidine; Esophageal and Gastric Varices; Gastrointestinal Hemor | 1983 |
Failure of proximal gastric vagotomy for duodenal ulcer resistant to cimetidine.
Topics: Adult; Aged; Cimetidine; Drug Resistance; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; M | 1984 |
Failure of proximal gastric vagotomy for duodenal ulcer resistant to cimetidine.
Topics: Cimetidine; Drug Resistance; Duodenal Ulcer; Humans; Recurrence; Vagotomy; Vagotomy, Proximal Gastri | 1984 |
Vagotomy for cimetidine resistant ulcers.
Topics: Cimetidine; Drug Resistance; Duodenal Ulcer; Follow-Up Studies; Humans; Male; Recurrence; Smoking; V | 1984 |
[Severe, recurrent and reversible neutropenia induced by cimetidine].
Topics: Agranulocytosis; Cimetidine; Female; Humans; Middle Aged; Neutropenia; Recurrence | 1984 |
Review of ulcer treatment: role of ranitidine.
Topics: Cimetidine; Humans; Patient Acceptance of Health Care; Peptic Ulcer; Ranitidine; Recurrence | 1983 |
[Clinical and cost benefit study of cimetidine for duodenal ulcer].
Topics: Cimetidine; Cost-Benefit Analysis; Duodenal Ulcer; Guanidines; Humans; Length of Stay; Recurrence | 1983 |
[Hyperselective vagotomy for duodenal ulcer. Apropos of 200 cases].
Topics: Adolescent; Adult; Aged; Cimetidine; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Humans | 1984 |
[Recurrent postoperative ulcers. Prospective endoscopic and therapeutic study].
Topics: Adult; Aged; Cimetidine; Female; Gastroscopy; Humans; Male; Middle Aged; Peptic Ulcer; Postoperative | 1984 |
Determinants of ulcer healing.
Topics: Cimetidine; Humans; Peptic Ulcer; Recurrence; Wound Healing | 1984 |
Cimetidine in gastric ulcer: a note of caution.
Topics: Chronic Disease; Cimetidine; Humans; Recurrence; Stomach Ulcer | 1984 |
Cimetidine in recurrent genital herpes simplex infection.
Topics: Adult; Cimetidine; Female; Herpes Genitalis; Humans; Male; Middle Aged; Recurrence | 1984 |
Approaches to the long-term treatment of duodenal ulcer disease.
Topics: Age Factors; Chronic Disease; Cimetidine; Duodenal Ulcer; Female; Gastric Mucosa; Humans; Male; Recu | 1984 |
Relapse rates of duodenal ulcer healed with concentrated antacid or cimetidine.
Topics: Adult; Aged; Aluminum Hydroxide; Cimetidine; Drug Combinations; Duodenal Ulcer; Female; Follow-Up St | 1984 |
Relapse rates following initial ulcer healing with sucralfate and cimetidine.
Topics: Aluminum; Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Follow-Up Studies; Humans; Recurrence; Stom | 1983 |
[Comparative evaluation of the efficacy of monotherapy with cimetidine and combined treatment of the recurrent duodenal ulcer].
Topics: Adult; Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Humans; Male; Recur | 1983 |
[Indications for the surgical treatment of peptic ulcer from the internal medicine viewpoint].
Topics: Aged; Antacids; Cimetidine; Diagnosis, Differential; Duodenal Ulcer; Emergencies; Female; Humans; Ma | 1983 |
Recurrent fever of unknown origin with cimetidine-induced interstitial nephritis.
Topics: Aged; Cimetidine; Fever of Unknown Origin; Humans; Male; Nephritis; Recurrence | 1983 |
[Short-term effects of cimetidine in patients with bleeding duodenal ulcer. Presentation of cases].
Topics: Adult; Aged; Antacids; Cimetidine; Duodenal Ulcer; Female; Gastrectomy; Humans; Male; Middle Aged; P | 1983 |
Pirenzepine in long-term therapy for duodenal ulcer.
Topics: Adult; Aged; Antacids; Anti-Ulcer Agents; Benzodiazepinones; Cimetidine; Duodenal Ulcer; Female; Hum | 1983 |
[Choline antagonists and antacids for the treatment of peptic ulcer].
Topics: Antacids; Cimetidine; Humans; Parasympatholytics; Peptic Ulcer; Recurrence | 1984 |
Unsuccessful cimetidine treatment of peptic ulcer: analysis of the factors involved.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Anti-Inflammatory Agents; Child; Cimetidine; Female; Gast | 1984 |
Duodenal ulcer perforation whilst on cimetidine therapy.
Topics: Adult; Aged; Chronic Disease; Cimetidine; Drainage; Duodenal Ulcer; Female; Humans; Male; Middle Age | 1984 |
[Frequency of surgery in ulcer after the introduction of H2-blockers].
Topics: Cimetidine; Humans; Recurrence; Statistics as Topic; Stomach Ulcer; Surgical Procedures, Operative | 1984 |
The effect of cimetidine and propantheline on the symptoms of a patient with systemic mastocytosis.
Topics: Adult; Celiac Disease; Cimetidine; Diarrhea; Female; Gastric Juice; Guanidines; Humans; Pepsin A; Pr | 1980 |
Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate?
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence | 1982 |
Cimetidine and gastric carcinoma.
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence; Stomach Neoplasms | 1983 |
Vagotomy in the cimetidine era.
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence; Vagotomy; Vagotomy, Proximal Gastric | 1983 |
Cimetidine for recurrent ulcer after gastric surgery.
Topics: Adult; Aged; Cimetidine; Dyspepsia; Female; Follow-Up Studies; Gastrectomy; Gastrins; Gastroscopy; G | 1983 |
[Predictive value of preoperative acidity tests in ulcer recurrence after supraselective vagotomy].
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Female; Gastric Acidity Determination; Humans; Male; Middle | 1983 |
Surgery or cimetidine? I. Comparison of two plans of treatment: operation or repeated cimetidine.
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; Patient Part | 1983 |
Surgery or cimetidine? II. Comparison of two plans of treatment: operation or cimetidine given as a low maintenance dose.
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; Recurrence | 1983 |
[Prevention of duodenal ulcer recurrences after treatment with cimetidine preparations].
Topics: Adolescent; Adult; Chlordiazepoxide; Cimetidine; Double-Blind Method; Doxepin; Drug Combinations; Du | 1982 |
Relapse rates after initial ulcer healing with sucralfate and cimetidine.
Topics: Aluminum; Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Follow-Up Studies; Guanidines; Humans; Recu | 1982 |
[Treatment of stomach ulcer (review)].
Topics: Aluminum; Antacids; Benzodiazepinones; Bismuth; Carbenoxolone; Cimetidine; Feeding Behavior; Gastrec | 1982 |
Frequency of relapses in duodenal ulcer patients treated with cimetidine during symptomatic periods.
Topics: Cimetidine; Duodenal Ulcer; Female; Gastric Juice; Guanidines; Humans; Male; Pain; Prognosis; Recurr | 1980 |
The value of the new interpretation of the insulin test in predicting duodenal ulcer relapse after treatment with cimetidine.
Topics: Cimetidine; Duodenal Ulcer; Female; Gastric Juice; Guanidines; Humans; Insulin; Male; Recurrence; Ri | 1980 |
Cimetidine versus surgery for recurrent ulcer after gastric surgery.
Topics: Adult; Aged; Chronic Disease; Cimetidine; Drug Evaluation; Duodenal Ulcer; Female; Follow-Up Studies | 1982 |
The role of surgery in peptic ulcer.
Topics: Cimetidine; Duodenal Ulcer; Gastrectomy; Humans; Life Expectancy; Peptic Ulcer; Recurrence; Stomach | 1982 |
[Cimetidine in the treatment of recurrent ulcer after partial gastrectomy].
Topics: Adult; Aged; Cimetidine; Female; Follow-Up Studies; Gastrectomy; Guanidines; Humans; Male; Middle Ag | 1982 |
Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks.
Topics: Aspirin; Chlorpheniramine; Cimetidine; Epinephrine; Humans; Hypotension; Infusions, Parenteral; Pros | 1982 |
[Long-term drug therapy of peptic ulcer].
Topics: Cimetidine; Guanidines; Humans; Peptic Ulcer; Recurrence | 1982 |
[Long-term cimetidine therapy dose not change the recurrence frequency of ulcer].
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence; Time Factors | 1982 |
[Cimetidine with suture ligature of ulcers - an alternative in the treatment of severe acute gastroduodenal ulcer hemorrhage].
Topics: Acute Disease; Cimetidine; Female; Germany, West; Guanidines; Humans; Ligation; Male; Middle Aged; P | 1982 |
Problems in the medical treatment of peptic ulcers.
Topics: Cimetidine; Endoscopy; Humans; Iatrogenic Disease; Pain Management; Peptic Ulcer; Recurrence | 1980 |
Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers.
Topics: Cimetidine; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Gastrins; Guanidines; Humans; Middle Aged; | 1980 |
Interstitial nephritis and cimetidine.
Topics: Cimetidine; Fever; Guanidines; Humans; Male; Middle Aged; Nephritis, Interstitial; Recurrence | 1981 |
An aggressive approach to the medical management of peptic ulcer disease.
Topics: Acute Disease; Antacids; Cimetidine; Duodenal Ulcer; Endoscopy; Fiber Optic Technology; Humans; Pept | 1981 |
[Cimetidine: solution to a problem?].
Topics: Cimetidine; Drug Evaluation; Guanidines; Humans; Peptic Ulcer; Recurrence; Risk | 1981 |
[Treatment of recurrent ulcer with cimetidine].
Topics: Adult; Aged; Cimetidine; Female; Guanidines; Humans; Male; Middle Aged; Postoperative Complications; | 1981 |
[Surgical vagotomy should as a rule be preferred to cimetidine in the treatment of recurrent duodenal ulcer].
Topics: Cimetidine; Duodenal Ulcer; Humans; Recurrence; Vagotomy | 1981 |
Cimetidine and the control of pain in chronic relapsing pancreatitis.
Topics: Chronic Disease; Cimetidine; Guanidines; Humans; Pain; Pancreatitis; Recurrence | 1981 |
[Medical treatment of duodenal peptic ulcer (author's transl)].
Topics: Antacids; Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Gastric Acid; Humans; Recurrence | 1981 |
The modern treatment of peptic ulceration.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Guanidines; Humans; Peptic Ulcer; Recu | 1981 |
Stomal and recurrent ulceration: medical or surgical management?
Topics: Cimetidine; Gastrectomy; Guanidines; Humans; Peptic Ulcer; Postoperative Complications; Recurrence; | 1980 |
Long-term management of duodenal ulcer.
Topics: Adult; Antacids; Cimetidine; Denmark; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; | 1980 |
Cimetidine treatment of recurrent ulcer after vagotomy.
Topics: Adult; Aged; Cimetidine; Female; Gastric Juice; Guanidines; Humans; Male; Middle Aged; Recurrence; R | 1980 |
Treating duodenal ulcer: antacids or cimetidine?
Topics: Antacids; Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence | 1980 |
Cimetidine: appropriate uses in 1980.
Topics: Cimetidine; Duodenal Ulcer; Esophagitis, Peptic; Guanidines; Humans; Recurrence; Stomach Ulcer; Zoll | 1980 |
[Strategy in the treatment of gastroduodenal ulcerous disease].
Topics: Cimetidine; Duodenal Ulcer; Humans; Recurrence; Stomach Ulcer; Vagotomy | 1980 |
Intermittent treatment of duodenal ulcer with cimetidine.
Topics: Aged; Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Guanidines; Humans; Male; Recurrence | 1980 |
[Surgical treatment of ulcers].
Topics: Cimetidine; Duodenal Ulcer; Gastrectomy; Humans; Recurrence; Stomach Ulcer; Vagotomy | 1980 |
[Cimetidine treatment of anastomotic ulcers (author's transl)].
Topics: Adult; Aged; Cimetidine; Female; Gastrectomy; Gastric Acid; Guanidines; Humans; Male; Middle Aged; P | 1980 |
Management and long-term results in patients with two-thirds gastrectomy and stomal ulcer.
Topics: Antacids; Bombesin; Calcium; Cimetidine; Female; Gastrectomy; Gastric Acid; Gastrins; Humans; Male; | 1981 |
Cimetidine and peptic ulcer.
Topics: Cimetidine; Guanidines; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Recurrence | 1980 |
Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine.
Topics: Acetates; Acetic Acid; Alanine; Animals; Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combination; M | 1995 |
Clinical usefulness of cimetidine treatment for acute relapse in intermittent porphyria.
Topics: Acute Disease; Adult; Aminolevulinic Acid; Blood Glucose; Cimetidine; Coproporphyrins; Feces; Humans | 1995 |
Late outcome of bleeding gastric ulcer. Five to eight years' follow-up.
Topics: Aged; Cimetidine; Electrocoagulation; Female; Follow-Up Studies; Hemostasis, Endoscopic; Humans; Mal | 1994 |
[Asynchronous bilateral hydronephrosis in retroperitoneal fibrosis with an interval of 44 months].
Topics: Cimetidine; Duodenal Ulcer; Follow-Up Studies; Humans; Hydronephrosis; Male; Middle Aged; Postoperat | 1995 |
Can the H2 receptor antagonists change the natural history of duodenal ulcer disease?
Topics: Cimetidine; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Ranitidine; Recurrence | 1994 |
[Zollinger-Ellison syndrome].
Topics: Adult; Cimetidine; Combined Modality Therapy; Diagnosis, Differential; Female; Gastrectomy; Humans; | 1994 |
Recurrent fever, leukocytosis, and abdominal pain due to treatment with cimetidine.
Topics: Abdominal Pain; Aged; Cimetidine; Fever; Humans; Leukocytosis; Male; Recurrence; Stomach Ulcer | 1994 |
Efficacy of twice-daily cimetidine in pediatric peptic ulcer.
Topics: Adolescent; Child; Child, Preschool; Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Femal | 1994 |
Refractoriness of eucapnic hyperventilation-induced bronchoconstriction in rabbits.
Topics: Airway Resistance; Animals; Asthma, Exercise-Induced; Bronchial Provocation Tests; Carbon Dioxide; C | 1994 |
[Hemostasis and treatment of stress hemorrhage in the upper gastrointestinal tract of trauma patients].
Topics: Cimetidine; Combined Modality Therapy; Croatia; Endoscopy, Gastrointestinal; Gastrectomy; Humans; Mi | 1993 |
[Study on omeprazole 20 mg twice weekly in prevention of duodenal ulcer relapse].
Topics: Adolescent; Adult; Aged; Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; M | 1993 |
Peptic esophageal stricture: is surgery still necessary?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cimetidine; Combined Modality Therapy | 1996 |
[Influence of KU-1257 on the recurrence and relapse of acetic acid-induced chronic gastric ulcers in rats].
Topics: Acetates; Acetic Acid; Animals; Chronic Disease; Cimetidine; Histamine H2 Antagonists; Male; Phenylu | 1996 |
Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor.
Topics: Acetic Acid; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agen | 1997 |
[Effect of lafutidine, a novel antiulcer agent, on healing and relapse of acetic acid-induced gastric ulcer in rats].
Topics: Acetamides; Acetic Acid; Animals; Anti-Ulcer Agents; Cimetidine; Dose-Response Relationship, Drug; F | 1998 |
The outcome of bleeding duodenal ulcer in the era of H2 receptor antagonist therapy.
Topics: Abdominal Pain; Adult; Aged; Cimetidine; Combined Modality Therapy; Duodenal Ulcer; Female; Follow-U | 1998 |
Common variable immunodeficiency following Epstein-Barr virus infection.
Topics: Adjuvants, Immunologic; Adult; Agammaglobulinemia; Antibodies, Viral; Bacterial Infections; Cimetidi | 1997 |
Cost-benefit analysis of medicinal treatment for gastric ulcers. Long-term model including healing and recurrence.
Topics: Cimetidine; Cost-Benefit Analysis; Gefarnate; Humans; Japan; Models, Theoretical; Polyenes; Recurren | 1985 |
Giant gastric ulcer: its natural history and outcome in the H2RA era.
Topics: Adult; Aged; Biopsy; Cause of Death; Cimetidine; Female; Follow-Up Studies; Gastric Mucosa; Histamin | 1999 |
Maintenance cimetidine in prevention of peptic-ulcer relapse.
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence | 1978 |
Misleading response of malignant gastric ulcers to cimetidine.
Topics: Adult; Cell Transformation, Neoplastic; Cimetidine; Diagnosis, Differential; Diagnostic Errors; Fema | 1978 |
Cimetidine maintenance: How long?
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence; Time Factors | 1978 |
Antibiotics for legionnaires' disease.
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence | 1978 |
Cimetidine for duodenal ulcer.
Topics: Cimetidine; Drug Administration Schedule; Drug Evaluation; Duodenal Ulcer; Guanidines; Humans; Recur | 1978 |
Peptic ulcer: antacids or cimetidine?
Topics: Antacids; Cimetidine; Cost-Benefit Analysis; Drug Interactions; Duodenal Ulcer; Evaluation Studies a | 1979 |
[Cimetidine's place in the treatment of duodenal and stomach ulcer].
Topics: Cimetidine; Duodenal Ulcer; Gastrointestinal Agents; Guanidines; Humans; Infertility, Male; Male; Re | 1979 |
Histamine blocker effective vs severe gastric bleeding.
Topics: Cimetidine; Gastric Mucosa; Gastritis; Gastrointestinal Hemorrhage; Guanidines; Humans; Recurrence; | 1977 |
Histamine receptor-bearing T lymphocytes in patients with allergy, autoimmune disease, or recurrent infection.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Child; Child, Preschool; Cimetidine; Female; Humans; H | 1978 |
Cimetidine and duodenal ulcer.
Topics: Cimetidine; Duodenal Ulcer; Gastric Juice; Guanidines; Humans; Recurrence | 1979 |
[Cimetidine versus antacids].
Topics: Antacids; Cimetidine; Costs and Cost Analysis; Duodenal Ulcer; Guanidines; Humans; Peptic Ulcer; Rec | 1979 |
[Depressive syndrome during cimetidine treatment].
Topics: Cimetidine; Confusion; Depression; Guanidines; Humans; Male; Middle Aged; Psychoses, Substance-Induc | 1979 |
H2-antagonists in the treatment of recurrent ulceration after vagotomy.
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Female; Guanidines; Humans; Male; Metiamide; Middle Aged; R | 1979 |
[Recurrence following short-time cimetidine therapy].
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence | 1979 |
Treatment of peptic ulcer in the cimetidine era.
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence; Stomach Ulcer | 1979 |
The influence of cimetidine on current surgical treatment of peptic ulceration.
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Guanidines; Humans; Middle Aged; Peptic Ulcer; Recurrence; | 1979 |
Prevention of duodenal ulcer relapse by cimetidine.
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence | 1979 |
The Andrew Melrose Lecture 1977 Part II. Therapeutic considerations in peptic ulcer.
Topics: Aged; Antacids; Bed Rest; Carbenoxolone; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Huma | 1979 |
[Progress in functional gastric surgery for stomach ulcers].
Topics: Adolescent; Adult; Aged; Child; Cimetidine; Duodenal Ulcer; Gastrectomy; Gastric Juice; Gastrins; Hu | 1979 |
[Cimetidine and pirenzepin--practical aspects of modern therapy for peptic ulcer (author's transl)].
Topics: Anti-Ulcer Agents; Benzodiazepinones; Cimetidine; Guanidines; Humans; Peptic Ulcer; Piperazines; Rec | 1979 |
Cimetidine treatment of recurrent ulcer.
Topics: Adult; Aged; Cimetidine; Drug Evaluation; Duodenal Ulcer; Female; Gastric Juice; Gastrins; Guanidine | 1979 |
Preventing recurrence of ulcers.
Topics: Carbenoxolone; Cimetidine; Humans; Peptic Ulcer; Recurrence | 1977 |
Recurrence of ulcer after cimetidine therapy.
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Male; Middle Aged; Recurrence | 1977 |
Role of cimetidine in gastrointestinal disease: present status and future potential.
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Peptic Ulcer Hemorrhage; Recurrence; Stomach Ulcer | 1978 |
Relapse of duodenal ulceration after cimetidine treatment.
Topics: Cimetidine; Duodenal Ulcer; Gastric Mucins; Guanidines; Humans; Recurrence | 1978 |
[Conservative and surgical therapy of peptic ulcer].
Topics: Antacids; Cimetidine; Duodenal Ulcer; Humans; Methods; Peptic Ulcer; Peptic Ulcer Hemorrhage; Peptic | 1978 |
Placebos, antacids and cimetidine for duodenal ulcer.
Topics: Antacids; Cimetidine; Drug Evaluation; Duodenal Ulcer; Guanidines; Humans; Placebos; Recurrence; Tim | 1978 |
Maintenance treatment of duodenal ulcer with cimetidine.
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence | 1978 |
Maintenance treatment of duodenal ulcer with cimetidine.
Topics: Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Guanidines; Humans; Recurrence | 1978 |
Maintenance treatment of duodenal ulcer with cimetidine.
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence | 1978 |
[Cimetidine--a revolution in ulcer therapy?].
Topics: Cimetidine; Duodenal Ulcer; Guanidines; Humans; Recurrence | 1978 |
The use of cimetidine in severe duodenal ulceration.
Topics: Adult; Cimetidine; Drug Evaluation; Duodenal Ulcer; Guanidines; Humans; Recurrence; Remission, Spont | 1977 |
[Epoch in the treatment of duodenal ulcer].
Topics: Cimetidine; Duodenal Ulcer; Humans; Recurrence; Time Factors; Vagotomy | 1977 |
[The local treatment of patients with a duodenal ulcer with millimeter-range electromagnetic radiation].
Topics: Adolescent; Adult; Cimetidine; Combined Modality Therapy; Duodenal Ulcer; Evaluation Studies as Topi | 1992 |
[Drug therapy of peptic ulcers].
Topics: Alkalies; Cimetidine; Drug Therapy, Combination; Histamine H2 Antagonists; Humans; Parasympatholytic | 1991 |
[Maintenance treatment of peptic ulcer and their problems].
Topics: Cimetidine; Histamine H2 Antagonists; Humans; Peptic Ulcer; Recurrence | 1991 |
Cimetidine and zinc sulfate in the treatment of relapsing herpetic infections.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Cimetidine; Drug Therapy, Combination; Female; Herp | 1991 |
Is antral gastrin important in the resistance of duodenal ulcers to H2 receptor antagonists or in recurrent ulceration after highly selective vagotomy?
Topics: Adolescent; Adult; Aged; Cimetidine; Drug Resistance; Duodenal Ulcer; Female; Gastrins; Histamine H2 | 1990 |
The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist.
Topics: Adolescent; Adult; Aged; Cimetidine; Duodenal Ulcer; Duodenoscopy; Famotidine; Female; Histamine H2 | 1990 |
[Recurrence of peptic ulcers and risk factors].
Topics: Campylobacter; Cimetidine; Duodenal Ulcer; Female; Gastric Mucosa; Humans; Male; Recurrence; Risk Fa | 1991 |
Cimetidine use and gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antacids; Case-Control Studies; Cimetidine; Esophagitis, Pe | 1990 |
High doses of ranitidine in maintenance therapy of duodenal ulcer patients.
Topics: Cimetidine; Duodenal Ulcer; Famotidine; Humans; Ranitidine; Recurrence; Smoking | 1990 |
Maintenance therapy of duodenal and gastric ulcer with H2-receptor antagonists.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cimetidine; Duodenal Ulcer; Gastrointestinal Hemorrhage; Hu | 1990 |
Effect of N-(3-aminopropionyl)-L-histidinato zinc (Z-103) on healing and hydrocortisone-induced relapse of acetic acid ulcers in rats with limited food-intake-time.
Topics: Acetates; Animals; Anti-Ulcer Agents; Carnosine; Chlorides; Cimetidine; Diet; Eating; Gastric Mucosa | 1990 |
Duodenal ulcer relapse after eradication of Campylobacter pylori.
Topics: Anti-Ulcer Agents; Campylobacter; Cimetidine; Duodenal Ulcer; Humans; Organometallic Compounds; Recu | 1989 |
Duodenal ulcer relapse after eradication of Campylobacter pylori.
Topics: Anti-Ulcer Agents; Campylobacter; Cimetidine; Duodenal Ulcer; Humans; Organometallic Compounds; Recu | 1989 |
Natural history of Campylobacter pylori in duodenal ulceration treated with an H2-antagonist.
Topics: Adult; Campylobacter; Campylobacter Infections; Cimetidine; Duodenal Ulcer; Female; Gastric Mucosa; | 1989 |
[Effectiveness of sucralfate in the treatment of gastric ulcer in women during menopause--comparison with cimetidine].
Topics: Adult; Cimetidine; Female; Humans; Menopause; Middle Aged; Recurrence; Stomach Ulcer; Sucralfate | 1989 |
[Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1989 |
Chronic duodenal ulcer in children: clinical observation and response to treatment.
Topics: Adolescent; Antacids; Child; Chronic Disease; Cimetidine; Duodenal Ulcer; Female; Humans; Male; Recu | 1989 |
Maintenance cimetidine instead of surgery for duodenal ulcer: the first decade.
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recur | 1989 |
Cimetidine versus ranitidine.
Topics: Alcohol Drinking; Cimetidine; Duodenal Ulcer; Duodenoscopy; Humans; Patient Compliance; Ranitidine; | 1985 |
Drinking and smoking when taking H2-antagonists.
Topics: Alcohol Drinking; Cimetidine; Humans; Peptic Ulcer; Ranitidine; Recurrence; Smoking | 1985 |
Cimetidine and ranitidine.
Topics: Cimetidine; Duodenal Ulcer; Humans; Patient Compliance; Ranitidine; Recurrence | 1985 |
Duodenitis and ulcer healing.
Topics: Cimetidine; Duodenal Ulcer; Duodenitis; Humans; Recurrence | 1985 |
Prophylaxis against repeated radiocontrast media reactions in 857 cases. Adverse experience with cimetidine and safety of beta-adrenergic antagonists.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anaphylaxis; Cimetidine; Contrast Media; Diphenhydra | 1985 |
Hereditary haemorrhagic telangiectasia: the use of H2 receptor antagonist in symptomatic gastric telangiectasia.
Topics: Aged; Cimetidine; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Male; Pedigree; Rec | 1985 |
Repeat chemonucleolysis.
Topics: Adolescent; Adult; Anaphylaxis; Chymopapain; Cimetidine; Female; Follow-Up Studies; Histamine H1 Ant | 1986 |
[The role of surgery in the comparison of peptic ulcer before and after the advent of H2 receptor blockers in the light of our experience].
Topics: Cimetidine; Duodenal Ulcer; Histamine H1 Antagonists; Hospitalization; Humans; Recurrence; Stomach U | 1987 |
[Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; intermittent and long-term administration].
Topics: Cimetidine; Drug Administration Schedule; Histamine H2 Antagonists; Humans; Peptic Ulcer; Ranitidine | 1988 |
[Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
Topics: Cimetidine; Gastric Acid; Histamine H2 Antagonists; Humans; Peptic Ulcer; Ranitidine; Recurrence | 1988 |
[Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; inhibitors of initiating factors causing peptic ulcer].
Topics: Cimetidine; Histamine H2 Antagonists; Humans; Peptic Ulcer; Pirenzepine; Ranitidine; Recurrence | 1988 |
Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
Topics: Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Middle Aged; Parotitis; Ranitidine | 1988 |
The progressive Zollinger-Ellison syndrome in multiple endocrine neoplasia.
Topics: Adult; Apudoma; Cimetidine; Follow-Up Studies; Gastrectomy; Gastrinoma; Humans; Male; Middle Aged; M | 1988 |
Response to "H2-receptor antagonists and duodenal ulcer recurrence".
Topics: Cimetidine; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Ranitidine; Recurrence | 1988 |
Resistant duodenal ulcer: when, why and what to do?
Topics: Aged; Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Male; Omepraz | 1988 |
-id reaction associated with chronic Trichophyton rubrum infection: flare-up induced by cimetidine.
Topics: Cimetidine; Drug Eruptions; Humans; Male; Middle Aged; Recurrence; Tinea | 1987 |
The clinical aspect of retained gastric antrum.
Topics: Adult; Aged; Cimetidine; Female; Follow-Up Studies; Gastrectomy; Gastric Juice; Humans; Iatrogenic D | 1986 |
[3-year long-term therapy of recurrent duodenal ulcer with 400 mg cimetidine nocte].
Topics: Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Humans; Long-Term Care; Recurrence | 1987 |
[Therapy and prevention of peptic lesions by prostaglandins].
Topics: Alprostadil; Anti-Ulcer Agents; Cimetidine; Enprostil; Humans; Misoprostol; Peptic Ulcer; Prostaglan | 1987 |
Highly selective vagotomy and duodenal ulcers that fail to respond to H2 receptor antagonists.
Topics: Adolescent; Adult; Aged; Cimetidine; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Middle | 1988 |
[Reflections on cimetidine treatment of ulcers].
Topics: Cimetidine; Duodenal Ulcer; Humans; Recurrence | 1988 |
Management of recurrent duodenal ulcer disease.
Topics: Anti-Ulcer Agents; Cimetidine; Drainage; Duodenal Ulcer; Follow-Up Studies; Humans; Methods; Recurre | 1988 |
Ranitidine-induced granulocytopenia: recurrence with cimetidine administration.
Topics: Agranulocytosis; Bone Marrow; Cimetidine; Humans; Male; Middle Aged; Ranitidine; Recurrence | 1988 |
[Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; combination therapy of inhibitors of attacking factors and synergistic drugs for protective factors in peptic ulcer--selection of drug combinations and clinical effi
Topics: Anti-Ulcer Agents; Cimetidine; Drug Administration Schedule; Drug Therapy, Combination; Gefarnate; H | 1988 |
Personality and duodenal ulcer response to antisecretory treatment.
Topics: Cimetidine; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Personality; Personality Inventory; P | 1987 |
Relapse of duodenal ulcers after cimetidine treatment: idol "indecently" assaulted?
Topics: Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Humans; Recurrence | 1986 |
Ulcer recurrences following initial ulcer healing with sucralfate or cimetidine.
Topics: Cimetidine; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Smokin | 1987 |
Clinical markers of slow healing and relapsing gastric ulcer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cimetidine; Female; Humans; Male; Middle Aged; Peptic U | 1987 |
Survey of ulcer-recurrence risk factors associated with long-term cimetidine prescribing.
Topics: Adult; Cimetidine; Drug Prescriptions; Humans; Male; Medication Errors; Middle Aged; Peptic Ulcer; R | 1987 |
The refractory ulcer.
Topics: Cimetidine; Drug Resistance; Duodenal Ulcer; Humans; Recurrence; Stomach Ulcer; Wound Healing | 1987 |
Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
Topics: Cimetidine; Duodenal Ulcer; Gastric Mucosa; Humans; Intestinal Mucosa; Organometallic Compounds; Pep | 1987 |
[Proximal gastric vagotomy in duodenal ulcer. III: Postoperative symptomatology, results and treatment of recurrence].
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Follow-Up Studies; Humans; Middle Aged; Recurrence; Vagotom | 1986 |
[Experience with objective evaluation of the action of cimetidine--a blocker of histamine-H2 receptors--in patients with peptic ulcer of the duodenum].
Topics: Anti-Ulcer Agents; Atropine; Choline; Cimetidine; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Gast | 1986 |
Recurrent myalgias associated with cimetidine.
Topics: Cimetidine; Duodenal Ulcer; Female; Humans; Middle Aged; Muscles; Nephritis, Interstitial; Pain; Rec | 1986 |
Low dose maintenance treatment with cimetidine in duodenal ulcer: intermediate-term results.
Topics: Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Humans; Probability; Recurrence | 1986 |
Effects of trimoprostil on healing and recurrence of acetic acid-induced gastric ulcer in rats.
Topics: Acetates; Acetic Acid; Animals; Anti-Ulcer Agents; Cimetidine; Dinoprostone; Gastric Acid; Male; Pro | 1986 |
[Postoperative recurrent peptic ulcer].
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Postoperative Complicati | 1986 |
Cytoprotective agents and ulcer relapse.
Topics: Aluminum; Antacids; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Humans; Organometallic Compo | 1985 |
Peptic ulcer disease: current management in the elderly.
Topics: Aged; Aluminum; Antacids; Antidepressive Agents; Cimetidine; Constipation; Diarrhea; Duodenal Ulcer; | 1985 |
Mucosal protective agents in the long-term management of gastric ulcer.
Topics: Aluminum; Aluminum Hydroxide; Anti-Ulcer Agents; Bismuth; Carbenoxolone; Chronic Disease; Cimetidine | 1985 |
Cytoprotective agents and ulcer relapse.
Topics: Aluminum; Anti-Ulcer Agents; Cimetidine; Drug Evaluation; Duodenal Ulcer; Gastric Mucosa; Humans; In | 1985 |
Relapse of duodenal ulcers after cimetidine treatment: idol 'indecently' assaulted?
Topics: Cimetidine; Duodenal Ulcer; Humans; Recurrence | 1985 |
Duodenal ulcer disease.
Topics: Anti-Ulcer Agents; Benzimidazoles; Campylobacter Infections; Cimetidine; Duodenal Ulcer; Duodenoscop | 1985 |
[Choice of operative method in duodenal ulcer and hemophilia A].
Topics: Adult; Blood Transfusion; Cimetidine; Combined Modality Therapy; Duodenal Ulcer; Factor VIII; Hemoph | 1985 |
Proximal gastric vagotomy in patients resistant to cimetidine.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cimetidine; Duodenal Ulcer; Female; Humans; Male; Middle A | 1985 |
A comparative study of two regimens of cimetidine in the treatment of active duodenal ulcer.
Topics: Adult; Aged; Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle | 1985 |
Effect of cimetidine on healing and surgical treatment of gastric ulcers.
Topics: Antacids; Cimetidine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Recurrence; Retr | 1985 |
Maintenance therapy: a two year comparison between Caved-S and cimetidine treatment in the prevention of symptomatic gastric ulcer recurrence.
Topics: Adult; Aluminum Hydroxide; Anti-Ulcer Agents; Bismuth; Cimetidine; Drug Combinations; Female; Glycyr | 1985 |
Cimetidine and recurrent genital herpes.
Topics: Administration, Oral; Adult; Cimetidine; Female; Herpes Genitalis; Humans; Male; Middle Aged; Recurr | 1985 |
[Emergency surgery of complicated gastroduodenal ulcers: risk factors and results].
Topics: Age Factors; Aged; Cimetidine; Emergencies; Humans; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrha | 1985 |
[Recurrence following ulcer operation: aggressive ulcer disease or inadequate therapy?].
Topics: Antacids; Cimetidine; Duodenal Ulcer; Gastrectomy; Humans; Postoperative Complications; Ranitidine; | 1985 |
[Symptomless and complicated peptic ulcer as an extreme clinical form of ulcer disease: consequences for choice between conservative and surgical therapy].
Topics: Cimetidine; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Postoperative Complications; Prognosis; R | 1985 |
Cigarette smoking and duodenal ulcer.
Topics: Adult; Cimetidine; Duodenal Ulcer; Humans; Male; Middle Aged; Recurrence; Smoking; Time Factors | 1985 |
[H2 antagonists and surgery of peptic ulcer].
Topics: Cimetidine; Humans; Peptic Ulcer; Ranitidine; Recurrence | 1985 |